"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL190333";"RWJ-67657";"1.0";"425.51";"1";"5.12";"RWJ-67657";"OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058802";"Antiprotozoal activity against 1 MOI Toxoplasma gondii RH tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL563826";"";"None";"279.32";"0";"2.75";"12";"CCOC(=O)c1csc(N/N=C(\C)c2ccco2)n1";"IC50";"'='";"49000.0";"nM";"4.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL570070";"";"None";"267.35";"0";"2.91";"2";"CCOC(=O)c1csc(N/N=C2/CCCC2C)n1";"IC50";"'='";"130000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL281803";"";"None";"354.41";"0";"2.15";"13o";"COc1ccc(OC)c(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23227";"";"None";"313.79";"0";"3.37";"16c";"Cc1cc(Cl)ccc1NCc1ccc2nc(N)nc(N)c2c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL561632";"";"None";"319.34";"0";"2.49";"20";"CCOC(=O)c1csc(N/N=C/c2ccc3c(c2)OCO3)n1";"IC50";"'='";"479000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1262128";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-TOU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"9.25";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262129";"Antimicrobial activity against Toxoplasma gondii NED infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.11";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262120";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1995-ABE harboring DHPS Ex5, A587V mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.04";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262124";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2005-HAG infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.04";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262133";"Antimicrobial activity against Toxoplasma gondii isolate GUY-2003-MEL harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex2, 145 sil Val mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL418995";"AMINEPTINE";"4.0";"337.46";"0";"4.50";"Amineptine";"O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213630";"";"None";"448.35";"0";"3.71";"SI,4";"NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)C34CC5CC(CC(C5)C3)C4)c(Cl)c2)c1N";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213006";"";"None";"255.34";"0";"4.33";"SI,8";"COc1ccc(Sc2cc3ccccc3[nH]2)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL296401";"";"None";"374.42";"0";"2.38";"6n";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)N(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"Diflunisal";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"Diclofenac";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL51";"KETANSERIN";"4.0";"395.43";"0";"2.42";"Ketanserin";"O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"chlorpromazine";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"hydroxyurea";"NC(=O)NO";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"Artemisinin";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"22900.0";"nM";"4.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL50514";"";"None";"384.44";"0";"2.16";"5a";"COc1cc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL807752";"Inhibitory concentration of Toxoplasma gondii cells in human embryonic lung cells with minimum essential medium";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"lung";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1126886";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1047657";"Antitoxoplasmic activity against Toxoplasma gondii PRU-betaGal tachyzoite after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1154711";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL938667";"Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival after 18 hrs by [5,6-13H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1155031";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulphadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL224182";"";"None";"329.48";"1";"5.70";"HDQ";"CCCCCCCCCCCCc1cc(=O)c2ccccc2n1O";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL918334";"Inhibition of Toxoplasma gondii lacZ-transfected RH strain in in human foreskin fibroblasts assessed as beta galactosidase activity after 30 hrs by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1147098";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL265419";"";"None";"387.85";"0";"3.65";"2j";"O=C(O)CC1S/C(=N\N=C\c2cccc(Cl)c2)N(c2ccccc2)C1=O";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL254322";"";"None";"315.40";"0";"3.02";"1n";"COc1ccc(/C=N/NC(=S)Nc2ccccc2)c(OC)c1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"Tocainide";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"Phenelzine";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"Phenacetin";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"Nadolol";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"Nabumetone";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL517199";"XIPAMIDE";"4.0";"354.81";"0";"2.56";"Xipamide";"Cc1cccc(C)c1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"Mexiletine";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"14a";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"Aspirin";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"Aminosalicylic acid";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL495";"ALPROSTADIL";"4.0";"354.49";"0";"3.48";"Alprostadil";"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"20400.0";"nM";"4.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"23400.0";"nM";"4.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"15200.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL524800";"";"None";"370.40";"0";"2.04";"(+/-)-21";"O=C1C=CC2(C=C1)CC[C@]1(C[C@@H](O)C[C@@]3(CCC4(C=CC(=O)C=C4)O3)O1)O2";"IC50";"'='";"173.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL526287";"";"None";"461.64";"0";"4.85";"(+/-)-15e";"CCCCCCN(CCCCCC)C(=O)C[C@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL450565";"";"None";"588.87";"2";"8.83";"(+/-)-15d";"CCCCCCCCCCC(CCCCCCCCCC)OC(=O)C[C@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"4450.0";"nM";"5.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL498298";"";"None";"434.57";"0";"4.54";"(+/-)-15b";"CCCCCCCCCCOC(=O)C[C@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"341.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL525723";"";"None";"336.38";"0";"1.81";"(+/-)-15a";"CCCOC(=O)C[C@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL498345";"";"None";"418.62";"1";"6.17";"(-)-aculeatin A";"CCCCCCCCCCCCC[C@@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"436.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Cipro";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223457";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL575569";"CIPROFLOXACIN ETHYL ESTER";"None";"359.40";"0";"2.06";"2";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223458";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL23495";"";"None";"365.32";"0";"2.22";"12r";"COc1ccc(C(F)(F)F)cc1NCc1cnc2nc(N)nc(N)c2n1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL22543";"";"None";"341.38";"0";"1.24";"12o";"COc1ccc(OC)c(N(C)Cc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL607568";"";"None";"335.86";"0";"3.20";"95";"Cc1cccc(C)c1Sc1[nH]c2nc(N)nc(N)c2c1C.Cl";"IC50";"'='";"2150.0";"nM";"5.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1071430";"Antimicrobial activity against Toxoplasma gondii infected in HEL cells assessed as inhibition of parasite growth by [3H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HEL";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156926";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3308090";"";"";""
"CHEMBL293522";"";"None";"297.14";"0";"0.02";"8";"O=P(O)(O)C(O)(CCc1cccnc1)P(=O)(O)O";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL278041";"SB-202190";"None";"331.35";"0";"4.65";"SB-202190";"Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058803";"Antiprotozoal activity against 5 MOI Toxoplasma gondii Me49 tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058802";"Antiprotozoal activity against 1 MOI Toxoplasma gondii RH tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL190333";"RWJ-67657";"1.0";"425.51";"1";"5.12";"RWJ-67657";"OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058803";"Antiprotozoal activity against 5 MOI Toxoplasma gondii Me49 tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL261432";"";"None";"287.19";"0";"0.59";"22";"O=P(O)(O)C(CNC1CCCCC1)P(=O)(O)O";"IC50";"'='";"57300.0";"nM";"4.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL260601";"";"None";"317.26";"0";"1.62";"19";"CCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL1774300";"";"None";"761.01";"2";"2.73";"21";"C=CO[C@]1(C)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"40000.0";"nM";"4.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774453";"";"None";"831.14";"2";"3.85";"31";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CC2CCCCC2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL834";"PAMIDRONIC ACID";"4.0";"235.07";"1";"-1.66";"5";"NCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"35600.0";"nM";"4.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL592044";"";"None";"297.24";"0";"2.35";"MMV000340";"Br.CCn1c2c(c(=N)c3c1CCC3)CCCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL319952";"";"None";"367.49";"0";"3.73";"MMV009015";"O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCCCC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589922";"";"None";"291.82";"0";"3.07";"MMV665812";"CCc1ccc(CNCC(O)c2ccccc2)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"hydroxyurea";"NC(=O)NO";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL436828";"";"None";"443.48";"0";"3.03";"2o";"COc1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc(OC)c1OC";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL404134";"";"None";"371.39";"0";"3.14";"2g";"O=C(O)CC1S/C(=N\N=C\c2ccc(F)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL251897";"";"None";"324.24";"0";"4.31";"1c";"S=C(N/N=C/c1ccc(Cl)cc1Cl)Nc1ccccc1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL254119";"";"None";"298.42";"0";"3.07";"1i";"CN(C)c1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL403382";"";"None";"273.34";"0";"3.15";"1f";"Fc1ccccc1/C=N/NC(=S)Nc1ccccc1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL403381";"";"None";"269.37";"0";"3.32";"1e";"Cc1cccc(/C=N/NC(=S)Nc2ccccc2)c1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL23146";"";"None";"314.37";"0";"1.89";"12g";"COc1ccc(SCc2cnc3nc(N)nc(N)c3n2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1096206";"";"None";"467.48";"0";"4.84";"22";"CC1=C(C(=O)NCc2ccc(C(F)(F)F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095738";"";"None";"431.60";"1";"6.17";"8";"CC1=C(c2nc(C3CCCCC3)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095536";"";"None";"349.45";"0";"4.12";"1";"CC1=C(c2nccs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"Etacrinic acid";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"Fluocinolone(acetonide)";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"Mianserin";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"L-Dopa";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"ketoprofen";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL307739";"IBOPAMINE";"2.0";"307.39";"0";"2.57";"Ibopamine";"CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1765148";"";"None";"359.34";"0";"2.79";"25";"CCCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL1774298";"";"None";"820.08";"2";"2.65";"19";"CCNC(=O)N1C[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"59000.0";"nM";"4.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"3";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL53903";"";"None";"360.42";"0";"3.27";"5b";"COc1ccc(NCc2cnc3nc(N)nc(N)c3c2C)c2ccccc12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL23787";"";"None";"318.79";"0";"2.53";"12j";"Nc1nc(N)c2nc(CSc3ccc(Cl)cc3)cnc2n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL403162";"";"None";"255.35";"0";"3.01";"1a";"S=C(N/N=C/c1ccccc1)Nc1ccccc1";"IC50";"'='";"5000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253040";"";"None";"383.43";"0";"3.01";"2m";"COc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"5000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL561037";"";"None";"281.38";"0";"3.30";"6";"CCOC(=O)c1csc(N/N=C2/CCCC(C)C2)n1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL550430";"";"None";"295.39";"0";"3.22";"9";"CCOC(=O)c1csc(N/N=C(\C)c2cccs2)n1";"IC50";"'='";"37000.0";"nM";"4.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL550351";"";"None";"281.38";"0";"3.30";"7";"CCOC(=O)c1csc(NN=C2CCC(C)CC2)n1";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL564991";"";"None";"281.38";"0";"3.44";"8";"CCOC(=O)c1csc(NN=C2CCCCCC2)n1";"IC50";"'='";"77000.0";"nM";"4.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL553425";"";"None";"253.33";"0";"2.66";"1";"CCOC(=O)c1csc(NN=C2CCCC2)n1";"IC50";"'='";"92000.0";"nM";"4.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL572118";"";"None";"239.30";"0";"2.43";"24";"CC1CCC/C1=N/Nc1nc(C(=O)O)cs1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1222857";"";"None";"428.85";"0";"2.79";"6b";"NS(=O)(=O)c1cc([N+](=O)[O-])c(N(CCCCl)Cc2ccccc2)c([N+](=O)[O-])c1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"6i";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL600305";"";"None";"657.77";"2";"7.70";"MMV007695";"COc1ccc(C(C)=O)cc1N1C(=O)C2C(C1=O)C1(c3ccccc3)C(=O)C2(c2ccccc2)C(c2ccc(C)cc2)=C1c1ccc(C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL475813";"";"None";"275.31";"0";"3.33";"MMV011099";"Cc1cc(Nc2ccc3ccccc3c2)n2ncnc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601771";"";"None";"621.78";"2";"7.23";"MMV007160";"Cc1ccc(N2C3c4ccccc4N(S(=O)(=O)c4ccc(C)cc4)C2c2ccccc2N3S(=O)(=O)c2ccc(C)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL605281";"";"None";"434.56";"1";"5.33";"MMV000662";"COc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591641";"";"None";"380.36";"0";"4.82";"MMV000620";"CC(O)(c1ccc(Cl)cc1)C(CN1CCCCC1)c1ccccc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584841";"";"None";"338.28";"0";"4.62";"MMV665929";"CCCCNCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"Atenolol";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"Triamcinolone";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"19200.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL374858";"";"None";"613.82";"2";"5.38";"ZL3VS";"CC(C)C[C@H](/C=C/S(=O)(=O)c1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL917067";"Inhibition of Toxoplasma gondii 2F1 invasion in HFF cells by red/green invasion assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1142206";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"CHEMBL3307525";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"Amlodipine";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23584";"";"None";"347.45";"0";"3.94";"13c";"Cc1c(CSc2cccc3ccccc23)cnc2nc(N)nc(N)c12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23713";"";"None";"324.39";"0";"2.43";"13l";"COc1ccc(C)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL404134";"";"None";"371.39";"0";"3.14";"2g";"O=C(O)CC1S/C(=N\N=C\c2ccc(F)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL253105";"";"None";"371.39";"0";"3.14";"2f";"O=C(O)CC1S/C(=N\N=C\c2ccccc2F)N(c2ccccc2)C1=O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL252966";"";"None";"285.37";"0";"3.02";"1m";"COc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.07";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262123";"Antimicrobial activity against Toxoplasma gondii isolate TOU-1998-TRI infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.03";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262125";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1995-MAE infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL515063";"TENELLONE B";"None";"424.49";"0";"4.16";"3";"CC(C)=CCc1ccc(O)c(C=O)c1C(=O)c1cc(C)cc2c1OC(C(C)(C)O)CO2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL973902";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as beta-galactosidase activity after 5 days by whole cell assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158743";"1";"Scientific Literature";"J Nat Prod";"2005";"None";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"Amrinone";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213628";"";"None";"316.41";"0";"4.95";"SI,12";"CSc1c(Sc2ccc([N+](=O)[O-])cc2)[nH]c2ccccc12";"IC50";"'='";"28000.0";"nM";"4.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL95155";"TROVAFLOXACIN4";"None";"344.35";"0";"0.96";"SI, trovafloxacin4";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]12";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"Cimetidine";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"SID11111502";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"Lidocaine";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"Levamisole";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213583";"GESTODENE";"3.0";"310.44";"0";"3.66";"Gestodene";"C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"5";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"Hydrochlorothiazide";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1765145";"";"None";"295.17";"0";"0.46";"22";"O=P(O)(O)C(CNCc1ccccc1)P(=O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL1765149";"";"None";"373.37";"0";"3.18";"26";"CCCCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"6230.0";"nM";"5.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL23466";"";"None";"365.32";"0";"2.22";"12s";"COc1cc(NCc2cnc3nc(N)nc(N)c3n2)cc(C(F)(F)F)c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"Phenindione";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"Aceclofenac";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"Diazepam";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"Cytarabine";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL169901";"DEBRISOQUIN";"4.0";"175.24";"0";"0.94";"Debrisoquin";"N=C(N)N1CCc2ccccc2C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"Clenbuterol";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"SI, azepine1, trimethroprim";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213131";"";"None";"369.43";"0";"2.18";"SI, azepine3";"COc1cc(C(N)c2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL22677";"";"None";"331.83";"0";"3.44";"13j";"Cc1c(CSc2ccc(Cl)cc2)cnc2nc(N)nc(N)c12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4228822";"";"None";"385.47";"0";"4.08";"6a";"CN(C)c1ccc(-c2nc3ccccc3c(=O)n2CCc2ccc(O)cc2)cc1";"IC50";"'='";"112000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4077094";"";"None";"266.26";"0";"2.32";"4b";"O=c1[nH]c(-c2ccc3c(c2)OCO3)nc2ccccc12";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL152046";"";"None";"349.48";"0";"4.71";"6g";"CCCCCCn1c(-c2ccc(N(C)C)cc2)nc2ccccc2c1=O";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4225119";"";"None";"468.64";"1";"7.78";"6h";"CCCCCCCCCCn1c(-c2ccc(OCc3ccccc3)cc2)nc2ccccc2c1=O";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1774288";"";"None";"789.02";"2";"2.78";"6";"C=CCO/N=C1\[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"S-1(Sulfadiazine)";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL135400";"ZOPICLONE";"4.0";"388.82";"0";"1.57";"zopiclone";"CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"Bromhexine";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23963";"";"None";"378.36";"0";"3.14";"13s";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(C(F)(F)F)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"Domperidone";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"Digitoxin";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL11";"IMIPRAMINE";"4.0";"280.42";"0";"3.88";"Imipramine";"CN(C)CCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL896";"HYDROXYZINE";"4.0";"374.91";"0";"3.06";"Hydroxyzine";"OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1085";"ACETOPHENAZINE";"4.0";"411.57";"0";"3.49";"Acetophenazine";"CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23911";"";"None";"327.41";"0";"2.80";"13g";"COc1ccc(SCc2cnc3nc(N)nc(N)c3c2C)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1774304";"";"None";"851.13";"2";"4.64";"25";"C=CO[C@]1(C)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774297";"";"None";"839.12";"2";"4.13";"18";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774297";"";"None";"839.12";"2";"4.13";"18";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1013";"LORACARBEF ANHYDROUS";"4.0";"349.77";"0";"0.71";"Loracarbef";"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL32800";"FENOTEROL";"4.0";"303.36";"0";"2.06";"Fenoterol";"CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"Medroxyprogesterone";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"Chlordiacepoxide";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL454450";"BUTIBUFEN";"2.0";"220.31";"0";"3.46";"Butibufen";"CCC(C(=O)O)c1ccc(CC(C)C)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulphadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL403229";"";"None";"345.42";"0";"3.03";"1o";"COc1cc(/C=N/NC(=S)Nc2ccccc2)cc(OC)c1OC";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL970";"HALAZEPAM";"4.0";"352.74";"0";"4.09";"Halazepam";"O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1774289";"";"None";"839.08";"2";"3.79";"7";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774290";"";"None";"777.05";"2";"2.68";"9";"CCCN1C[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"hydroxyurea";"NC(=O)NO";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL1213251";"CLOBENZOREX";"2.0";"259.78";"0";"4.06";"Clobenzorex";"CC(Cc1ccccc1)NCc1ccccc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213594";"";"None";"275.38";"1";"5.47";"SI,10";"c1ccc2[nH]c(Sc3cccc4ccccc34)cc2c1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"28500.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"27700.0";"nM";"4.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"24200.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"26600.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"22200.0";"nM";"4.65";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL407221";"";"None";"247.12";"0";"-0.33";"23";"CC(C)NCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"69810.0";"nM";"4.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL406087";"";"None";"261.15";"0";"0.06";"15";"CCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"48670.0";"nM";"4.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL1213593";"";"None";"343.59";"0";"3.14";"SI,1";"O=C(O)COCCOCCOc1cc(Cl)c(Cl)cc1Cl";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213353";"PRIFINIUM BROMIDE";"2.0";"386.38";"1";"5.14";"Prifinium";"CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C.[Br-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"Piroxicam";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"Vinorelbine";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"nitrendipine";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"Trimethadione";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"Metoclopramide";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"Phenylbutazone";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1082607";"SALMETEROL XINAFOATE";"4.0";"603.76";"0";"4.11";"Salmeterol xinafoate";"O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1574";"PHENTERMINE";"4.0";"149.24";"0";"1.97";"Phentermine";"CC(C)(N)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"Azathioprine";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL370876";"";"None";"322.30";"0";"0.99";"3b";"O=C(O)CC1SC(N/N=C/c2ccc([N+](=O)[O-])cc2)=NC1=O";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'>'";"50.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262120";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1995-ABE harboring DHPS Ex5, A587V mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'>'";"50.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262119";"Antimicrobial activity against Toxoplasma gondii B1 harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"18.8";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262126";"Antimicrobial activity against Toxoplasma gondii isolate PSP-2005-MUP infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"4.9";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262131";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-DJO infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"6.52";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262134";"Antimicrobial activity against Toxoplasma gondii RH harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"16.85";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262127";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1998-TRA infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1214188";"TROVAFLOXACIN10";"None";"358.37";"0";"1.35";"SI, trovafloxacin10";"NCC12CC1CN(c1nc3c(cc1F)c(=O)c(C(=O)O)cn3C1CC1)C2";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL55886";"";"None";"283.11";"0";"-0.37";"3";"O=P(O)(O)C(O)(Cc1ccncc1)P(=O)(O)O";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL533017";"";"None";"309.82";"0";"3.80";"MMV020492";"CC1CN(C(=O)c2sc3ccccc3c2Cl)CC(C)O1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028043";"";"None";"341.33";"0";"0.31";"MMV306025";"CCn1nc(-c2ccc(C(=O)OC)cc2)nc2c(=O)n(C)c(=O)nc1-2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1623897";"";"None";"335.83";"0";"3.57";"MMV396632";"CCOc1c(Cl)cc(CNCC(O)c2ccccc2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591395";"";"None";"469.31";"0";"3.61";"MMV000356";"O=C(O)C(=O)O.Oc1ccc(Br)cc1CN1CCN(Cc2cccc(F)c2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028056";"";"None";"301.78";"0";"2.52";"MMV396704";"CN1CCN(c2ncnc3c2[nH]c2ccc(Cl)cc23)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547266";"";"None";"447.54";"1";"6.42";"MMV000720";"Cc1ccnc(NC(c2cccc(OCc3ccccc3)c2)c2ccc3cccnc3c2O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592123";"";"None";"425.96";"0";"4.84";"MMV000787";"CCCOCc1cc(CN2CCN(c3cccc(Cl)c3)CC2)c(O)c2ncccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028046";"";"None";"487.69";"1";"6.59";"MMV396652";"Cc1sc(NC(=O)c2ccccc2)c(C(c2cccs2)N2CCN(c3ccccc3)CC2)c1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586026";"";"None";"387.49";"1";"6.34";"MMV008160";"CN1C=C(c2ccc3ccccc3n2)C(c2c[nH]c3ccccc23)c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.18";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262122";"Antimicrobial activity against Toxoplasma gondii isolate TRS-2004-REV infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1223140";"";"None";"350.30";"0";"3.73";"18b";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"Travafloxacin";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"4.28";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262118";"Antimicrobial activity against Toxoplasma gondii ENT harboring DHPS Ex2, E474D/Ex3, 156 sil Leu/Ex4, R560K/Ex5, 580 sil Gly/A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1223065";"";"None";"335.28";"0";"4.15";"14b";"CCCN(CCC)c1c([N+](=O)[O-])cc([N+](=O)[O-])cc1C(F)(F)F";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1223141";"";"None";"378.35";"0";"4.51";"18c";"CCCCN(CCCC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL529732";"";"None";"571.68";"2";"7.18";"MMV666062";"Cc1ccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccccc3)=C2c2ccccc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581175";"";"None";"459.62";"0";"4.69";"MMV020439";"CCn1c(CN2CCN(Cc3ccccc3)CC2)nc2cc(NC(=O)c3cccs3)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL523237";"";"None";"292.33";"0";"3.24";"4";"COC1=CC(c2ccccc2)C(=O)C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL976724";"Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1157340";"1";"Scientific Literature";"J Nat Prod";"2006";"None";"";"";""
"CHEMBL301769";"";"None";"367.42";"0";"3.41";"SI, azepine6";"Nc1nc(N)c2nc(CN3c4ccccc4C=Cc4ccccc43)cnc2n1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL169";"URSOLIC ACID";"2.0";"456.71";"1";"7.09";"SI,3";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214244";"TROVAFLOXACIN3";"None";"430.39";"0";"2.20";"SI, trovafloxacin3";"Cc1c(F)c(N2C[C@@H]3[C@@H](N)[C@@H]3C2)nc2c1c(=O)c(C(=O)O)cn2-c1ccc(F)cc1F";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL646";"TRIAZOLAM";"4.0";"343.22";"0";"4.23";"Triazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"Triamterene";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"Perphenazine";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL485253";"METHYSERGIDE";"4.0";"353.47";"0";"1.94";"Methysergide";"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"Methyldopa";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1590";"PSEUDOEPHEDRINE";"4.0";"165.24";"0";"1.33";"Pseudoephedrine";"CN[C@@H](C)[C@@H](O)c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"Paracetamol";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL70";"MORPHINE";"4.0";"285.34";"0";"1.20";"Morphine";"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL730";"NITROGLYCERIN";"4.0";"227.08";"0";"-1.02";"14";"O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL236089";"";"None";"289.33";"0";"4.21";"2";"N#CSCCOc1ccc(Oc2cccc(F)c2)cc1";"IC50";"'='";"15800.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"30300.0";"nM";"4.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"23900.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"12800.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL3334538";"";"None";"373.48";"0";"4.70";"35B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1ccc2ccccc2c1";"IC50";"'='";"109000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334529";"";"None";"323.42";"0";"3.54";"26B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1ccccc1";"IC50";"'='";"61000.0";"nM";"4.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335817";"";"None";"289.40";"0";"3.29";"4B";"CCC(CC)=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL190228";"";"None";"335.43";"0";"4.69";"5";"CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL976724";"Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1157340";"1";"Scientific Literature";"J Nat Prod";"2006";"None";"";"";""
"CHEMBL4289911";"";"None";"543.62";"1";"4.75";"D11";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4ccc(C)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"365900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4292587";"";"None";"543.57";"1";"2.26";"B1";"COC(=O)CNC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"157000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4286066";"";"None";"499.56";"0";"2.52";"E4";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCC(=O)N3CCOCC3)c(OC)c2)cc1OC";"IC50";"'>='";"600000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL23288";"";"None";"356.39";"0";"1.83";"15c";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2)cc(OC)c1OC";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"6.26";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262122";"Antimicrobial activity against Toxoplasma gondii isolate TRS-2004-REV infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"5.35";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262133";"Antimicrobial activity against Toxoplasma gondii isolate GUY-2003-MEL harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex2, 145 sil Val mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.1";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262134";"Antimicrobial activity against Toxoplasma gondii RH harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"Propranolol";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"Flurbiprofen";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"Fluoxetine";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL652";"FLECAINIDE";"4.0";"414.35";"0";"3.44";"Flecainide";"O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL488914";"GLUCAMETACIN";"2.0";"518.95";"1";"0.60";"Glucametacine";"COc1ccc2c(c1)c(CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL3335721";"";"None";"209.23";"0";"0.83";"22A";"O=C1CS/C(=N/N=C\c2ccco2)N1";"IC50";"'='";"126000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"Clomipramine";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1072";"BUMETANIDE";"4.0";"364.42";"0";"3.04";"Bumetanide";"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"12400.0";"nM";"4.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"12400.0";"nM";"4.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1950475";"";"None";"526.68";"2";"6.13";"25";"COc1cc(CNCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1";"IC50";"'='";"1530.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4143599";"Antiparasitic activity against Toxoplasma gondii RH infected in HFF treated at 4 hrs post infection measured at 5 days post infection by crystal violet staining based method";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4138238";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL601497";"";"None";"394.52";"0";"4.80";"71; KGW7";"CC(C)(C)c1cc(C2C(C#N)=C(N)OC3=C2C(=O)CCC3)cc(C(C)(C)C)c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403520";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL527577";"";"None";"339.44";"0";"3.70";"72; KGW8";"CC(C)(C)C1=CC(=NNC(=O)c2ccncc2)C=C(C(C)(C)C)C1=O";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403520";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3637929";"";"None";"455.53";"1";"6.40";"MMV688509";"O=C(OCc1ccccc1)N1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL190228";"";"None";"335.43";"0";"4.69";"MMV688703";"CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL23705";"";"None";"354.41";"0";"2.15";"14e";"COc1ccc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c(OC)c1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"6.55";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262121";"Antimicrobial activity against Toxoplasma gondii ME49 infected in human MRC-5 cells infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'>'";"50.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262132";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2001-MAU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.05";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262127";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1998-TRA infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL535730";"";"None";"367.53";"1";"5.10";"MMV019406";"CCC1(C)CC(CCNCc2ccccc2O)(c2ccc(C)cc2)CCO1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.35";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262119";"Antimicrobial activity against Toxoplasma gondii B1 harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.15";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262123";"Antimicrobial activity against Toxoplasma gondii isolate TOU-1998-TRI infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.09";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262131";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-DJO infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL546162";"";"None";"322.45";"0";"4.08";"MMV009063";"OC(CNC1CCCCC1)Cn1c2ccccc2c2ccccc21";"IC50";"'='";"8720.0";"nM";"5.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1578";"ANISOTROPINE METHYLBROMIDE";"4.0";"362.35";"0";"3.52";"Octatropine(methylbromide)";"CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C.[Br-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213351";"PROPOXYPHENE";"4.0";"339.48";"0";"4.28";"Dextropropoxyphene, Propoxyphene";"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"Dexfenfluramine";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL487258";"CYNARIN";"None";"516.46";"3";"1.03";"Cynaricine";"O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL861";"MEPHENYTOIN";"4.0";"218.26";"0";"1.47";"Mephenytoin";"CCC1(c2ccccc2)NC(=O)N(C)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"Digoxin";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"6m";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1223064";"";"None";"306.39";"0";"1.70";"12";"CCCN(CCC)c1c(C#N)cc(S(N)(=O)=O)cc1C#N";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"18a";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1828281";"Antiparasitic activity against Toxoplasma gondii PRU tachyzoites harboring beta-Gal gene infected in human HFF cells after 72 hrs by microtiter plate based assay";"F";"BAO_0000219";"cell-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1821638";"1";"Scientific Literature";"Eur J Med Chem";"2011";"CHEMBL3307525";"";"";""
"CHEMBL195506";"";"None";"252.30";"0";"1.82";"2f";"CC/N=C(/S)N/N=C/c1ccccc1[N+](=O)[O-]";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL4278150";"";"None";"497.59";"0";"3.68";"E3";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCC(=O)N3CCCCC3)c(OC)c2)cc1OC";"IC50";"'='";"312600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4290307";"";"None";"529.59";"1";"4.45";"D6";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4ccccc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"135500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL564098";"";"None";"253.33";"0";"2.82";"28";"CC1CCC/C(=N/Nc2nc(C(=O)O)cs2)C1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1095739";"";"None";"439.58";"1";"6.10";"9";"CC1=C(c2nc(-c3ccc(C)cc3)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095723";"";"None";"363.48";"0";"4.43";"4";"CC1=C(c2ncc(C)s2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095740";"";"None";"455.58";"1";"5.80";"10";"COc1ccc(-c2csc(C3=C(C)[C@@H]4CC[C@@H](C)[C@@H]5CC[C@@]6(C)OO[C@@]45[C@H](O3)O6)n2)cc1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL254121";"";"None";"269.37";"0";"3.32";"1k";"Cc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"4000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL251896";"";"None";"289.79";"0";"3.66";"1b";"S=C(N/N=C/c1ccc(Cl)cc1)Nc1ccccc1";"IC50";"'='";"7000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL402145";"";"None";"387.85";"0";"3.65";"2b";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL253099";"";"None";"353.40";"0";"3.00";"2a";"O=C(O)CC1S/C(=N\N=C\c2ccccc2)N(c2ccccc2)C1=O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL4213697";"";"None";"499.97";"1";"6.08";"B23";"FC(F)(F)c1ccc2c(NCCCN3CCN(c4cccc5nc(Cl)ccc45)CC3)ccnc2c1";"IC50";"'='";"425.0";"nM";"6.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL634";"ALFENTANIL";"4.0";"416.53";"0";"1.38";"Alfentanil";"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"Theophylline";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"Terbutaline";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"Dexchlorpheniramine";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213252";"CLORAZEPIC ACID";"4.0";"314.73";"0";"2.58";"Clorazepate";"O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"Paroxetine";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23569";"";"None";"340.39";"0";"2.13";"13p";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23425";"";"None";"298.38";"0";"2.18";"12e";"Cc1ccc(SCc2cnc3nc(N)nc(N)c3n2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"SID90340850";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"SID11110971";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL7492";"PIRITREXIM";"2.0";"325.37";"0";"2.11";"azepine4";"COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"SI, trovafloxacin5";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214245";"TROVAFLOXACIN6";"None";"415.37";"0";"2.50";"SI, trovafloxacin6";"N[C@@H]1[C@H]2CN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"28700.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"17700.0";"nM";"4.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"26200.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL4564871";"";"None";"627.91";"2";"8.51";"102";"C[C@H]1[C@H](C)CC[C@]2(C(=O)OCCn3cnnc3-c3ccccc3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"128.0";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL410525";"O-ACETYLURSOLIC ACID";"None";"498.75";"1";"7.66";"103";"CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C";"IC50";"'='";"7900.0";"nM";"5.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL599621";"";"None";"338.75";"0";"3.55";"97; LQB-151";"O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccc(Cl)cc3[C@H]1CO2";"IC50";"'<'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL586031";"";"None";"362.43";"0";"3.88";"MMV085203";"COc1ccccc1NC1=C(N2CCCCC2)C(=O)c2ccccc2C1=O";"IC50";"'='";"4540.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602764";"";"None";"274.32";"0";"3.41";"MMV007906";"CCCCOc1ccc(C(=O)Nc2cc(C)on2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL261473";"";"None";"303.23";"0";"1.23";"18";"CCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL1765147";"";"None";"345.31";"0";"2.40";"24";"CCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL98";"VORINOSTAT";"4.0";"264.32";"0";"2.47";"SAHA";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185237";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4228248";"";"None";"347.46";"0";"4.63";"6b";"CN(C)c1ccc(-c2nc3ccccc3c(=O)n2C2CCCCC2)cc1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4078597";"";"None";"407.27";"0";"4.82";"5g";"COc1ccc(-c2nc3ccccc3c(=O)n2-c2ccc(Br)cc2)cc1";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL342675";"";"None";"252.27";"0";"3.01";"4f";"COc1ccccc1-c1nc(O)c2ccccc2n1";"IC50";"'='";"56000.0";"nM";"4.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1333995";"";"None";"265.32";"0";"3.07";"4d";"CN(C)c1ccc(-c2nc(O)c3ccccc3n2)cc1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4224737";"";"None";"410.52";"1";"6.15";"6e";"O=c1c2ccccc2nc(-c2ccc(OCc3ccccc3)cc2)n1C1CCCCC1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4228765";"";"None";"418.50";"1";"5.69";"6f";"O=c1c2ccccc2nc(-c2ccc(OCc3ccccc3)cc2)n1Cc1ccccc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4225675";"";"None";"464.61";"1";"7.34";"6j";"CC(C)=CCC/C(C)=C\Cn1c(-c2ccc(OCc3ccccc3)cc2)nc2ccccc2c1=O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL525162";"";"None";"482.57";"0";"4.56";"26a";"CCCCCCC(=O)OC1C[C@]2(CCC3(C=CC(=O)C=C3)O2)O[C@]2(CCC3(C=CC(=O)C=C3)O2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL497294";"";"None";"370.40";"0";"2.04";"22";"O=C1C=CC2(C=C1)CC[C@]1(CC(O)C[C@]3(CCC4(C=CC(=O)C=C4)O3)O1)O2";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL504388";"";"None";"546.79";"2";"7.66";"(+/-)-18c";"CCCCCCCCCCCCCCCCCCOC(=O)C[C@H]1C[C@@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"3520.0";"nM";"5.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL403750";"ACULEATINS B";"None";"418.62";"1";"6.17";"(+)-aculeatin 6-epi-D";"CCCCCCCCCCCCC[C@@H]1C[C@@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL403750";"ACULEATINS B";"None";"418.62";"1";"6.17";"(+)-aculeatin 6-epi-D";"CCCCCCCCCCCCC[C@@H]1C[C@@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"377.0";"nM";"6.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"Emetine";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL395429";"OXYTOCIN";"4.0";"1007.21";"None";"None";"Oxytocin";"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"6-methylprednisolone";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"Timolol";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"Fluphenazine";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1222856";"";"None";"414.83";"0";"2.40";"6a";"NS(=O)(=O)c1cc([N+](=O)[O-])c(N(CCCl)Cc2ccccc2)c([N+](=O)[O-])c1";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL645";"BISOPROLOL";"4.0";"325.45";"0";"2.37";"Bisoprolol";"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL527012";"";"None";"420.63";"1";"6.10";"(-)-29";"CCCCCCCCCCCCC[C@@H](O)C[C@@H](O)CC(=O)CCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL498699";"";"None";"418.62";"1";"6.17";"(-)-aculeatin B";"CCCCCCCCCCCCC[C@@H]1C[C@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"627.0";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL4544363";"";"None";"318.38";"0";"3.94";"125";"CC(C)n1c(/C=N/Nc2nc3ccccc3[nH]2)nc2ccccc21";"IC50";"'='";"1360.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL896";"HYDROXYZINE";"4.0";"374.91";"0";"3.06";"132";"OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3547502";"";"None";"485.57";"0";"1.25";"133";"O=c1[nH]ccc2nc(NC3CCCNC3)nc(Nc3ccc(S(=O)(=O)N4CCOCC4)cc3)c12";"IC50";"'<'";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL403162";"";"None";"255.35";"0";"3.01";"1a";"S=C(N/N=C/c1ccccc1)Nc1ccccc1";"IC50";"'='";"4000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL402358";"";"None";"422.29";"0";"4.31";"2c";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)cc2Cl)N(c2ccccc2)C1=O";"IC50";"'='";"1500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253099";"";"None";"353.40";"0";"3.00";"2a";"O=C(O)CC1S/C(=N\N=C\c2ccccc2)N(c2ccccc2)C1=O";"IC50";"'='";"4000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"1";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"147000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4207687";"";"None";"163.18";"0";"1.47";"Quinoline N-oxide hydrate";"O.[O-][n+]1cccc2ccccc21";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL52761";"";"None";"234.08";"0";"-0.21";"4";"CCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2348633";"";"None";"343.39";"0";"4.63";"MMV688471";"CC(C(=O)Nc1ccc2oc(-c3ccncc3)nc2c1)c1ccccc1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL480000";"";"None";"403.46";"0";"1.34";"6s";"COc1ccc(CSc2ncnc3c2ccn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL938667";"Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival after 18 hrs by [5,6-13H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1155031";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL254322";"";"None";"315.40";"0";"3.02";"1n";"COc1ccc(/C=N/NC(=S)Nc2ccccc2)c(OC)c1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL254120";"";"None";"289.79";"0";"3.66";"1j";"S=C(N/N=C/c1cccc(Cl)c1)Nc1ccccc1";"IC50";"'='";"7000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253916";"";"None";"273.34";"0";"3.15";"1g";"Fc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL251897";"";"None";"324.24";"0";"4.31";"1c";"S=C(N/N=C/c1ccc(Cl)cc1Cl)Nc1ccccc1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"pyrimethamine(PYR)";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044352";"Antitoxoplasmic activity against Toxoplasma gondii PRU tachyzoites infected in human HFF cells assessed as beta-galactosidase activity after 72 hrs by colorimetric assay";"F";"BAO_0000219";"cell-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2040716";"1";"Scientific Literature";"Eur J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL4283543";"";"None";"578.07";"2";"5.16";"D2";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(Cc4ccccc4Cl)nn3)c(OC)c2)cc1OC";"IC50";"'='";"24300.0";"nM";"4.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL195486";"";"None";"238.27";"0";"1.43";"2d";"C/N=C(/S)N/N=C/c1cccc([N+](=O)[O-])c1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"Paclitaxel";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1261960";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255235";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"None";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL4289168";"";"None";"599.68";"1";"3.68";"B3";"COC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"62500.0";"nM";"4.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4281976";"";"None";"585.65";"1";"3.29";"B2";"COC(=O)[C@@H](NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC)C(C)C";"IC50";"'='";"32700.0";"nM";"4.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL22672";"";"None";"301.74";"0";"1.85";"12k";"Nc1nc(N)c2nc(CNc3ccc(Cl)cc3)cnc2n1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL7492";"PIRITREXIM";"2.0";"325.37";"0";"2.11";"Piritrexim";"COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23380";"";"None";"314.37";"0";"1.89";"12f";"COc1cccc(SCc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL284544";"";"None";"339.40";"0";"2.30";"13u";"COc1ccc(OC)c(CCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL50514";"";"None";"384.44";"0";"2.16";"1b";"COc1cc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL286820";"";"None";"298.38";"0";"2.18";"12d";"Cc1cccc(SCc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23867";"";"None";"330.39";"0";"3.26";"5a";"Cc1c(CNc2cccc3ccccc23)cnc2nc(N)nc(N)c12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL1213033";"APRINDINE";"2.0";"322.50";"0";"4.39";"Aprindine";"CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL446237";"ANFEPRAMONE";"None";"220.32";"0";"1.11";"Anfepramone";"NCCC(CCN)C(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"Aminocaproic acid";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL2041766";"";"None";"390.12";"1";"6.26";"5";"Clc1ccc(Sc2nc(C(Cl)(Cl)Cl)nc3ccccc23)cc1";"IC50";"'>'";"31000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2045330";"Antimicrobial activity against tachyzoites of Toxoplasma gondii expressing PRU-beta-Gal gene infected in HFF after 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2040813";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL311220";"";"None";"763.02";"2";"2.55";"15";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"89000.0";"nM";"4.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2030555";"";"None";"359.44";"0";"2.62";"MMV688411";"Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2CC1CCNCC1";"IC50";"'='";"7550.0";"nM";"5.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL2348633";"";"None";"343.39";"0";"4.63";"MMV688471";"CC(C(=O)Nc1ccc2oc(-c3ccncc3)nc2c1)c1ccccc1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL2347835";"";"None";"334.72";"0";"3.98";"MMV688955";"Cc1cc(NC(=O)c2ccc(Oc3ccc(Cl)cc3O)o2)no1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL1774299";"";"None";"882.15";"2";"3.83";"20";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(C(=O)NCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774449";"";"None";"832.09";"2";"3.17";"26";"C=CO[C@]1(C)C[C@@H](C)CN(C(=O)NCC)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774304";"";"None";"851.13";"2";"4.64";"25";"C=CO[C@]1(C)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774304";"";"None";"851.13";"2";"4.64";"25";"C=CO[C@]1(C)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774451";"";"None";"839.12";"2";"3.78";"28";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(C)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL602234";"";"None";"403.95";"0";"3.86";"MMV000444";"CCCCCn1c(=N)n(CC(O)COc2cccc(C)c2)c2ccccc21.Cl";"IC50";"'='";"17890.0";"nM";"4.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028067";"";"None";"493.57";"1";"5.11";"MMV667490";"COc1ccc(C2c3ccc4ccccc4c3Oc3ncn(CCCn4ccnc4)c(=N)c32)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028042";"";"None";"321.31";"0";"3.81";"MMV011259";"Cc1cc(C)cc(Nc2cc(C)nc3nc(C(F)(F)F)nn23)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL535079";"";"None";"426.54";"0";"4.88";"MMV665831";"CCOC(=O)c1c(NC(=O)c2ccccc2)sc2c(O)c(CN(CC)CC)ccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL49055";"";"None";"291.40";"0";"3.88";"MMV006704";"CN(C)CCNc1cc(-c2ccccc2)nc2ccccc12";"IC50";"'='";"3050.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL611070";"";"None";"378.49";"0";"4.12";"MMV007881";"CCCCN(CCCC)S(=O)(=O)c1ccc(NC(=O)c2ccco2)cc1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602366";"";"None";"199.25";"0";"2.41";"MMV665843";"O=c1c2c([nH]c3ccccc13)CCCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532987";"";"None";"377.87";"0";"4.09";"TCMDC-124488";"CCOc1cc2c(cc1OCC)C(c1cc(OC)c(O)cc1Cl)NCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL597855";"";"None";"293.32";"0";"3.78";"MMV006457";"CCOC(=O)c1ccc2nc(-c3ccccc3)cc(O)c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2104161";"CLOPIMOZIDE";"2.0";"496.00";"1";"6.51";"22; NSC335305";"O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL88430";"";"None";"359.82";"0";"3.08";"127; MMV675968";"COc1ccc(OC)c(NCc2ccc3nc(N)nc(N)c3c2Cl)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4525036";"";"None";"400.44";"0";"4.80";"74; KGW59";"CC(C)(C)C1=CC(=NNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])C=C(C(C)(C)C)C1=O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403520";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4294363";"";"None";"608.49";"2";"5.21";"D10";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4ccc(Br)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"429200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL402299";"";"None";"367.43";"0";"3.31";"2k";"Cc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL265419";"";"None";"387.85";"0";"3.65";"2j";"O=C(O)CC1S/C(=N\N=C\c2cccc(Cl)c2)N(c2ccccc2)C1=O";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL404133";"";"None";"367.43";"0";"3.31";"2e";"Cc1cccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253516";"";"None";"422.29";"0";"4.31";"2d";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)c(Cl)c2)N(c2ccccc2)C1=O";"IC50";"'='";"1500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL403118";"";"None";"383.56";"1";"5.31";"1p";"CC(C)(C)c1cc(/C=N/NC(=S)Nc2ccccc2)cc(C(C)(C)C)c1O";"IC50";"'='";"5000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL254119";"";"None";"298.42";"0";"3.07";"1i";"CN(C)c1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253845";"";"None";"481.62";"1";"5.30";"2p";"CC(C)(C)c1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc(C(C)(C)C)c1O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL403118";"";"None";"383.56";"1";"5.31";"1p";"CC(C)(C)c1cc(/C=N/NC(=S)Nc2ccccc2)cc(C(C)(C)C)c1O";"IC50";"'='";"4000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL253916";"";"None";"273.34";"0";"3.15";"1g";"Fc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL403079";"";"None";"324.24";"0";"4.31";"1d";"S=C(N/N=C/c1ccc(Cl)c(Cl)c1)Nc1ccccc1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL546284";"";"None";"269.30";"0";"2.52";"52";"CCc1ccc(C(=O)NC(=O)c2ccccc2O)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL23383";"";"None";"308.39";"0";"2.73";"14a";"Cc1ccc(C)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4228507";"";"None";"448.52";"1";"5.59";"6d";"O=c1c2ccccc2nc(-c2ccc(OCc3ccccc3)cc2)n1CCc1ccc(O)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4087426";"";"None";"483.37";"1";"6.39";"5i";"O=c1c2ccccc2nc(-c2ccc(OCc3ccccc3)cc2)n1-c1ccc(Br)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4226131";"";"None";"407.27";"0";"4.82";"5a";"COc1ccc(-n2c(-c3ccc(Br)cc3)nc3ccccc3c2=O)cc1";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4225548";"";"None";"306.24";"0";"3.49";"4e";"O=c1[nH]c(-c2ccc(OC(F)(F)F)cc2)nc2ccccc12";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1213004";"";"None";"270.31";"0";"4.23";"SI,6";"O=[N+]([O-])c1cccc(Sc2cc3ccccc3[nH]2)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213005";"";"None";"275.38";"1";"5.47";"SI,7";"c1ccc2cc(Sc3cc4ccccc4[nH]3)ccc2c1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"TMP";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL540186";"";"None";"239.30";"0";"2.43";"25";"CC1CC/C(=N/Nc2nc(C(=O)O)cs2)C1";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.06";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262126";"Antimicrobial activity against Toxoplasma gondii isolate PSP-2005-MUP infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"130";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL581874";"";"None";"500.19";"2";"5.13";"MMV666025";"OC(Cn1nnc2ccccc21)Cn1c2ccc(Br)cc2c2cc(Br)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL534589";"";"None";"631.73";"2";"7.20";"MMV666101";"COc1ccc(C2=C(c3ccc(OC)cc3)C3(c4ccccc4)C(=O)C2(c2ccccc2)C2C(=O)N(c4ccc(C)cc4)C(=O)C23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL578952";"";"None";"469.01";"1";"5.99";"MMV000642";"COc1ccc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL531222";"";"None";"319.36";"0";"3.47";"MMV665826";"COc1cccc(NC(=O)Cn2c(C)c(C#N)c3ccccc32)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584237";"";"None";"376.43";"0";"4.97";"MMV008149";"Cc1c(C)n(Cc2ccc(F)cc2)c2ccc(C(=O)NCc3ccco3)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547193";"";"None";"366.35";"1";"5.45";"MMV665798";"FC(F)(F)c1cccc(Nc2nc(-c3ccccc3)nc3ncccc23)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL261095";"";"None";"440.46";"1";"5.39";"TCMDC-125220";"O=C(Nc1ccccc1O)c1ccc(Oc2cccc(C(=O)Nc3ccccc3O)c2)cc1";"IC50";"'='";"13150.0";"nM";"4.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527620";"";"None";"405.50";"0";"4.80";"MMV019758";"COc1ccc(C(=O)Nc2ccc3nc(N4CCCCC4)cc(C)c3c2)cc1OC";"IC50";"'='";"25680.0";"nM";"4.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581349";"";"None";"335.45";"0";"3.89";"MMV007617";"CC(=O)NCCc1nc2ccccc2n1Cc1ccc(C(C)C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586888";"";"None";"412.49";"1";"5.47";"MMV665879";"CC(C)(C)C(=O)Nc1ccc(C(=O)Nc2cccc(-c3nc4ccccc4[nH]3)c2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL596741";"";"None";"299.40";"0";"3.20";"91";"Cc1cccc(C)c1Sc1[nH]c2nc(N)nc(N)c2c1C";"IC50";"'='";"1920.0";"nM";"5.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1071430";"Antimicrobial activity against Toxoplasma gondii infected in HEL cells assessed as inhibition of parasite growth by [3H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HEL";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156926";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3308090";"";"";""
"CHEMBL550282";"";"None";"267.35";"0";"2.91";"3";"CCOC(=O)c1csc(N/N=C2/CCC(C)C2)n1";"IC50";"'='";"59000.0";"nM";"4.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL561626";"";"None";"267.35";"0";"3.05";"4";"CCOC(=O)c1csc(NN=C2CCCCC2)n1";"IC50";"'='";"160000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL563336";"";"None";"253.33";"0";"2.96";"30";"O=C(O)c1csc(NN=C2CCCCCC2)n1";"IC50";"'='";"179000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL569138";"";"None";"314.37";"0";"3.25";"21";"CCOC(=O)c1csc(N/N=C/c2c[nH]c3ccccc23)n1";"IC50";"'='";"280000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL550285";"";"None";"265.29";"0";"2.36";"11";"CCOC(=O)c1csc(N/N=C/c2ccco2)n1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL555525";"";"None";"276.32";"0";"2.16";"16";"CCOC(=O)c1csc(N/N=C/c2ccncc2)n1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"Atropine";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL2042580";"";"None";"163.61";"0";"2.89";"2-chloroquinoline";"Clc1ccc2ccccc2n1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL525005";"";"None";"482.57";"0";"4.56";"(+/-)-25a";"CCCCCCC(=O)O[C@@H]1C[C@]2(CCC3(C=CC(=O)C=C3)O2)O[C@]2(CCC3(C=CC(=O)C=C3)O2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL525743";"";"None";"434.57";"0";"4.54";"(+/-)-16b";"CCCCCCCCCCOC(=O)C[C@@H]1C[C@@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"1630.0";"nM";"5.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL22924";"";"None";"316.37";"0";"2.95";"15a";"Nc1nc(N)c2cc(CNc3cccc4ccccc34)cnc2n1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL235669";"";"None";"332.37";"0";"4.54";"10";"Fc1ccc(Oc2ccc(OCCOC3CCCCO3)cc2)cc1";"IC50";"'='";"6160.0";"nM";"5.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL430060";"APICIDIN";"None";"623.80";"1";"3.07";"9";"CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185236";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL23532";"";"None";"370.41";"0";"2.14";"4a";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL807752";"Inhibitory concentration of Toxoplasma gondii cells in human embryonic lung cells with minimum essential medium";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"lung";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1126886";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL279983";"";"None";"340.39";"0";"2.13";"14d";"COc1ccc(NCc2cnc3nc(N)nc(N)c3c2C)c(OC)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1774452";"";"None";"843.08";"2";"3.61";"29";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(F)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774286";"";"None";"762.98";"2";"2.22";"4";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1222181";"";"None";"734.97";"3";"1.56";"8";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"65000.0";"nM";"4.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL195459";"";"None";"238.27";"0";"1.43";"2e";"C/N=C(/S)N/N=C/c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"9.65";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262130";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1994-LEF harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 204 sil Ala mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL253516";"";"None";"422.29";"0";"4.31";"2d";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)c(Cl)c2)N(c2ccccc2)C1=O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL254313";"";"None";"285.37";"0";"3.02";"1l";"COc1cccc(/C=N/NC(=S)Nc2ccccc2)c1";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL253917";"";"None";"301.37";"0";"2.72";"1h";"COc1cc(/C=N/NC(=S)Nc2ccccc2)ccc1O";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058803";"Antiprotozoal activity against 5 MOI Toxoplasma gondii Me49 tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL259192";"";"None";"289.21";"0";"0.84";"8";"CCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"9370.0";"nM";"5.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767770";"Antiparasitic activity against Toxoplasma gondii assessed as growth inhibition";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL283518";"";"None";"340.39";"0";"2.13";"14g";"COc1ccc(NCc2cnc3nc(N)nc(N)c3c2C)cc1OC";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL279243";"";"None";"284.35";"0";"1.88";"12b";"Nc1nc(N)c2nc(CSc3ccccc3)cnc2n1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL222649";"";"None";"527.69";"1";"3.55";"LHVS";"CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL917068";"Inhibition of microsome protein secretion in Toxoplasma gondii 2F1";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1142206";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL1774451";"";"None";"839.12";"2";"3.78";"28";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(C)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774451";"";"None";"839.12";"2";"3.78";"28";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(C)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774292";"";"None";"825.09";"2";"3.47";"11";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL4228364";"";"None";"471.56";"1";"6.37";"6m";"O=c1c2ccccc2nc(-c2ccc(OCc3ccccc3)cc2)n1CCc1cc2ccccc2[nH]1";"IC50";"'='";"154000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"6";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774295";"";"None";"791.08";"2";"3.34";"16";"CCCN1C[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774301";"";"None";"775.03";"2";"3.07";"22";"C=CO[C@]1(C)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL258541";"";"None";"274.15";"0";"-0.73";"26";"O=P(O)(O)C(CNN1CCCC1)P(=O)(O)O";"IC50";"'='";"13300.0";"nM";"4.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.39";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262127";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1998-TRA infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"2.95";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262123";"Antimicrobial activity against Toxoplasma gondii isolate TOU-1998-TRI infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.07";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262118";"Antimicrobial activity against Toxoplasma gondii ENT harboring DHPS Ex2, E474D/Ex3, 156 sil Leu/Ex4, R560K/Ex5, 580 sil Gly/A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.05";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262121";"Antimicrobial activity against Toxoplasma gondii ME49 infected in human MRC-5 cells infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"27700.0";"nM";"4.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL23919";"";"None";"327.35";"0";"1.21";"12p";"COc1cc(NCc2cnc3nc(N)nc(N)c3n2)cc(OC)c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23402";"";"None";"327.35";"0";"1.21";"12n";"COc1ccc(OC)c(NCc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4520942";"";"None";"426.69";"1";"7.25";"104";"CC(=O)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12";"IC50";"'='";"24400.0";"nM";"4.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.19";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262129";"Antimicrobial activity against Toxoplasma gondii NED infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"Artemether";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"2";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774291";"";"None";"775.03";"2";"2.46";"10";"C=CCN1C[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774297";"";"None";"839.12";"2";"4.13";"18";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774450";"";"None";"894.16";"2";"4.35";"27";"C=CO[C@]1(C)C[C@@H](C)CN(C(=O)NCc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1773086";"";"None";"853.15";"2";"3.90";"30";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774292";"";"None";"825.09";"2";"3.47";"11";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL222649";"";"None";"527.69";"1";"3.55";"LHVS";"CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL917067";"Inhibition of Toxoplasma gondii 2F1 invasion in HFF cells by red/green invasion assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1142206";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"CHEMBL3307525";"";"";""
"CHEMBL23416";"";"None";"314.78";"0";"2.76";"13k";"Cc1c(CNc2ccc(Cl)cc2)cnc2nc(N)nc(N)c12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL498345";"";"None";"418.62";"1";"6.17";"(-)-aculeatin A";"CCCCCCCCCCCCC[C@@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"309.0";"nM";"6.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL498515";"(+)-ACULEATIN B";"None";"418.62";"1";"6.17";"(+)-aculeatin B";"CCCCCCCCCCCCC[C@H]1C[C@@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"365.0";"nM";"6.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL501746";"";"None";"546.79";"2";"7.66";"(+/-)-15c";"CCCCCCCCCCCCCCCCCCOC(=O)C[C@H]1C[C@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"Mannitol";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"Procaine";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"Minoxidil";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213460";"ETHYL LOFLAZEPATE";"2.0";"360.77";"0";"3.20";"Ethyl-loflazepate";"CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"Dexamethasone";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL497";"CLIOQUINOL";"4.0";"305.50";"0";"3.20";"Clioquinol";"Oc1c(I)cc(Cl)c2cccnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL4227501";"";"None";"336.44";"0";"4.65";"5d";"CCCCCCn1c(-c2ccc(OC)cc2)nc2ccccc2c1=O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4105280";"";"None";"434.50";"1";"5.64";"5c";"COc1ccc(-n2c(-c3ccc(OCc4ccccc4)cc3)nc3ccccc3c2=O)cc1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1429848";"";"None";"223.24";"0";"2.40";"4g";"Oc1nc(-c2cccnc2)nc2ccccc12";"IC50";"'='";"94000.0";"nM";"4.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL336718";"";"None";"252.27";"0";"3.01";"4a";"COc1ccc(-c2nc(O)c3ccccc3n2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL434024";"";"None";"283.11";"0";"-0.37";"9";"O=P(O)(O)C(O)(Cc1ccccn1)P(=O)(O)O";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL253107";"";"None";"396.47";"0";"3.07";"2i";"CN(C)c1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL253917";"";"None";"301.37";"0";"2.72";"1h";"COc1cc(/C=N/NC(=S)Nc2ccccc2)ccc1O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL258540";"";"None";"261.15";"0";"-0.09";"25";"CC(C)CNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"74470.0";"nM";"4.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL405827";"";"None";"261.15";"0";"0.06";"21";"CC(C)(C)NCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"42840.0";"nM";"4.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.09";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262121";"Antimicrobial activity against Toxoplasma gondii ME49 infected in human MRC-5 cells infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.08";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262131";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-DJO infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL496051";"";"None";"308.33";"0";"4.15";"3";"COc1c(O)c(-c2ccccc2)cc(O)c1-c1ccccc1O";"IC50";"'='";"10400.0";"nM";"4.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL976724";"Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1157340";"1";"Scientific Literature";"J Nat Prod";"2006";"None";"";"";""
"CHEMBL1222996";"";"None";"438.46";"0";"3.64";"6l";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccc(O)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1094435";"";"None";"503.64";"2";"5.19";"12";"CC1=C(c2nc(-c3ccc(S(C)(=O)=O)cc3)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1097757";"";"None";"323.39";"0";"2.25";"17";"CNC(=O)C1=C(C)[C@@H]2CC[C@@H](C)[C@@H]3CC[C@@]4(C)OO[C@@]23[C@H](O1)O4";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL187266";"TANSHINONE IIA";"None";"294.35";"0";"4.25";"131";"Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1082723";"CIPARGAMIN";"2.0";"390.24";"0";"4.34";"76; NITD609";"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403521";"Antiparasitic activity against Toxoplasma gondii infected in human HuH7 cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL24983";"";"None";"215.03";"0";"3.10";"3,4-DCI";"O=c1oc(Cl)c(Cl)c2ccccc12";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL917067";"Inhibition of Toxoplasma gondii 2F1 invasion in HFF cells by red/green invasion assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1142206";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"CHEMBL3307525";"";"";""
"CHEMBL87708";"LOFEPRAMINE";"4.0";"418.97";"1";"5.78";"Lofepramine";"CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1575";"ESTRAMUSTINE";"3.0";"440.41";"1";"5.18";"Estramustine";"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL782";"TOLBUTAMIDE";"4.0";"270.35";"0";"1.78";"Tolbutamide";"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"Melfalan";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"Megestrol(acetate)";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL39581";"";"None";"271.34";"0";"4.07";"1 (wc-9)";"N#CSCCOc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.17";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262120";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1995-ABE harboring DHPS Ex5, A587V mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL22434";"";"None";"334.41";"0";"3.03";"12c";"Nc1nc(N)c2nc(CSc3cccc4ccccc34)cnc2n1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL253105";"";"None";"371.39";"0";"3.14";"2f";"O=C(O)CC1S/C(=N\N=C\c2ccccc2F)N(c2ccccc2)C1=O";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL402145";"";"None";"387.85";"0";"3.65";"2b";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"1500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL403079";"";"None";"324.24";"0";"4.31";"1d";"S=C(N/N=C/c1ccc(Cl)c(Cl)c1)Nc1ccccc1";"IC50";"'='";"5000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253106";"";"None";"399.43";"0";"2.71";"2h";"COc1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)ccc1O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL254120";"";"None";"289.79";"0";"3.66";"1j";"S=C(N/N=C/c1cccc(Cl)c1)Nc1ccccc1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL278041";"SB-202190";"None";"331.35";"0";"4.65";"SB-202190";"Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058802";"Antiprotozoal activity against 1 MOI Toxoplasma gondii RH tachyzoites infected in confluent HFF assessed as inhibition of [3H]uracil incorporation into tachyzoites treated 4 hrs after infection measured after overnight incubation post uracil addition by liquid scintillation counting";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152459";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL279679";"";"None";"368.44";"0";"2.91";"2e";"CCOc1ccc(OCC)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL23076";"";"None";"392.39";"0";"3.16";"14k";"COc1ccc(C(F)(F)F)cc1N(C)Cc1cnc2nc(N)nc(N)c2c1C";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23532";"";"None";"370.41";"0";"2.14";"13q";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23021";"";"None";"340.39";"0";"2.13";"13n";"COc1ccc(OC)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23382";"";"None";"324.39";"0";"2.43";"14b";"COc1ccc(NCc2cnc3nc(N)nc(N)c3c2C)c(C)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL24007";"";"None";"331.83";"0";"3.44";"13i";"Cc1c(CSc2cccc(Cl)c2)cnc2nc(N)nc(N)c12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4520262";"";"None";"349.48";"1";"5.78";"3e";"Cc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"160900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL855";"TRIPROLIDINE";"4.0";"278.40";"0";"3.92";"Triprolidin";"Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"1a";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"46000.0";"nM";"4.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"Flutamide";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1597";"DIMERCAPROL";"4.0";"124.23";"0";"0.21";"Dimercaprol";"OCC(S)CS";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"Estradiol";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"1, AAZ";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL115788";"";"None";"398.42";"0";"1.69";"6a";"COc1cc(N(C=O)Cc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"";"";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL873259";"Inhibitory concentration of Toxoplasma gondii cells in human embryonic lung cells with minimum essential medium; inactive";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"lung";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1126886";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"Amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL509924";"DIFLUCORTOLONE";"4.0";"394.46";"0";"2.73";"Diflucortolone";"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"Diltiazem";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL499915";"CARBENOXOLONE";"4.0";"570.77";"2";"6.83";"Carbenoxolone";"CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL453904";"SULFOBROMOPHTHALEIN SODIUM";"-1.0";"838.00";"2";"5.10";"Bromosulfophthalein";"O=C1OC(c2ccc(O)c(S(=O)(=O)[O-])c2)(c2ccc(O)c(S(=O)(=O)[O-])c2)c2c(Br)c(Br)c(Br)c(Br)c21.[Na+].[Na+]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1071430";"Antimicrobial activity against Toxoplasma gondii infected in HEL cells assessed as inhibition of parasite growth by [3H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HEL";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156926";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"CHEMBL3308090";"";"";""
"CHEMBL190228";"";"None";"335.43";"0";"4.69";"1";"CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1";"IC50";"'='";"210000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL973902";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as beta-galactosidase activity after 5 days by whole cell assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158743";"1";"Scientific Literature";"J Nat Prod";"2005";"None";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"Ranitidine";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1774453";"";"None";"831.14";"2";"3.85";"31";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CC2CCCCC2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774304";"";"None";"851.13";"2";"4.64";"25";"C=CO[C@]1(C)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1773086";"";"None";"853.15";"2";"3.90";"30";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774292";"";"None";"825.09";"2";"3.47";"11";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774304";"";"None";"851.13";"2";"4.64";"25";"C=CO[C@]1(C)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774452";"";"None";"843.08";"2";"3.61";"29";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(F)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL408745";"";"None";"247.12";"0";"-0.33";"14";"CCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"6330.0";"nM";"5.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL254121";"";"None";"269.37";"0";"3.32";"1k";"Cc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL279705";"";"None";"324.39";"0";"2.43";"14c";"COc1ccc(C)cc1NCc1cnc2nc(N)nc(N)c2c1C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL281648";"";"None";"378.36";"0";"3.14";"13r";"COc1ccc(C(F)(F)F)cc1NCc1cnc2nc(N)nc(N)c2c1C";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1774297";"";"None";"839.12";"2";"4.13";"18";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"Alprazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL277217";"";"None";"327.41";"0";"2.80";"13f";"COc1cccc(SCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL24344";"";"None";"311.41";"0";"3.10";"13e";"Cc1ccc(SCc2cnc3nc(N)nc(N)c3c2C)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"Bromocriptine";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213284";"COMPOUND A";"None";"343.51";"1";"6.01";"A";"CCCCCCCCCCCCc1c(C)c(=O)c2ccccc2n1O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1218417";"Antimicrobial activity against Toxoplasma gondii type 1 RH strain infected in human foreskin fibroblasts monolayer assessed as inhibition of parasite replication after 24 hrs by phase-contrast microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212767";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"Lorazepam";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23867";"";"None";"330.39";"0";"3.26";"13a";"Cc1c(CNc2cccc3ccccc23)cnc2nc(N)nc(N)c12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL276954";"";"None";"316.37";"0";"2.52";"12t";"Nc1nc(N)c2nc(CCc3cccc4ccccc34)cnc2n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23092";"";"None";"299.76";"0";"3.06";"16b";"Nc1nc(N)c2cc(CNc3ccc(Cl)cc3)ccc2n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL4519104";"";"None";"369.90";"1";"6.12";"3b";"Clc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"81030.0";"nM";"4.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4448283";"";"None";"414.35";"1";"6.23";"3c";"Brc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"142110.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL254313";"";"None";"285.37";"0";"3.02";"1l";"COc1cccc(/C=N/NC(=S)Nc2ccccc2)c1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL404133";"";"None";"367.43";"0";"3.31";"2e";"Cc1cccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL374975";"FUSIDIC ACID";"4.0";"516.72";"2";"5.67";"102";"CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5271586";"";"None";"295.36";"0";"2.52";"114a";"O=C(NNC(=S)Nc1ccc(F)cc1)c1cccs1";"IC50";"'='";"33.17";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1614712";"";"None";"439.56";"0";"4.92";"95; NVP-AEW541";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'='";"1170.0";"nM";"5.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232785";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in HFF cells assessed as parasitic growth inhibition incubated for 72 hrs in presence of CPRG by absorbance based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";""
"CHEMBL611070";"";"None";"378.49";"0";"4.12";"116";"CCCCN(CCCC)S(=O)(=O)c1ccc(NC(=O)c2ccco2)cc1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL479811";"";"None";"398.44";"0";"1.21";"6m";"N#Cc1ccc(CSc2ncnc3c2ccn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL938667";"Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival after 18 hrs by [5,6-13H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1155031";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL259786";"";"None";"288.18";"0";"-0.34";"27";"O=P(O)(O)C(CNN1CCCCC1)P(=O)(O)O";"IC50";"'='";"70600.0";"nM";"4.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL262598";"";"None";"261.15";"0";"0.06";"24";"CCC(C)NCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL261562";"";"None";"275.18";"0";"0.30";"20";"CC(C)CCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"36940.0";"nM";"4.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL403229";"";"None";"345.42";"0";"3.03";"1o";"COc1cc(/C=N/NC(=S)Nc2ccccc2)cc(OC)c1OC";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL365175";"";"None";"252.30";"0";"1.82";"2h";"CC/N=C(/S)N/N=C/c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL531611";"";"None";"282.55";"0";"2.73";"MMV665927";"O=C(CCl)NCCOc1ccc(Cl)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1616787";"";"None";"431.37";"0";"4.60";"MMV396723";"N=c1n(CCN2CCCCC2)c2ccccc2n1CC(=O)c1ccc(Cl)c(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1437888";"";"None";"440.55";"0";"4.76";"MMV667491";"COc1ccc(C2c3ccc4ccccc4c3Oc3ncn(CCCN(C)C)c(=N)c32)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028060";"";"None";"484.60";"1";"6.20";"MMV396726";"N#Cc1nc(Cc2cccc3ccccc23)oc1N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582478";"";"None";"420.51";"0";"3.92";"MMV000704";"CCOC(=O)c1cnc2ccc(OC)cc2c1Nc1ccc(N2CCN(C)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028045";"";"None";"519.98";"2";"5.52";"MMV396635";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc2nc(-c3ccc(Cl)s3)cc(C(F)(F)F)n2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL609628";"";"None";"384.31";"0";"3.95";"MMV007764";"CCCCc1c(CCC)c(=N)c2ccccc2n1C.I";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579315";"";"None";"358.39";"0";"3.93";"MMV084434";"COc1ccc(C=C2SC(Nc3ccc(F)cc3)=NC2=O)c(OC)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1765151";"";"None";"429.48";"0";"4.74";"28";"CCCCCCCCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"4130.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL500238";"";"None";"324.33";"0";"3.85";"2";"COc1c(O)c(-c2ccccc2)cc(O)c1-c1cc(O)ccc1O";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL976724";"Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1157340";"1";"Scientific Literature";"J Nat Prod";"2006";"None";"";"";""
"CHEMBL497656";"";"None";"420.63";"1";"6.25";"(+)-28";"CCCCCCCCCCCCC[C@]1(O)C[C@H](O)C[C@H](CCc2ccc(O)cc2)O1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL565002";"";"None";"290.35";"0";"2.55";"13";"CCOC(=O)c1csc(N/N=C(\C)c2ccccn2)n1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL561823";"";"None";"253.33";"0";"2.82";"27";"CC1CCCC/C1=N/Nc1nc(C(=O)O)cs1";"IC50";"'='";"128000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL553162";"";"None";"325.39";"0";"3.92";"18";"CCOC(=O)c1csc(N/N=C/c2cccc3ccccc23)n1";"IC50";"'='";"52000.0";"nM";"4.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"18800.0";"nM";"4.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1822422";"";"None";"374.05";"1";"5.90";"7";"Clc1ccc(Oc2nc(C(Cl)(Cl)Cl)nc3ccccc23)cc1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1828281";"Antiparasitic activity against Toxoplasma gondii PRU tachyzoites harboring beta-Gal gene infected in human HFF cells after 72 hrs by microtiter plate based assay";"F";"BAO_0000219";"cell-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1821638";"1";"Scientific Literature";"Eur J Med Chem";"2011";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343684";"Antiparasitic activity against Toxoplasma gondii RH transfected with fluorescent transgene dTom";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4342427";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL1773086";"";"None";"853.15";"2";"3.90";"30";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL23220";"";"None";"348.45";"0";"3.01";"14m";"Cc1c(CN(C)c2cccc3c2CCCC3)cnc2nc(N)nc(N)c12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1765146";"";"None";"331.29";"0";"2.01";"23";"CCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"PY";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223457";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL496052";"TERFEROL";"None";"292.33";"0";"4.44";"1";"COc1cc(-c2ccccc2)c(O)c(O)c1-c1ccccc1";"IC50";"'='";"26800.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL976724";"Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1157340";"1";"Scientific Literature";"J Nat Prod";"2006";"None";"";"";""
"CHEMBL445654";"";"None";"252.30";"0";"1.82";"2g";"CC/N=C(/S)N/N=C/c1cccc([N+](=O)[O-])c1";"IC50";"'='";"80000.0";"nM";"4.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL587022";"";"None";"307.86";"0";"3.70";"MMV020788";"Cl.Oc1ccccc1CNCC12CC3CC(CC(C3)C1)C2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532079";"";"None";"261.41";"0";"4.11";"MMV665785";"CC(C)(C)c1ccc(O)c(CNC2CCCCC2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529640";"";"None";"338.28";"0";"4.62";"MMV665928";"CCC(C)NCC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591362";"";"None";"360.24";"0";"4.22";"MMV665909";"O=C(Nc1nc(-c2ccccn2)cs1)c1ccccc1Br";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591128";"";"None";"293.32";"0";"3.76";"MMV665940";"CCOc1ccc(/C=C/c2nc(=O)c3ccccc3o2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529603";"";"None";"270.33";"0";"4.90";"MMV665891";"c1ccc(-c2ccc(-c3nc4ccccc4[nH]3)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600439";"";"None";"487.03";"0";"3.59";"MMV665914";"COc1ccccc1N1CCN(C(CNS(=O)(=O)c2ccc(Cl)cc2)c2cccnc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600906";"";"None";"201.27";"0";"3.20";"MMV666081";"CCCc1c(C)nc2ccccc2c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602409";"";"None";"268.32";"0";"3.00";"MMV666009";"CN1c2ccccc2N(C)C1c1ccc2c(c1)OCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL526587";"";"None";"440.53";"0";"3.52";"MMV665906";"Cc1ccc(-c2cc(C(=O)Nc3ccc(S(=O)(=O)N4CCCCC4)cc3)[nH]n2)c(O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602940";"";"None";"390.51";"0";"4.42";"MMV665954";"O=C(NCC1Cc2cccc(-c3ccncc3)c2O1)c1csc2c1CCCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589916";"";"None";"310.42";"0";"4.85";"MMV142383";"CC(C)(C)c1ccc(C(=O)Nc2nc3ccccc3s2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL597857";"";"None";"345.83";"0";"2.90";"MMV006587";"Clc1ccc2[nH]c3c(NCCCN4CCOCC4)ncnc3c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582420";"";"None";"357.41";"0";"4.88";"MMV019202";"CCOc1cccc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602211";"";"None";"359.48";"0";"3.73";"MMV006706";"Cc1cc(N2CCN(C3CCCC3)CC2)n2c(nc3ccccc32)c1C#N";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"32100.0";"nM";"4.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"25100.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"Clonidine";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214316";"TROVAFLOXACIN9";"None";"358.37";"0";"1.21";"SI, trovafloxacin9";"NC[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]12";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL575569";"CIPROFLOXACIN ETHYL ESTER";"None";"359.40";"0";"2.06";"2";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"'='";"960.0";"nM";"6.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223457";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL3219284";"";"None";"449.53";"0";"3.97";"4";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCN(Cc4ccccc4)CC3)c(F)cc2c1=O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223457";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL3219285";"";"None";"521.68";"2";"5.38";"5";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCN(CCC45CC6CC(CC(C6)C4)C5)CC3)c(F)cc2c1=O";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223458";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL587892";"";"None";"284.75";"0";"3.92";"MMV011522";"Cc1ccc(Nc2nc(N)c3ccccc3n2)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581860";"";"None";"349.22";"0";"4.08";"MMV001041";"OCCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"Nifedipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"Procarbazine";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL32350";"PIRLINDOLE";"2.0";"226.32";"0";"2.93";"Pirlindole";"Cc1ccc2c(c1)c1c3n2CCNC3CCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL596852";"";"None";"460.54";"1";"6.38";"MMV007384";"COc1ccc(-c2nc3cc(Cc4ccc5[nH]c(-c6ccc(OC)cc6)nc5c4)ccc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL524784";"";"None";"397.50";"0";"4.24";"MMV019258";"COc1ccc(-n2ccnc2SCC(=O)Nc2cc(C)ccc2C)c(OC)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586310";"";"None";"346.40";"0";"3.33";"MMV665827";"CCOC(=O)c1cn(CC)c2cc(N3CCCCC3)c(F)cc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590435";"";"None";"367.41";"0";"4.09";"MMV665805";"CCOc1ccc(-c2nonc2NC(=O)c2cccc(C)c2)cc1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602946";"";"None";"450.58";"1";"5.35";"MMV000634";"CC1CCCCN1CCCNC(=O)c1ccc2c(c1)sc1nc(-c3ccc(F)cc3)cn12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588516";"";"None";"441.86";"0";"4.82";"MMV666103";"CCn1c(SCC(=O)Nc2cc(C(F)(F)F)ccc2Cl)nc2ccccc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589060";"";"None";"420.68";"1";"5.55";"MMV666057";"O=C(Nc1ccc(Cl)cc1C(=O)Nc1ccncc1)c1ccc(Cl)cc1Cl";"IC50";"'='";"19040.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601580";"";"None";"371.46";"1";"5.95";"MMV000563";"COc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533921";"";"None";"438.90";"0";"4.04";"MMV666072";"COCCNC(=O)c1ccc(OC2CCN(Cc3ccc(F)c(F)c3)CC2)c(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602312";"";"None";"368.91";"1";"5.09";"MMV665961";"CCN(CC)CCCNc1nc(-c2ccc(Cl)cc2)nc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591147";"";"None";"348.19";"1";"5.21";"MMV665948";"O=C(Nc1ccccc1O)c1ccc(-c2ccc(Cl)cc2Cl)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582552";"";"None";"252.32";"0";"2.88";"MMV666102";"CN(C)c1ccc(-c2nc3cc(N)ccc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL525519";"";"None";"384.50";"0";"4.03";"MMV666061";"COc1cccc(O)c1CN1CCC2(CCCN(Cc3ccc(F)cc3)C2)C1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533399";"";"None";"418.59";"0";"4.27";"MMV666069";"COc1ccc(CCN2CCC(CN(C)Cc3cnn(-c4ccccc4)c3)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588501";"";"None";"497.75";"0";"4.59";"MMV019780";"Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCC(N5CCCCC5)CC4)CC3)sc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588155";"";"None";"383.67";"0";"4.94";"MMV019700";"O=C(Nc1ccc(N2CCCCC2)c(Cl)c1)c1ccc(Br)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587371";"";"None";"491.54";"0";"4.32";"MMV019670";"O=C(Nc1ccc(N2CCN(Cc3ccccc3)CC2)cc1)c1cccs1.O=C(O)C(F)(F)F";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1619026";"";"None";"363.89";"0";"4.35";"MMV396633";"CCOc1cc(CNC(C)C(O)c2ccccc2)cc(Cl)c1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL603943";"";"None";"267.34";"0";"3.05";"MMV007374";"CCc1ccc(Nc2cc(C)nc3nc(C)nn23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589236";"";"None";"279.41";"0";"3.29";"MMV056726";"COc1cc(SC)ccc1C(=O)N1CCCC(C)C1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1740701";"";"None";"280.33";"0";"4.00";"MMV274073";"COc1ccc2nc(C)cc(Nc3ccccc3O)c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580819";"";"None";"422.44";"1";"5.33";"MMV665883";"O=C(Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1cccc(NC(=O)c2ccco2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601825";"";"None";"319.43";"0";"3.52";"MMV007978";"CCOc1ccc(CCNC(=O)c2cccs2)cc1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532597";"";"None";"312.42";"0";"4.34";"MMV019266";"Cc1sc2ncnc(Sc3nc4ccccc4[nH]3)c2c1C";"IC50";"'='";"13930.0";"nM";"4.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600235";"";"None";"416.29";"0";"4.16";"MMV000760";"Oc1c(CN2CCN(c3ccccc3F)CC2)cc(Br)c2cccnc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL531060";"";"None";"189.22";"0";"1.53";"MMV665897";"COc1ccc2nc(N)nc(C)c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592305";"";"None";"281.14";"0";"4.29";"MMV665949";"Oc1ccc(C(=C(Cl)Cl)c2ccc(O)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601492";"";"None";"414.49";"0";"4.73";"MMV001241";"COc1ccc(C)c2sc(N(Cc3cccnc3)C(=O)c3ccc(C#N)cc3)nc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592808";"";"None";"458.86";"1";"5.49";"MMV000619";"CCCCC(O)(c1ccc(Cl)cc1)C(CN1CCOCC1)c1ccc(Cl)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585839";"";"None";"413.59";"1";"6.79";"MMV007574";"O=C(Nc1ccc(C23CC4CC(CC(c5ccccc5)(C4)C2)C3)cc1)c1cccs1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590683";"";"None";"432.91";"1";"5.43";"MMV665969";"COc1cccc(C(=O)NC(c2ccc(C)cc2)c2cc(Cl)c3cccnc3c2O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL534319";"";"None";"515.15";"1";"7.63";"MMV019555";"Cl.c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL577874";"";"None";"391.41";"0";"4.14";"MMV006303";"CCN(CC)CCNc1ccnc2cc3ccccc3cc12.O=P(O)(O)O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1097758";"";"None";"399.49";"0";"3.82";"18";"CC1=C(C(=O)NCc2ccccc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL574671";"";"None";"502.47";"2";"5.58";"16";"Cc1ccc(S(=O)(=O)Cc2nc(Nc3cccc(C(F)(F)F)c3)c3cc([N+](=O)[O-])ccc3n2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1047657";"Antitoxoplasmic activity against Toxoplasma gondii PRU-betaGal tachyzoite after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1154711";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL572726";"";"None";"452.47";"0";"4.70";"17";"Cc1ccc(S(=O)(=O)Cc2nc(Nc3ccc(F)cc3)c3cc([N+](=O)[O-])ccc3n2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1047657";"Antitoxoplasmic activity against Toxoplasma gondii PRU-betaGal tachyzoite after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1154711";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.11";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262125";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1995-MAE infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.1";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262119";"Antimicrobial activity against Toxoplasma gondii B1 harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.07";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262122";"Antimicrobial activity against Toxoplasma gondii isolate TRS-2004-REV infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.06";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262132";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2001-MAU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL2347835";"";"None";"334.72";"0";"3.98";"MMV688955";"Cc1cc(NC(=O)c2ccc(Oc3ccc(Cl)cc3O)o2)no1";"IC50";"'='";"7320.0";"nM";"5.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL524973";"";"None";"341.44";"1";"5.94";"MMV645672";"OC1=C2C(=Nc3ccccc3SC2c2ccccc2)c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL563936";"";"None";"281.38";"0";"3.30";"5";"CCOC(=O)c1csc(N/N=C2/CCCCC2C)n1";"IC50";"'='";"185000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL535556";"";"None";"445.53";"1";"5.14";"MMV666070";"O=C(NC1CCCC1)c1ccc(N2CCC(NCc3cccc(C(F)(F)F)c3)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL549216";"";"None";"431.32";"1";"5.34";"MMV020651";"O=C(Nc1ccc(CN2CCOCC2)cc1)c1ccc(-c2cc(Cl)ccc2Cl)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1622128";"";"None";"254.31";"0";"1.62";"MMV396693";"C[n+]1c2ccccc2nc2ccc(NCCO)cc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4205976";"";"None";"556.70";"1";"1.63";"52; FR235222";"CC[C@@]1(C)NC(=O)[C@H](CCCCCC(=O)[C@@H](C)O)NC(=O)[C@H]2C[C@H](C)CN2C(=O)[C@H](Cc2ccccc2)NC1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185234";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii assessed as incorporation of [3H]uracil after 72 hrs by liquid scintillation spectrometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3416958";"";"None";"299.40";"0";"3.78";"8";"Cc1ccc(-c2cc3nc(NC(C)C)[nH]c(=O)c3s2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420013";"Antitoxoplasmic activity against tachyzoite stage of Toxoplasma gondii PRU transfected with beta galactosidase infected in HFF assessed as parasite growth inhibition after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000019";"assay format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3414541";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";"";"";""
"CHEMBL561631";"";"None";"276.32";"0";"2.16";"14";"CCOC(=O)c1csc(N/N=C/c2cccnc2)n1";"IC50";"'='";"162000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL550630";"";"None";"225.27";"0";"2.18";"23";"O=C(O)c1csc(NN=C2CCCC2)n1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL584655";"";"None";"484.60";"1";"5.96";"MMV008455";"COc1ccc(C2C(C(=O)Nc3cccc(OC)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548374";"";"None";"364.45";"1";"5.25";"MMV665797";"CCCCOC(=O)c1ccc(Nc2cc(C)nc3ccc(OC)cc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602586";"";"None";"309.41";"0";"3.34";"MMV073843";"CN(C)c1ccc(N=Cc2ccc(N3CCOCC3)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580388";"";"None";"340.79";"0";"4.72";"MMV665899";"O=C(c1ccccc1F)N(Cc1ccc(Cl)cc1)c1ccccn1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592338";"";"None";"416.52";"0";"4.17";"MMV665913";"CCOc1ccc(-c2nc(NC(=O)c3cccc(S(C)(=O)=O)c3)sc2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590182";"";"None";"448.59";"1";"5.01";"MMV000648";"COc1ccccc1CNC(=O)C1c2ccccc2C(=O)N(CC(C)C)C1c1cccs1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028054";"";"None";"472.45";"1";"5.30";"MMV396681";"Cc1cc(NC(=O)c2cccc(C(F)(F)F)c2)n(-c2nc(-c3ccc4c(c3)OCO4)cs2)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4102877";"";"None";"456.14";"1";"5.58";"5h";"O=c1c2ccccc2nc(-c2ccc(Br)cc2)n1-c1ccc(Br)cc1";"IC50";"'='";"44000.0";"nM";"4.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"Lomustine";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"Ketamine";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"Chlorthalidone";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"Guanethidine";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"Acebutolol";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1098706";"";"None";"417.48";"0";"3.96";"20";"CC1=C(C(=O)NCc2ccc(F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2045330";"Antimicrobial activity against tachyzoites of Toxoplasma gondii expressing PRU-beta-Gal gene infected in HFF after 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2040813";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"Tenoxicam";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1579";"PARAMETHASONE";"None";"392.47";"0";"1.75";"Paramethasone";"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"Naproxen";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"Naloxone";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"Nortriptyline";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL320497";"SUBEROHYDROXAMIC ACID";"None";"204.23";"0";"0.34";"13; SBHA";"O=C(CCCCCCC(=O)NO)NO";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185237";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"43";"NC(=O)c1cccnc1";"IC50";"'='";"50000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185237";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL510070";"";"None";"622.80";"2";"7.25";"(+/-)-25c";"CCCCCCCCCCCCCC(=O)CC(=O)O[C@@H]1C[C@]2(CCC3(C=CC(=O)C=C3)O2)O[C@]2(CCC3(C=CC(=O)C=C3)O2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL428425";"ACULEATIN A";"None";"418.62";"1";"6.17";"(-)-aculeatin D";"CCCCCCCCCCCCC[C@@H]1C[C@@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"436.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL3219285";"";"None";"521.68";"2";"5.38";"5";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCN(CCC45CC6CC(CC(C6)C4)C5)CC3)c(F)cc2c1=O";"IC50";"'='";"920.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223457";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL23657";"";"None";"311.35";"0";"1.51";"12m";"COc1cccc(C)c1NCc1cnc2nc(N)nc(N)c2n1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL570076";"";"None";"239.30";"0";"2.57";"26";"O=C(O)c1csc(NN=C2CCCCC2)n1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL23272";"";"None";"311.41";"0";"3.10";"13d";"Cc1cccc(SCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL586704";"";"None";"409.51";"0";"4.62";"MMV006429";"Cc1cc(NC(=O)C2c3ccccc3C(=O)N(CC(C)C)C2c2cccs2)no1";"IC50";"'='";"20850.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028055";"";"None";"317.82";"0";"3.52";"MMV396703";"CCN(CC)CCNc1ncnc2c1[nH]c1ccc(Cl)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL525486";"";"None";"413.53";"0";"4.11";"MMV020548";"CCN1CCN(Cc2ccc(NC(=O)c3cc4ccc5cccnc5c4[nH]3)cc2)CC1";"IC50";"'='";"3850.0";"nM";"5.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL524930";"";"None";"354.47";"0";"4.02";"MMV666116";"Oc1ccccc1CN1CCC2(CCCN(Cc3ccccc3F)C2)C1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL607975";"";"None";"199.25";"0";"2.98";"MMV006913";"C=CCc1c(C)nc2ccccc2c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028064";"";"None";"465.47";"0";"4.32";"MMV403679";"Cc1cccc(-n2ncc3c(O)nc(-n4nc(C)cc4NC(=O)c4cc5ccccc5o4)nc32)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL534288";"";"None";"448.52";"0";"4.30";"MMV011795";"O=C(O)C(=O)O.Oc1ccccc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL23244";"";"None";"357.44";"0";"2.81";"13h";"COc1ccc(SCc2cnc3nc(N)nc(N)c3c2C)cc1OC";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL796";"METHYLPHENIDATE";"4.0";"233.31";"0";"2.09";"Methylphenidate";"COC(=O)C(c1ccccc1)C1CCCCN1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1595";"DIHYDROCODEINE";"4.0";"301.39";"0";"1.73";"Dihydrocodeine";"COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"Lacidipine";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL535514";"";"None";"637.73";"2";"5.50";"MMV666601";"CCOC(=O)C1=C(c2ccccc2)N=c2sc(=Cc3cc(C)n(-c4ccc(F)cc4)c3C)c(=O)n2C1c1cccc(OC)c1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592125";"";"None";"401.89";"1";"5.65";"MMV665972";"O=C(Cc1ccccc1)NC(c1ccc(Cl)cc1)c1c(O)ccc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028048";"";"None";"489.52";"1";"5.36";"MMV396664";"CCOC(=O)c1c(C)n(-c2ccccc2)c2ccc(OC(=O)c3cc(OC)c(OC)c(OC)c3)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL597248";"";"None";"326.40";"0";"4.99";"MMV006169";"c1ccc(CNc2nc(Nc3ccccc3)nc3ccccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL3099581";"";"None";"358.43";"0";"4.29";"3";"Nc1nc2[nH]c3cccc(Sc4cccc5ccccc45)c3c2c(=O)[nH]1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101464";"Antibacterial activity against tachyzoite stage of Toxoplasma gondii PHdeltaHX infected in human TerT cells measured after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"TerT";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3098035";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"19100.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"2";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL259192";"";"None";"289.21";"0";"0.84";"17";"CCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"9370.0";"nM";"5.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL1441";"ETHIONAMIDE";"4.0";"166.25";"0";"1.28";"Ethionamide";"CCc1cc(C(N)=S)ccn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214314";"TROVAFLOXACIN7";"None";"444.41";"0";"2.53";"SI, trovafloxacin7";"C[C@@H]1[C@@H]2[C@@H](CN)[C@@H]2CN1c1nc2c(cc1F)c(=O)c(C(=O)O)cn2-c1ccc(F)cc1F";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL23492";"";"None";"300.75";"0";"2.45";"15b";"Nc1nc(N)c2cc(CNc3ccc(Cl)cc3)cnc2n1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1774292";"";"None";"825.09";"2";"3.47";"11";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL376149";"";"None";"749.00";"2";"2.21";"14";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"106000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774302";"";"None";"803.09";"2";"3.85";"23";"C=CO[C@]1(C)C[C@@H](C)CN(CCC)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774292";"";"None";"825.09";"2";"3.47";"11";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774453";"";"None";"831.14";"2";"3.85";"31";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CC2CCCCC2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"3";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"3";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"44000.0";"nM";"4.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774297";"";"None";"839.12";"2";"4.13";"18";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)CN(Cc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774451";"";"None";"839.12";"2";"3.78";"28";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(C)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL23569";"";"None";"340.39";"0";"2.13";"2b";"COc1cc(NCc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL50514";"";"None";"384.44";"0";"2.16";"1b";"COc1cc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813897";"Inhibitory concentration of cell growth from Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1132261";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL598279";"";"None";"356.43";"0";"4.99";"MMV000963";"COc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530978";"";"None";"328.17";"0";"4.12";"MMV666599";"O=c1nc(C=Cc2ccc(Br)cc2)oc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602179";"";"None";"286.76";"0";"4.34";"MMV665924";"COc1ccc(C(=O)C2CC2c2ccc(Cl)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL606252";"";"None";"405.50";"0";"3.62";"MMV008474";"CCN1CCN(c2c(C(=O)c3ccccc3)cnc3cc(OC)c(OC)cc23)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532510";"";"None";"436.58";"1";"5.22";"MMV666106";"O=C(NC1CCCCC1)C(c1cccs1)N(CCc1ccccc1)C(=O)c1ccco1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601814";"";"None";"440.29";"0";"3.00";"MMV006764";"CCOc1c(Br)cc(C2C(C(=O)OC)=CN(C)C=C2C(=O)OC)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600706";"";"None";"354.81";"1";"5.78";"MMV007275";"Cc1ccc(F)cc1NC(=O)c1cc(Cl)ccc1Nc1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529968";"";"None";"393.40";"0";"4.51";"MMV666060";"COc1ccc(CN2CCCC(C(=O)c3ccc(C(F)(F)F)cc3)C2)c(O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL599885";"";"None";"659.69";"2";"6.64";"MMV007228";"Cc1cccc(N2C(=O)C3C(C2=O)C2(c4ccccc4)C(=O)C3(c3ccccc3)C(c3ccc4c(c3)OCO4)=C2c2ccc3c(c2)OCO3)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529874";"";"None";"332.36";"0";"4.70";"MMV086103";"Cc1ccc(C(=O)c2oc3ccc4c(C)cc(=O)oc4c3c2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580353";"";"None";"360.89";"0";"3.32";"MMV665782";"C=CC12CCN(CC1)C(C(O)c1ccnc3ccc(OC)cc13)C2.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL605751";"";"None";"453.55";"1";"8.40";"MMV666023";"c1ccc(Cn2c(N=Nc3c(Nc4ccccc4)ccc4ccccc34)nc3ccccc32)cc1";"IC50";"'='";"13480.0";"nM";"4.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL546994";"";"None";"309.32";"0";"3.38";"MMV666693";"COc1cccc(C=Cc2nc(=O)c3ccccc3o2)c1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602413";"";"None";"308.39";"0";"3.39";"MMV001038";"Cc1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590919";"";"None";"355.95";"0";"3.72";"MMV665817";"CC(C)(C)CC(C)(C)NCC(O)COc1ccc2c(c1)CCC2.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL525826";"";"None";"346.82";"0";"2.79";"MMV011944";"COc1cccc(Nc2nc(NCCO)c3ccccc3n2)c1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL511190";"TIROXINE";"None";"475.75";"None";"None";"Tiroxine";"CC1=C(C(=O)Nc2ccccc2)SCCO1.CN(C)C(=S)SSC(=S)N(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"Salbutamol";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213420";"DROXICAM";"2.0";"357.35";"0";"0.99";"Droxicam";"CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL781";"MAZINDOL";"4.0";"284.75";"0";"2.61";"Mazindol";"OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"Diazoxide";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"Ketotifen";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL485";"CODEINE";"4.0";"299.37";"0";"1.50";"Codeine";"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"1";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL839";"CARTEOLOL";"4.0";"292.38";"0";"1.70";"Carteolol";"CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"Carbamazepine";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1008";"BEPRIDIL";"4.0";"366.55";"0";"4.83";"Bepridil";"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"Beclomethasone";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1222994";"";"None";"374.42";"0";"2.27";"6h";"CC(C)CN(CC(C)C)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1222995";"";"None";"390.42";"0";"1.40";"6k";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)NCCO)cc1[N+](=O)[O-]";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"Vitamin C";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL433";"VALPROATE SODIUM";"4.0";"166.20";"0";"2.29";"Valproate";"CCCC(CCC)C(=O)[O-].[Na+]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1095421";"";"None";"471.64";"1";"6.51";"11";"CSc1ccc(-c2csc(C3=C(C)[C@@H]4CC[C@@H](C)[C@@H]5CC[C@@]6(C)OO[C@@]45[C@H](O3)O6)n2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1094437";"";"None";"410.47";"0";"4.71";"14";"CC1=C(c2nc(-c3ccccc3)no2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095737";"";"None";"377.51";"0";"4.68";"7";"CCc1csc(C2=C(C)[C@@H]3CC[C@@H](C)[C@@H]4CC[C@@]5(C)OO[C@@]34[C@H](O2)O5)n1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL282948";"";"None";"334.43";"0";"2.99";"14l";"Cc1c(CNc2cccc3c2CCCC3)cnc2nc(N)nc(N)c12";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL597444";"";"None";"298.77";"1";"5.03";"MMV007285";"CCOc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL3099582";"";"None";"358.43";"0";"4.29";"1";"Nc1nc2[nH]c3cccc(Sc4ccc5ccccc5c4)c3c2c(=O)[nH]1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101464";"Antibacterial activity against tachyzoite stage of Toxoplasma gondii PHdeltaHX infected in human TerT cells measured after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"TerT";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3098035";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1260.0";"nM";"5.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"115";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420013";"Antitoxoplasmic activity against tachyzoite stage of Toxoplasma gondii PRU transfected with beta galactosidase infected in HFF assessed as parasite growth inhibition after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000019";"assay format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3414541";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";"";"";""
"CHEMBL1222933";"";"None";"406.42";"0";"2.57";"6g";"NS(=O)(=O)c1cc([N+](=O)[O-])c(N(Cc2ccccc2)CC2CC2)c([N+](=O)[O-])c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL370691";"";"None";"350.36";"0";"1.72";"3h";"CCN1C(=O)C(CC(=O)O)S/C1=N\N=C\c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL586442";"";"None";"359.77";"0";"3.66";"MMV020660";"COc1ccc(-c2nonc2NC(=O)c2cccc(Cl)c2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601378";"";"None";"420.33";"1";"6.70";"MMV007127";"OC1=C2C(=Nc3ccccc3SC2c2ccc(Br)cc2)c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589951";"";"None";"411.96";"1";"5.82";"MMV666123";"CC(C)(C)c1ccc(C(=O)Nc2c3c(nn2-c2cccc(Cl)c2)CSC3)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527541";"";"None";"268.14";"0";"4.11";"MMV665994";"Cc1nc2ccccc2c(O)c1CC=C(Cl)Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"Phenytoin";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213285";"";"None";"343.51";"1";"6.01";"B";"CCCCCCCCCCCCc1c(C)n(O)c2ccccc2c1=O";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1218417";"Antimicrobial activity against Toxoplasma gondii type 1 RH strain infected in human foreskin fibroblasts monolayer assessed as inhibition of parasite replication after 24 hrs by phase-contrast microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212767";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";""
"CHEMBL1201891";"DEFLAZACORT";"4.0";"441.52";"0";"2.56";"Deflazacort";"CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1256901";"BUTYLSCOPOLAMINE BROMIDE";"4.0";"440.38";"0";"2.23";"Butyl Hioscine";"CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL511142";"BUPRENORPHINE";"4.0";"467.65";"0";"4.41";"Buprenorphine";"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"13800.0";"nM";"4.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL2042573";"";"None";"190.16";"0";"1.85";"21";"O=[N+]([O-])c1cccc2ccc(O)nc12";"IC50";"'='";"56100.0";"nM";"4.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2044352";"Antitoxoplasmic activity against Toxoplasma gondii PRU tachyzoites infected in human HFF cells assessed as beta-galactosidase activity after 72 hrs by colorimetric assay";"F";"BAO_0000219";"cell-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2040716";"1";"Scientific Literature";"Eur J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL2179162";"";"None";"549.26";"1";"4.05";"14b";"CN(CC(=O)NN)C(=O)Oc1ccc(Cl)cc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183807";"Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites expressing yellow fluorescent protein infected in HFF cells after 72 hrs by fluorescence assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2176997";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL4229196";"";"None";"335.45";"0";"4.18";"6l";"CC(C)CCn1c(-c2ccc(N(C)C)cc2)nc2ccccc2c1=O";"IC50";"'='";"35000.0";"nM";"4.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"ATO, ATOV";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL919805";"Inhibition of Toxoplasma gondii RH replication in human foreskin fibroblasts incubated for 24 hrs with drug after 36 hrs postinfection by immunofluorescence microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1147098";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"Labetalol";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"Indomethacin";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"ibuprofen";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL568";"OXAZEPAM";"4.0";"286.72";"0";"2.45";"Oxazepam";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"Bambuterol";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"Thioridazine";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1765150";"";"None";"401.42";"0";"3.96";"27";"CCCCCCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"11270.0";"nM";"4.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"13500.0";"nM";"4.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL81995";"";"None";"383.42";"0";"3.11";"SI, azepine7";"Nc1nc(N)c2nc(CN3c4ccccc4C=Cc4cc(O)ccc43)cnc2n1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213595";"";"None";"270.31";"0";"4.23";"SI,11";"O=[N+]([O-])c1ccc(Sc2cc3ccccc3[nH]2)cc1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214187";"TROVAFLOXACIN1";"None";"430.39";"0";"2.28";"SI, trovafloxacin1";"C[C@@H]1[C@@H]2[C@@H](N)[C@@H]2CN1c1nc2c(cc1F)c(=O)c(C(=O)O)cn2-c1ccc(F)cc1F";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214190";"TROVAFLOXACIN2";"None";"430.39";"0";"2.16";"SI, trovafloxacin2";"CN[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL2028049";"";"None";"420.49";"0";"4.83";"MMV396665";"COc1cc(C(=O)Nc2nc3c(cc4c5c(cccc53)CC4)s2)cc(OC)c1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586344";"";"None";"273.33";"0";"2.44";"MMV665841";"CCCc1cc(O)c2c3c(c(=O)oc2c1)CN(C)CC3";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592344";"";"None";"462.62";"1";"5.40";"MMV000653";"CCOc1ccccc1CNC(=O)C1c2ccccc2C(=O)N(CC(C)C)C1c1cccs1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL583844";"";"None";"423.43";"0";"3.39";"MMV665918";"O=C(CSc1ccc2nnc(-c3cccc(F)c3)n2n1)Nc1ccc2c(c1)OCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579105";"";"None";"308.36";"0";"4.28";"MMV006319";"Cc1cc(Nc2cccc(F)c2)nc(NCc2ccccc2)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530531";"";"None";"347.26";"0";"3.78";"MMV020505";"CN(C)CCCNCc1ccc(-c2ccc(F)c(Cl)c2)o1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600374";"";"None";"366.89";"0";"3.95";"MMV000839";"Cl.OC(CNCc1ccccc1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590201";"";"None";"391.90";"0";"4.48";"MMV000481";"CCOc1cc2c(cc1OCC)C(c1cc(Cl)c(O)c(OCC)c1)NCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3335811";"";"None";"269.33";"0";"2.39";"34A";"O=C1CS/C(=N/N=C\c2cccc3ccccc23)N1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL1201519";"VITAMIN K";"4.0";"None";"None";"None";"Vitamin K";"";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1228";"OXYPHENBUTAZONE ANHYDROUS";"4.0";"324.38";"0";"3.49";"Oxyphenbutazone, SI, Hydrazide";"CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL224182";"";"None";"329.48";"1";"5.70";"HDQ";"CCCCCCCCCCCCc1cc(=O)c2ccccc2n1O";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1218417";"Antimicrobial activity against Toxoplasma gondii type 1 RH strain infected in human foreskin fibroblasts monolayer assessed as inhibition of parasite replication after 24 hrs by phase-contrast microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212767";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"None";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"Procainamide";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213352";"PINAZEPAM";"2.0";"308.77";"0";"3.16";"Pinazepam";"C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"Terfenadine";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"Reserpine";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL281803";"";"None";"354.41";"0";"2.15";"3c";"COc1ccc(OC)c(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813897";"Inhibitory concentration of cell growth from Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1132261";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"21200.0";"nM";"4.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"15700.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1096207";"";"None";"435.47";"0";"4.10";"23";"CC1=C(C(=O)NCc2ccc(F)c(F)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"21700.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"28700.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"18400.0";"nM";"4.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"9700.0";"nM";"5.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"16900.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1098512";"";"None";"557.28";"2";"5.35";"25";"CC1=C(C(=O)NCc2cc(Br)cc(Br)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"10200.0";"nM";"4.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"17200.0";"nM";"4.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL601156";"";"None";"335.32";"0";"3.56";"MMV666125";"CC1=C(CC(=O)c2cccc([N+](=O)[O-])c2)C(=O)c2ccccc2C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL583682";"";"None";"334.38";"0";"3.52";"MMV666686";"COc1ccccc1C(=O)ON=C(N)Cc1cccc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600444";"";"None";"395.73";"0";"4.13";"MMV665809";"Oc1ccc(Br)cc1CN1CCN(Cc2ccc(Cl)cc2)CC1";"IC50";"'='";"14460.0";"nM";"4.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL549208";"";"None";"494.66";"0";"4.96";"MMV666105";"COCCN(C(=O)Cc1cccs1)C(C(=O)NCc1ccc(OC)cc1)c1ccc(C(C)C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601567";"";"None";"349.86";"0";"3.96";"MMV665857";"CCOc1c(Cl)cc(CNC(C)C(O)c2ccccc2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591183";"";"None";"425.96";"0";"4.84";"MMV000788";"CC(C)OCc1cc(CN2CCN(c3cccc(Cl)c3)CC2)c(O)c2ncccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590944";"";"None";"278.71";"0";"4.43";"MMV000911";"Cc1ccc(NC(=O)Nc2cccc(Cl)c2)cc1F";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1545915";"";"None";"368.40";"0";"3.79";"MMV396749";"COc1ccc2c(c1)C1(Nc3ccccc3-c3nc4ccccc4n31)C(=O)N2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL597262";"";"None";"260.35";"0";"0.94";"MMV667487";"CN(C)c1ccc(N2C(N)=NC(N)=NC2(C)C)cc1";"IC50";"'='";"28920.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028050";"";"None";"401.51";"0";"4.70";"MMV396669";"Cc1cc(N2CCCC2)nc(Nc2ccc(NC(=O)CCc3ccccc3)cc2)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3334515";"";"None";"301.42";"0";"3.29";"12B";"CC1CCC/C1=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"53000.0";"nM";"4.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335821";"";"None";"317.46";"0";"4.07";"8B";"CCCCC/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335820";"";"None";"303.43";"0";"3.54";"7B";"C/C(CC(C)C)=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335815";"";"None";"275.38";"0";"2.90";"2B";"CC/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"99000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"6.7";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262124";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2005-HAG infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRI";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL119";"TRIMETREXATE";"4.0";"369.43";"0";"2.74";"Trimetrexate";"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813900";"Inhibitory activity against Toxoplasma gondii cell growth(ca denotes calculated value)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1464005";"IPRATROPIUM BROMIDE";"None";"412.37";"0";"2.85";"Ipratropium";"CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.[Br-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"Furosemide";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL279679";"";"None";"368.44";"0";"2.91";"14i";"CCOc1ccc(OCC)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Cipr";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223458";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL224182";"";"None";"329.48";"1";"5.70";"HDQ";"CCCCCCCCCCCCc1cc(=O)c2ccccc2n1O";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL918333";"Inhibition of Toxoplasma gondii RH replication in human foreskin fibroblasts incubated for 24 hrs with drug after 2 hrs postinfection by immunofluorescence microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1147098";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL3416970";"";"None";"333.84";"0";"4.52";"20";"CC(C)(C)Nc1nc2cc(-c3ccc(Cl)cc3)sc2c(=O)[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420013";"Antitoxoplasmic activity against tachyzoite stage of Toxoplasma gondii PRU transfected with beta galactosidase infected in HFF assessed as parasite growth inhibition after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000019";"assay format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3414541";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";"";"";""
"CHEMBL402300";"";"None";"413.46";"0";"3.02";"2n";"COc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c(OC)c1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL403382";"";"None";"273.34";"0";"3.15";"1f";"Fc1ccccc1/C=N/NC(=S)Nc1ccccc1";"IC50";"'='";"1500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL402300";"";"None";"413.46";"0";"3.02";"2n";"COc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c(OC)c1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL251896";"";"None";"289.79";"0";"3.66";"1b";"S=C(N/N=C/c1ccc(Cl)cc1)Nc1ccccc1";"IC50";"'='";"1500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"880.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"14700.0";"nM";"4.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264575";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"28500.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL409012";"";"None";"275.18";"0";"0.45";"16";"CCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL939263";"Growth inhibition of Toxoplasma gondii tachyzoites in HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1143873";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.25";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262133";"Antimicrobial activity against Toxoplasma gondii isolate GUY-2003-MEL harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly/ A597E/627 sil Glu mutant gene and DHFR Ex2, 145 sil Val mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.03";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262129";"Antimicrobial activity against Toxoplasma gondii NED infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.11";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262124";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2005-HAG infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1214315";"TROVAFLOXACIN8";"None";"416.36";"0";"2.04";"SI, trovafloxacin8";"NC12CC1CN(c1nc3c(cc1F)c(=O)c(C(=O)O)cn3-c1ccc(F)cc1F)C2";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL584015";"";"None";"496.69";"1";"5.56";"MMV007591";"COc1ccc(C(=O)C(CCC(CNC(C)(C)C)C(=O)c2ccc(OC)cc2)CNC(C)(C)C)cc1";"IC50";"'='";"8230.0";"nM";"5.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579331";"";"None";"289.34";"0";"4.03";"MMV011832";"Oc1ccc2ccccc2c1CNc1nc2ccccc2[nH]1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548334";"";"None";"303.39";"0";"3.91";"MMV665894";"CC(=O)c1sc(NC(=O)Nc2ccc(C)cc2C)nc1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1237255";"";"None";"472.47";"1";"4.43";"MMV666689";"COc1ccc(Nc2nc(N/N=C/c3ccc(O)cc3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592105";"METHYLROSANILINE";"-1.0";"389.54";"0";"4.17";"MMV665941";"CN(C)c1ccc(C(O)(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530973";"";"None";"456.51";"0";"4.03";"MMV665977";"CCOC(=O)c1cn(CC)c2cc(N(C)CCc3ccc(OC)c(OC)c3)c(F)cc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1615697";"";"None";"468.11";"1";"8.20";"MMV666596";"CSC1=NC(=Nc2c(C)cccc2C)C2(CCC(C(C)(C)C)CC2)N1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1460047";"";"None";"309.33";"0";"2.18";"MMV396797";"COc1ccc(-c2c(C)nn3c(N)c(C#N)cnc23)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601348";"";"None";"334.39";"0";"3.58";"MMV007686";"CCCCCCOC(=O)C1=C(C)NC(=O)NC1c1ccccc1F";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1459149";"";"None";"329.84";"0";"3.61";"MMV396678";"CCN1CCCC1CNc1[nH]cnc2c3cc(Cl)ccc3nc1-2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL261693";"";"None";"272.31";"0";"3.66";"MMV666021";"Cc1ccc(-c2cc3c(nn2)-c2ccccc2C3=O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582486";"";"None";"357.81";"0";"2.13";"MMV665917";"O=C(Nc1ccc(Cl)cc1)N1CCN(c2ccc3nncn3n2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580159";"";"None";"273.72";"0";"3.53";"MMV665850";"Oc1ccc(Cl)cc1CNc1nc2ccccc2[nH]1";"IC50";"'='";"26830.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580876";"";"None";"381.82";"0";"4.25";"MMV665799";"COc1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccncc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028044";"";"None";"380.49";"0";"3.69";"MMV396595";"CCOc1ccccc1CN1CCc2nc3cc(C(C)(C)C)nn3c(O)c2C1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1744512";"";"None";"310.38";"0";"3.59";"MMV665836";"COc1ccc(/C=C2/SC(=Nc3ccccc3)NC2=O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601534";"";"None";"645.20";"2";"6.86";"MMV007474";"COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1C(Cc1ccc(O)c(c1)Oc1ccc(cc1)CC3N(C)CC2)N(C)CC4.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL528492";"";"None";"297.79";"0";"1.27";"MMV667486";"CCOc1ccc(N2C(N)=NC(N)=NC2(C)C)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587104";"";"None";"372.42";"1";"5.13";"MMV020750";"COc1cc(-c2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)cc(OC)c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585966";"";"None";"394.43";"0";"3.54";"MMV666687";"COc1cc(C(=O)ON=C(N)Cc2cccc3ccccc23)cc(OC)c1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3334533";"";"None";"310.38";"0";"2.55";"30B";"O=C1CS/C(=N/N=C\c2ccncc2)N1Cc1ccccc1";"IC50";"'='";"118000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335816";"";"None";"289.40";"0";"3.29";"3B";"CCC/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"47000.0";"nM";"4.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335726";"";"None";"234.28";"0";"1.02";"27A";"C/C(=N/N=C1\NC(=O)CS1)c1ccccn1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334519";"";"None";"315.44";"0";"3.68";"16B";"CC1CCC/C(=N/N=C2/SCC(=O)N2Cc2ccccc2)C1";"IC50";"'='";"58000.0";"nM";"4.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334514";"";"None";"287.39";"0";"3.05";"11B";"O=C1CS/C(=N/N=C2CCCC2)N1Cc1ccccc1";"IC50";"'='";"105000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.14";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262126";"Antimicrobial activity against Toxoplasma gondii isolate PSP-2005-MUP infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL531290";"";"None";"326.45";"0";"4.46";"MMV665876";"CCC(c1ccccc1)c1nn2c(-c3cccs3)nnc2s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580381";"";"None";"279.34";"0";"3.29";"MMV006937";"Cc1ccc(-c2cc3nc4c(c(O)n3n2)CCCC4)cc1";"IC50";"'='";"8220.0";"nM";"5.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590888";"";"None";"293.53";"0";"3.63";"MMV665820";"COc1ccc2c(=O)cc(C(Cl)(Cl)Cl)oc2c1";"IC50";"'='";"6450.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585686";"";"None";"422.96";"0";"3.07";"MMV666093";"CCCC(c1nnnn1C1CCCCC1)N1CCN(C(=O)c2ccco2)CC1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602127";"";"None";"458.63";"0";"4.56";"MMV000561";"CCCN(CCC)CCCNC(=O)c1cc2c(-c3ccc(OC)c(OC)c3)nn(C)c2s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028061";"";"None";"405.48";"0";"3.93";"MMV396744";"CC(C)CNC(=O)c1c(N)n(CCc2ccccc2F)c2nc3ccccc3nc12";"IC50";"'='";"26750.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL604389";"";"None";"496.50";"1";"5.20";"MMV009108";"Br.CCN(CC)S(=O)(=O)c1ccc(-c2csc(Nc3ccc(C)c(C)c3)n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581240";"";"None";"493.40";"0";"4.64";"MMV019127";"CCN(Cc1ccccc1)C1CCN(Cc2cc(Br)ccc2O)CC1.O=C(O)C(=O)O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601612";"";"None";"445.52";"0";"3.51";"MMV011576";"CCOC(=O)C1CCN(C(=O)CN2C(=O)c3ccccc3C2c2c[nH]c3ccccc23)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL606531";"";"None";"314.47";"0";"3.79";"MMV665806";"Cc1c(C)n(CC(O)CNC2CCCCC2C)c2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585431";"";"None";"357.41";"0";"2.07";"MMV007791";"CCOc1ccccc1NC(=O)CN1CCN(C(=O)c2ccco2)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590933";"";"None";"417.98";"0";"4.25";"MMV000445";"CCCCCCn1c(=N)n(CC(O)COc2cccc(C)c2)c2ccccc21.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532015";"";"None";"403.92";"0";"4.79";"MMV666124";"CC(=O)c1ccc(NC(=O)CSc2nc(-c3ccccc3Cl)ns2)cc1";"IC50";"'='";"14920.0";"nM";"4.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL599886";"";"None";"318.33";"0";"4.39";"MMV006753";"Cc1cc(=O)oc2c1ccc1oc(C(=O)c3ccccc3)c(C)c12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL528437";"";"None";"448.37";"1";"7.15";"MMV665794";"FC(F)(F)c1cccc(Nc2nc3ccccc3nc2Nc2cccc(C(F)(F)F)c2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589723";"";"None";"352.79";"1";"5.61";"MMV000326";"Cc1ccc2nc(C)cc(Nc3cccc(C(F)(F)F)c3)c2c1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601041";"";"None";"350.85";"1";"5.53";"MMV000304";"CCOc1ccc(Nc2c3ccccc3nc3ccccc23)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600488";"";"None";"280.17";"0";"3.96";"MMV666095";"CCCc1c(C)nc2ccc(Br)cc2c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548209";"";"None";"430.52";"1";"5.53";"MMV665943";"Nc1ccc(-c2nc3cc(Cc4ccc5[nH]c(-c6ccc(N)cc6)nc5c4)ccc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581475";"";"None";"501.37";"2";"7.04";"MMV006962";"O=C(Nc1ccc(-c2nc3cc(NC(=O)c4ccc(Cl)cc4)ccc3[nH]2)cc1)c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529385";"";"None";"302.76";"0";"2.96";"MMV019199";"COc1cccc(Nc2nc(N)c3ccccc3n2)c1.Cl";"IC50";"'='";"28120.0";"nM";"4.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588481";"";"None";"574.24";"2";"5.29";"MMV665882";"OC(CNC1CCCCC1)Cn1c2ccc(I)cc2c2cc(I)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"Ticlopidine";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"Sulindac";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"SID11111623";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"Ethosuximide";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL13828";"OXATOMIDE";"4.0";"426.56";"0";"4.13";"Oxatomide";"O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1095407";"";"None";"377.51";"0";"4.74";"3";"CC1=C(c2nc(C)c(C)s2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095724";"";"None";"425.55";"1";"5.79";"5";"CC1=C(c2nc(-c3ccccc3)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1098511";"";"None";"435.47";"0";"4.10";"24";"CC1=C(C(=O)NCc2cc(F)cc(F)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1095537";"";"None";"363.48";"0";"4.43";"2";"CC1=C(c2nc(C)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1099046";"";"None";"413.51";"0";"4.13";"21";"CC1=C(C(=O)NCc2ccc(C)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1094436";"";"None";"348.40";"0";"3.35";"13";"CC1=C(c2nc(C)no2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1098749";"";"None";"337.42";"0";"2.64";"15";"CCNC(=O)C1=C(C)[C@@H]2CC[C@@H](C)[C@@H]3CC[C@@]4(C)OO[C@@]23[C@H](O1)O4";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL582119";"";"None";"465.62";"1";"7.40";"MMV085471";"CCOc1ccc(-n2cc(-c3ccccc3)c3c(SCc4cc(C)ccc4C)ncnc32)cc1";"IC50";"'='";"11160.0";"nM";"4.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580516";"";"None";"507.05";"0";"4.87";"MMV019690";"COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1CN1CCN(c2ccc(F)cc2)CC1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601743";"";"None";"436.01";"1";"5.10";"MMV000621";"CCCCCCC(O)(c1ccc(F)cc1)C(CN1CCOCC1)c1ccccc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL578933";"";"None";"480.59";"1";"7.28";"MMV007273";"COc1cc(-c2nc(-c3ccc(Sc4ccccc4)cc3)c(-c3ccccc3)[nH]2)cc(OC)c1O";"IC50";"'='";"5850.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL578508";"";"None";"290.25";"0";"2.92";"MMV665923";"N=c1c2ccccc2nnn1-c1cccc(C(F)(F)F)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028062";"";"None";"352.44";"0";"2.43";"MMV396770";"O=C(NNc1cc(N2CCCC2)nc(N2CCCC2)n1)c1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL253845";"";"None";"481.62";"1";"5.30";"2p";"CC(C)(C)c1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc(C(C)(C)C)c1O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL253107";"";"None";"396.47";"0";"3.07";"2i";"CN(C)c1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL3335723";"";"None";"225.30";"0";"1.30";"24A";"O=C1CS/C(=N/N=C\c2cccs2)N1";"IC50";"'='";"135000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"13300.0";"nM";"4.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"25300.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"9700.0";"nM";"5.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256668";"BENFLURALIN";"None";"335.28";"0";"4.15";"2";"CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"9300.0";"nM";"5.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1223066";"DINITRAMINE";"None";"322.24";"0";"2.95";"4";"CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-]";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"19500.0";"nM";"4.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256704";"FLUCHLORALIN";"None";"355.70";"0";"3.98";"6";"CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"20500.0";"nM";"4.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL23211";"";"None";"315.38";"0";"3.56";"16a";"Nc1nc(N)c2cc(CNc3cccc4ccccc34)ccc2n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1341";"METHOXYFLURANE";"4.0";"164.97";"0";"2.03";"Methoxyflurane";"COC(F)(F)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"Felodipine";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"Etoposide";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL358150";"ETOFIBRATE";"2.0";"363.80";"0";"3.29";"Etofibrate";"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL59";"DOPAMINE";"4.0";"153.18";"0";"0.60";"Dopamine";"NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1199080";"BRETYLIUM";"4.0";"243.17";"0";"3.05";"Bretylium";"CC[N+](C)(C)Cc1ccccc1Br";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1102";"GLUTETHIMIDE";"4.0";"217.27";"0";"1.77";"Glutethimide";"CCC1(c2ccccc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213007";"";"None";"241.32";"0";"3.33";"SI,9";"[O-][S+](c1ccccc1)c1cc2ccccc2[nH]1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1214189";"TROVAFLOXACIN11";"None";"430.39";"0";"2.14";"SI, trovafloxacin11";"NC[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL592786";"";"None";"321.80";"0";"3.40";"MMV128432";"COc1cc(CNCCc2ccc(Cl)cc2)cc(OC)c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL577445";"";"None";"286.33";"0";"3.96";"MMV665824";"Cn1c(C(=O)c2cccc3ccccc23)nc2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL604323";"";"None";"380.44";"0";"4.79";"MMV008294";"CCOC(=O)c1cnc2c(C)cc(C)cc2c1Nc1ccc(OC)c(OC)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579443";"";"None";"459.93";"1";"6.39";"MMV666600";"CCOC(=O)c1c(C)n(-c2ccc(Cl)cc2)c2ccc(OC(=O)C=Cc3ccccc3)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547269";"";"None";"434.54";"0";"3.95";"MMV019074";"CCN1CCN(c2cc(C)c3cc(NC(=O)c4ccc(OC)c(OC)c4)ccc3n2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533917";"";"None";"354.41";"0";"4.46";"MMV666080";"O=C(NC(c1ccccc1)c1ccc2cccnc2c1O)c1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586962";"";"None";"493.61";"0";"4.00";"MMV019064";"COc1cccc(-c2nn(C)c3sc(C(=O)NCCN4CCN(c5ccccc5F)CC4)cc23)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL596652";"";"None";"427.32";"0";"2.76";"MMV007430";"O=C(NCc1ccco1)C1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600132";"";"None";"287.32";"0";"1.31";"MMV084940";"COc1cc2c(cc1OC)C1=NNC(=O)C1=NC(C)(C)C2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580757";"";"None";"218.26";"0";"1.35";"MMV665904";"COCCn1c(C)nc2ccccc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589205";"";"None";"377.91";"0";"4.04";"MMV000483";"CCOc1cc2c(cc1OCC)C(c1cc(C)c(O)c(C)c1)NCC2.Cl";"IC50";"'='";"12850.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591623";"";"None";"417.44";"0";"4.96";"MMV000604";"COc1ccc(-c2cc(=O)oc3c4c(ccc23)OCN(Cc2ccc(F)cc2)C4)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548338";"";"None";"496.01";"1";"7.33";"MMV020403";"COc1ccc(-c2cn3c(C(=O)Nc4ccccc4Cl)c(-c4ccccc4)c4c3n2CCCC4)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602580";"";"None";"292.51";"0";"4.08";"MMV665830";"CC1CC2=C(CC1CNCCCN(C)C)C(C)(C)CCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532525";"";"None";"385.87";"1";"5.30";"MMV665886";"CC(Oc1ccc(NC(=O)c2cccs2)cc1)C(=O)c1ccc(Cl)cc1";"IC50";"'='";"10460.0";"nM";"4.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3334517";"";"None";"301.41";"0";"3.44";"14B";"O=C1CS/C(=N/N=C2CCCCC2)N1Cc1ccccc1";"IC50";"'='";"255000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334516";"";"None";"301.42";"0";"3.29";"13B";"CC1CC/C(=N/N=C2/SCC(=O)N2Cc2ccccc2)C1";"IC50";"'='";"184000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL591053";"";"None";"211.29";"0";"1.53";"14A";"O=C1CSC(NN=C2CCCCC2)=N1";"IC50";"'='";"28000.0";"nM";"4.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335634";"";"None";"199.28";"0";"1.38";"4A";"CCC(CC)=N/N=C1\NC(=O)CS1";"IC50";"'='";"126000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334534";"";"None";"324.41";"0";"2.94";"31B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1ccncc1";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL577440";"";"None";"331.42";"0";"2.60";"MMV008127";"CN1CCN(c2c3c(c(C#N)c4nc5ccccc5n24)CCC3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579294";"";"None";"268.36";"0";"3.67";"MMV075490";"CCOc1ccc(C2N(C)c3ccccc3N2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586468";"";"None";"278.31";"0";"3.90";"MMV018984";"Cc1cc(NC(=O)c2ccc(-c3ccccc3)cc2)no1";"IC50";"'='";"21060.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL470514";"";"None";"267.36";"0";"4.26";"MMV007907";"Cc1ccc(Nc2nc(-c3ccccn3)cs2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588732";"";"None";"444.60";"0";"4.99";"MMV007564";"Cc1ccc(Cn2c(N3CCC(C(=O)NCc4cccs4)CC3)nc3ccccc32)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL338094";"";"None";"337.18";"0";"4.12";"MMV665934";"O=C1c2ccccc2-c2nnc(-c3ccc(Br)cc3)cc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586078";"";"None";"420.56";"1";"6.03";"MMV007577";"Cc1ccccc1OCCSc1nc2ccc(NC(=O)c3ccccc3)cc2s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL598881";"";"None";"554.51";"2";"7.90";"MMV007208";"COc1ccc(OC)c(C2C3=C(CC(C)(C)CC3=O)N(c3ccc(Cl)c(Cl)c3)C3=C2C(=O)CC(C)(C)C3)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579760";"";"None";"265.40";"0";"2.82";"MMV666020";"Cc1ccc(OCCCCCCNCCO)c(C)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL602552";"";"None";"400.46";"0";"4.42";"MMV001239";"COc1ccc2sc(N(Cc3cccnc3)C(=O)c3ccc(C#N)cc3)nc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL291239";"";"None";"297.39";"0";"2.79";"13b";"Cc1c(CSc2ccccc2)cnc2nc(N)nc(N)c12";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL26006";"";"None";"317.36";"0";"2.35";"12a";"Nc1nc(N)c2nc(CNc3cccc4ccccc34)cnc2n1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyr";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101464";"Antibacterial activity against tachyzoite stage of Toxoplasma gondii PHdeltaHX infected in human TerT cells measured after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"TerT";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3098035";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL558091";"";"None";"339.42";"0";"4.31";"19";"CCOC(=O)c1csc(N/N=C(\C)c2ccc3ccccc3c2)n1";"IC50";"'='";"43000.0";"nM";"4.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL193474";"";"None";"224.25";"0";"1.17";"2a";"N/C(S)=N/N=C/c1cccc([N+](=O)[O-])c1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL193804";"";"None";"224.25";"0";"1.17";"2b";"N/C(S)=N/N=C/c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL191686";"";"None";"238.27";"0";"1.43";"2c";"C/N=C(/S)N/N=C/c1ccccc1[N+](=O)[O-]";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"23300.0";"nM";"4.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL194091";"";"None";"322.30";"0";"0.99";"3a";"O=C(O)CC1SC(N/N=C/c2cccc([N+](=O)[O-])c2)=NC1=O";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL80070";"";"None";"310.36";"0";"2.12";"7";"COc1cccc(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"371.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813897";"Inhibitory concentration of cell growth from Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1132261";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL23454";"";"None";"325.37";"0";"2.42";"16d";"COc1ccc(OC)c(NCc2ccc3nc(N)nc(N)c3c2)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL281131";"";"None";"324.39";"0";"2.43";"13m";"COc1cccc(C)c1NCc1cnc2nc(N)nc(N)c2c1C";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL279680";"";"None";"354.41";"0";"2.15";"14h";"COc1ccc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)cc1OC";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL427";"MECHLORETHAMINE";"4.0";"156.06";"0";"1.40";"Mustine";"CN(CCCl)CCCl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL22623";"";"None";"354.41";"0";"2.15";"14f";"COc1cc(OC)cc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL281803";"";"None";"354.41";"0";"2.15";"3a";"COc1ccc(OC)c(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL53153";"";"None";"422.46";"0";"3.93";"7, GB-II-5";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"17100.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine, SDZ";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"14.95";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262125";"Antimicrobial activity against Toxoplasma gondii isolate GRE-1995-MAE infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1262128";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-TOU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.04";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262130";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1994-LEF harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 204 sil Ala mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL23459";"";"None";"357.37";"0";"1.22";"12q";"COc1cc(NCc2cnc3nc(N)nc(N)c3n2)cc(OC)c1OC";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL23374";"";"None";"329.41";"0";"3.44";"13t";"Cc1c(CCc2cccc3ccccc23)cnc2nc(N)nc(N)c12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL194029";"";"None";"300.34";"0";"3.33";"2j";"O=[N+]([O-])c1cccc(/C=N/N=C(\S)Nc2ccccc2)c1";"IC50";"'='";"80000.0";"nM";"4.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"13500.0";"nM";"4.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264585";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"31300.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264584";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"13200.0";"nM";"4.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL298771";"";"None";"263.12";"1";"-0.88";"7";"NCCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3335810";"";"None";"263.28";"0";"0.97";"33A";"O=C1CS/C(=N/N=C\c2ccc3c(c2)OCO3)N1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334536";"";"None";"353.40";"0";"2.88";"33B";"O=C1CS/C(=N/N=C\c2ccc3c(c2)OCO3)N1Cc1ccccc1";"IC50";"'='";"290000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL194123";"";"None";"336.33";"0";"1.33";"3c";"CN1C(=O)C(CC(=O)O)S/C1=N\N=C\c1ccccc1[N+](=O)[O-]";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL23705";"";"None";"354.41";"0";"2.15";"3c";"COc1ccc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c(OC)c1";"IC50";"'='";"1730.0";"nM";"5.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL193649";"";"None";"300.34";"0";"3.33";"2i";"O=[N+]([O-])c1ccccc1/C=N/N=C(\S)Nc1ccccc1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833904";"Compound tested on intracellular parasites Toxoplasma gondii in vero cells after 24 h";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1145251";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3307520";"";"";""
"CHEMBL3334537";"";"None";"359.45";"0";"4.31";"34B";"O=C1CS/C(=N/N=C\c2cccc3ccccc23)N1Cc1ccccc1";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334532";"";"None";"324.41";"0";"2.94";"29B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1cccnc1";"IC50";"'='";"82000.0";"nM";"4.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334526";"";"None";"313.38";"0";"3.14";"23B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1ccco1";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335640";"";"None";"241.36";"0";"2.55";"10A";"CCCCCC/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335639";"";"None";"227.33";"0";"2.16";"9A";"CCCC/C(CC)=N\N=C1/NC(=O)CS1";"IC50";"'='";"89000.0";"nM";"4.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL374858";"";"None";"613.82";"2";"5.38";"ZL3VS";"CC(C)C[C@H](/C=C/S(=O)(=O)c1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL917068";"Inhibition of microsome protein secretion in Toxoplasma gondii 2F1";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1142206";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL550488";"";"None";"290.35";"0";"2.55";"15";"CCOC(=O)c1csc(N/N=C(\C)c2cccnc2)n1";"IC50";"'='";"34000.0";"nM";"4.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL561627";"";"None";"281.36";"0";"2.83";"10";"CCOC(=O)c1csc(N/N=C/c2cccs2)n1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.34";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262118";"Antimicrobial activity against Toxoplasma gondii ENT harboring DHPS Ex2, E474D/Ex3, 156 sil Leu/Ex4, R560K/Ex5, 580 sil Gly/A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.07";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262130";"Antimicrobial activity against Toxoplasma gondii isolate RMS-1994-LEF harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 204 sil Ala mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.12";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262132";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2001-MAU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1262128";"Antimicrobial activity against Toxoplasma gondii isolate RMS-2003-TOU infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"Atovaquone";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"0.05";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL1262134";"Antimicrobial activity against Toxoplasma gondii RH harboring DHPS Ex2, E474D/Ex4, R560K/Ex5, 580 sil Gly; A597E/627 sil Glu mutant gene and DHFR Ex3, 156 sil Leu mutant gene infected in human MRC-5 cells after 72 hrs by ELISA";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"MRC5";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255293";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2008";"CHEMBL3308499";"";"";""
"CHEMBL1256669";"BUTRALIN";"None";"295.34";"0";"4.01";"3";"CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256703";"ETHALFLURALIN";"None";"333.27";"0";"3.92";"5";"C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL575956";"";"None";"468.92";"1";"5.22";"19";"Cc1ccc(S(=O)(=O)Cc2nc(Nc3cccc(Cl)c3)c3cc([N+](=O)[O-])ccc3n2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1047657";"Antitoxoplasmic activity against Toxoplasma gondii PRU-betaGal tachyzoite after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1154711";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL536151";"IMD-0354";"1.0";"383.68";"1";"5.34";"3j";"O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183807";"Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites expressing yellow fluorescent protein infected in HFF cells after 72 hrs by fluorescence assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2176997";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL563578";"";"None";"406.62";"1";"6.22";"22";"FC(F)(F)c1cccc(Nc2nc(C(Cl)(Cl)Cl)nc3ccccc23)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052416";"Antitoxoplasmic activity against Toxoplasma gondii tachyzoites infected in HFF assessed as beta-galactosidase activity after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152965";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"1";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"93000.0";"nM";"4.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774287";"";"None";"791.03";"2";"3.00";"5";"CCCO/N=C1\[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774293";"";"None";"806.05";"3";"2.00";"12";"CCNC(=O)N1C[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"85000.0";"nM";"4.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774294";"";"None";"868.12";"3";"3.18";"13";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C(=O)NCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774303";"";"None";"801.07";"2";"3.62";"24";"C=CCN1C[C@H](C)C[C@@](C)(OC=C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL556582";"";"None";"373.07";"1";"5.85";"10";"Clc1cccc(Nc2nc(C(Cl)(Cl)Cl)nc3ccccc23)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052416";"Antitoxoplasmic activity against Toxoplasma gondii tachyzoites infected in HFF assessed as beta-galactosidase activity after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152965";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052416";"Antitoxoplasmic activity against Toxoplasma gondii tachyzoites infected in HFF assessed as beta-galactosidase activity after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152965";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL2179161";"";"None";"492.70";"0";"2.57";"14a";"CN(CC(=O)NN)C(=O)Oc1ccc(Cl)cc1C(=O)Nc1ccc([N+](=O)[O-])cc1Cl.Cl";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183807";"Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites expressing yellow fluorescent protein infected in HFF cells after 72 hrs by fluorescence assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2176997";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL1095725";"";"None";"405.56";"1";"5.42";"6";"CC1=C(c2nc(C(C)(C)C)cs2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1099088";"";"None";"365.47";"0";"3.37";"16";"CCN(CC)C(=O)C1=C(C)[C@@H]2CC[C@@H](C)[C@@H]3CC[C@@]4(C)OO[C@@]23[C@H](O1)O4";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1112924";"Antiparasitic activity against Toxoplasma gondii 2F infected in HFF cells assessed as beta galactosidase activity after 5 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158535";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307525";"";"";""
"CHEMBL561525";"";"None";"407.51";"1";"6.51";"33";"Clc1ccc(Nc2nc(C(Cl)(Cl)Cl)nc3ccccc23)c(Cl)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052416";"Antitoxoplasmic activity against Toxoplasma gondii tachyzoites infected in HFF assessed as beta-galactosidase activity after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152965";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL559303";"";"None";"417.52";"1";"5.96";"19";"ClC(Cl)(Cl)c1nc(Nc2cccc(Br)c2)c2ccccc2n1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052416";"Antitoxoplasmic activity against Toxoplasma gondii tachyzoites infected in HFF assessed as beta-galactosidase activity after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1152965";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL3335812";"";"None";"283.36";"0";"2.78";"35A";"C/C(=N/N=C1\NC(=O)CS1)c1ccc2ccccc2c1";"IC50";"'='";"56000.0";"nM";"4.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL565196";"";"None";"357.39";"0";"3.26";"22";"CCOC(=O)c1csc(N/N=C(\C)c2cc3ccccc3oc2=O)n1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1256629";"AMIPROPHOS METHYL";"None";"304.31";"0";"3.15";"1, APM";"COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-]";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264578";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL435734";"ARCTIGENIN";"None";"372.42";"0";"2.99";"Arctigenin";"COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O";"IC50";"'='";"586400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4282687";"";"None";"483.56";"0";"3.29";"E2";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCC(=O)N3CCCC3)c(OC)c2)cc1OC";"IC50";"'='";"336500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4286902";"";"None";"561.61";"1";"4.64";"D4";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(Cc4ccccc4F)nn3)c(OC)c2)cc1OC";"IC50";"'='";"17100.0";"nM";"4.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4287979";"";"None";"633.69";"1";"3.87";"B9";"COC(=O)[C@@H](Cc1ccccc1)NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"226300.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4284602";"";"None";"619.67";"1";"4.00";"B7";"COC(=O)[C@@H](NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC)c1ccccc1";"IC50";"'='";"84400.0";"nM";"4.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL582547";"";"None";"362.44";"0";"4.24";"MMV020243";"Cc1cc(N(C)C)nc(Nc2ccc(NC(=O)Nc3ccccc3)cc2)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL557959";"";"None";"290.35";"0";"2.55";"17";"CCOC(=O)c1csc(N/N=C(\C)c2ccncc2)n1";"IC50";"'='";"64000.0";"nM";"4.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL524914";"";"None";"546.79";"2";"7.66";"(+/-)-17c";"CCCCCCCCCCCCCCCCCCOC(=O)C[C@H]1C[C@@H](O)C[C@@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"3540.0";"nM";"5.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL153452";"";"None";"355.44";"0";"4.18";"6c";"CN(C)c1ccc(-c2nc3ccccc3c(=O)n2Cc2ccccc2)cc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL18688";"";"None";"240.24";"0";"3.14";"4h";"Oc1nc(-c2ccc(F)cc2)nc2ccccc12";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4067699";"";"None";"328.37";"0";"4.17";"4c";"O=c1[nH]c(-c2ccc(OCc3ccccc3)cc2)nc2ccccc12";"IC50";"'='";"153000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1784974";"";"None";"464.60";"0";"3.21";"MMV688470";"CS(=O)(=O)N1CCC(CCn2nc(Cc3cccc4ccccc34)c3c(N)ncnc32)CC1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL2171519";"";"None";"306.32";"0";"2.83";"18";"Cn1c(=O)c(/C=C/c2ccc3c(c2)OCO3)nc2ccccc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2173062";"Antiprotozoal activity against Toxoplasma gondii expressing low level of ROP18 infected in human HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2169756";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3307525";"";"";""
"CHEMBL3335823";"";"None";"331.49";"0";"4.46";"10B";"CCCCCC/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335717";"";"None";"225.32";"0";"1.77";"16A";"CC1CCC/C(=N/N=C2\NC(=O)CS2)C1";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL591000";"";"None";"197.26";"0";"1.14";"11A";"O=C1CSC(NN=C2CCCC2)=N1";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL534283";"";"None";"294.45";"0";"3.50";"MMV665864";"CCCCNc1nc(NC(C)(C)C)nc(NC(C)(C)C)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586033";"";"None";"419.48";"1";"6.33";"MMV665814";"Oc1c(C(Nc2ccccn2)c2cccc(Oc3ccccc3)c2)ccc2cccnc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028047";"";"None";"485.65";"1";"6.65";"MMV396663";"Cc1sc(NC(=O)c2ccco2)c(C(c2cccnc2)N2CCC(Cc3ccccc3)CC2)c1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL596856";"";"None";"341.42";"0";"4.76";"MMV007041";"Cc1ccc2c(C)nc(Nc3nc(C)cc(-c4ccccc4)n3)nc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530308";"";"None";"546.60";"2";"7.48";"MMV011438";"COC(=O)c1ccc(C2C3=C(O)CC(c4ccc(F)cc4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL604982";"";"None";"393.49";"0";"2.91";"MMV008829";"CCCn1c(=N)c(C(=O)NC2CCCCC2)cc2c(=O)n3cccc(C)c3nc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL504996";"";"None";"580.76";"2";"7.29";"(+/-)-25b";"CCCCCCCCCCCCCC(=O)O[C@@H]1C[C@]2(CCC3(C=CC(=O)C=C3)O2)O[C@]2(CCC3(C=CC(=O)C=C3)O2)C1";"IC50";"'='";"346.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL457810";"TENELLONE A";"None";"442.51";"0";"3.47";"2";"CC(C)=CCc1ccc(O)c(C=O)c1C(=O)c1cc(C)cc(OCC(O)C(C)(C)O)c1O";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL973902";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as beta-galactosidase activity after 5 days by whole cell assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158743";"1";"Scientific Literature";"J Nat Prod";"2005";"None";"";"";""
"CHEMBL2028057";"";"None";"311.39";"0";"4.85";"MMV396715";"CC1(c2ccccc2)Nc2ccccc2-c2nc3ccccc3n21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590675";"";"None";"453.58";"0";"3.84";"MMV665908";"COc1ccc(N2CCN(C(CNC(=O)CC(C)(C)C)c3ccc4c(c3)OCO4)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584829";"";"None";"335.84";"0";"3.43";"MMV006882";"CCOC(=O)c1cnc2ccc(Cl)cc2c1NCCCN(C)C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028051";"";"None";"396.48";"1";"5.11";"MMV396672";"O=C(NCC(c1ccsc1)N1CCCCCC1)c1ccc(C(F)(F)F)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547488";"";"None";"329.38";"0";"2.38";"MMV019871";"Fc1ccc2[nH]c3c(NCCCN4CCOCC4)ncnc3c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601957";"";"None";"228.34";"0";"3.17";"MMV008416";"CCCc1c(CC)c(=N)c2ccccc2n1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532879";"";"None";"281.28";"0";"2.92";"MMV666607";"O=[N+]([O-])c1ccc(C=NNc2nc3ccccc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL526981";"";"None";"420.49";"0";"3.68";"MMV665915";"COc1ccc(-c2nc(NC(=O)CS(=O)(=O)c3ccc(F)cc3)sc2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587083";"";"None";"249.75";"0";"2.91";"MMV020500";"CNCCCNc1ccnc2cc(Cl)ccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527593";"";"None";"361.23";"0";"4.16";"MMV008138";"O=C(O)C1Cc2c([nH]c3ccccc23)C(c2ccc(Cl)cc2Cl)N1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL525692";"";"None";"500.58";"1";"3.67";"MMV666604";"CCOC(=O)C1=C(C)N=c2sc(=Cc3ccccc3O)c(=O)n2C1c1ccc(OC)c2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582286";"";"None";"426.59";"1";"6.09";"MMV007396";"Cc1ccccc1OCCSc1nc2ccc(NC(=O)c3cccs3)cc2s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL534612";"";"None";"479.54";"0";"3.31";"MMV665881";"COc1ccc(CNC(=O)c2cc3c(=O)n4ccccc4nc3n(CCc3ccccc3)c2=N)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL206540";"";"None";"245.28";"0";"2.68";"MMV007116";"CCOC(=O)c1cnc2ccc(CC)cc2c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL598369";"";"None";"327.70";"0";"3.85";"MMV011256";"Cc1cc(Nc2ccc(Cl)cc2)n2nc(C(F)(F)F)nc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548399";"";"None";"389.80";"0";"3.67";"MMV011567";"COc1ccc(C(=O)Nc2nonc2-c2ccc(OC)c(OC)c2)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3335807";"";"None";"220.26";"0";"0.63";"30A";"O=C1CS/C(=N/N=C\c2ccncc2)N1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335725";"";"None";"233.30";"0";"1.63";"26A";"C/C(=N/N=C1\NC(=O)CS1)c1ccccc1";"IC50";"'='";"114000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335718";"";"None";"225.32";"0";"1.77";"17A";"CC1CCC(=N/N=C2\NC(=O)CS2)CC1";"IC50";"'='";"226000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL238006";"";"None";"332.37";"0";"4.54";"9";"Fc1cccc(Oc2ccc(OCCOC3CCCCO3)cc2)c1";"IC50";"'='";"3990.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"Aminoglutethimide";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"SI, P1, Pyrimethamine, azepine2";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213629";"";"None";"564.81";"2";"9.63";"SI,2";"CCCCCCCCC(Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl)C(O)CCCCCCCC(=O)O";"IC50";"'='";"0.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1213631";"";"None";"225.32";"0";"4.32";"SI,5";"c1ccc(Sc2cc3ccccc3[nH]2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL428425";"ACULEATIN A";"None";"418.62";"1";"6.17";"(+)-aculeatine D";"CCCCCCCCCCCCC[C@@H]1C[C@@H](O)C[C@]2(CCC3(C=CC(=O)C=C3)O2)O1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL497655";"";"None";"422.65";"1";"6.62";"(+/-)-27";"CCCCCCCCCCCCC[C@@H]1C[C@@H](O)C[C@]2(CCC3(CCC(=O)CC3)O2)O1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL504412";"";"None";"580.76";"2";"7.29";"26b";"CCCCCCCCCCCCCC(=O)OC1C[C@]2(CCC3(C=CC(=O)C=C3)O2)O[C@]2(CCC3(C=CC(=O)C=C3)O2)C1";"IC50";"'='";"636.0";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006440";"Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1156632";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307525";"";"";""
"CHEMBL2078794";"";"None";"267.34";"0";"2.83";"MMV688548";"CC(C)(C)n1nc(-c2ccccc2)c2c(N)ncnc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL317017";"";"None";"311.41";"0";"2.41";"MMV688345";"Nc1nc(N)c2c3c(sc2n1)CN(Cc1ccccc1)CC3";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL2348815";"";"None";"393.83";"0";"4.95";"MMV688472";"CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc2oc(-c3ccncc3)nc2c1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL79123";"";"None";"280.33";"0";"2.11";"5";"Cc1c(CNc2ccccc2)cnc2nc(N)nc(N)c12";"IC50";"'='";"317.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813897";"Inhibitory concentration of cell growth from Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1132261";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL253106";"";"None";"399.43";"0";"2.71";"2h";"COc1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)ccc1O";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL436828";"";"None";"443.48";"0";"3.03";"2o";"COc1cc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc(OC)c1OC";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL402299";"";"None";"367.43";"0";"3.31";"2k";"Cc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL224182";"";"None";"329.48";"1";"5.70";"HDQ";"CCCCCCCCCCCCc1cc(=O)c2ccccc2n1O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL919805";"Inhibition of Toxoplasma gondii RH replication in human foreskin fibroblasts incubated for 24 hrs with drug after 36 hrs postinfection by immunofluorescence microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1147098";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"41200.0";"nM";"4.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL938667";"Antitoxoplasma activity against wild type Toxoplasma gondii RH assessed as survival after 18 hrs by [5,6-13H]uracil incorporation assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1155031";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL23560";"";"None";"311.35";"0";"1.51";"12l";"COc1ccc(C)c(NCc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL1256728";"ISOPROPALIN";"None";"309.37";"0";"4.25";"8";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-]";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264576";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL3334530";"";"None";"324.41";"0";"2.94";"27B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1ccccn1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334528";"";"None";"329.45";"0";"3.60";"25B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1cccs1";"IC50";"'='";"37000.0";"nM";"4.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334520";"";"None";"315.44";"0";"3.68";"17B";"CC1CCC(=N/N=C2/SCC(=O)N2Cc2ccccc2)CC1";"IC50";"'='";"88000.0";"nM";"4.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335822";"";"None";"317.46";"0";"4.07";"9B";"CCCC/C(CC)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335809";"";"None";"258.31";"0";"1.72";"32A";"O=C1CS/C(=N/N=C\c2c[nH]c3ccccc23)N1";"IC50";"'='";"166000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335724";"";"None";"239.32";"0";"1.69";"25A";"C/C(=N/N=C1\NC(=O)CS1)c1cccs1";"IC50";"'='";"64000.0";"nM";"4.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL592240";"";"None";"239.34";"0";"2.31";"20A";"O=C1CSC(NN=C2CCCCCCC2)=N1";"IC50";"'='";"79000.0";"nM";"4.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335635";"";"None";"211.29";"0";"1.55";"5A";"CC(C)=C/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"97000.0";"nM";"4.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335633";"";"None";"199.28";"0";"1.38";"3A";"CCC/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"262000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL417932";"";"None";"297.14";"1";"-0.19";"8";"Nc1ccc(CC(O)(P(=O)(O)O)P(=O)(O)O)cc1";"IC50";"'='";"68200.0";"nM";"4.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL872644";"Inhibition of Toxoplasma gondii tachyzoites in human foreskin fibroblast monolayer(DMEM with 10%fetal calf serum)";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1134372";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL579459";"";"None";"312.19";"0";"2.55";"MMV007839";"COc1ccc2c(c1)OC(O)(C(F)(F)C(F)(F)F)CC2=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL23844";"";"None";"382.47";"0";"2.93";"14j";"CCOc1ccc(OCC)c(N(C)Cc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL3334523";"";"None";"329.47";"0";"4.22";"20B";"O=C1CS/C(=N/N=C2CCCCCCC2)N1Cc1ccccc1";"IC50";"'='";"43000.0";"nM";"4.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334522";"";"None";"315.44";"0";"3.83";"19B";"O=C1CS/C(=N/N=C2CCCCCC2)N1Cc1ccccc1";"IC50";"'='";"255000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335813";"";"None";"301.33";"0";"1.74";"36A";"C/C(=N/N=C1\NC(=O)CS1)c1cc2ccccc2oc1=O";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335808";"";"None";"234.28";"0";"1.02";"31A";"C/C(=N\N=C1/NC(=O)CS1)c1ccncc1";"IC50";"'='";"53000.0";"nM";"4.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335728";"";"None";"234.28";"0";"1.02";"29A";"C/C(=N/N=C1\NC(=O)CS1)c1cccnc1";"IC50";"'='";"74000.0";"nM";"4.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL4574501";"";"None";"486.39";"1";"5.05";"54a";"C/C(=N\Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1)c1ccc(Nc2nc(N)nc(N)n2)cc1";"IC50";"'='";"14.95";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"453.0";"nM";"6.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL284733";"DICLAZURIL";"2.0";"407.64";"0";"3.54";"100";"N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL200585";"";"None";"360.24";"1";"6.10";"61g";"Oc1cc(Cl)ccc1Oc1ccc(NCc2ccccc2)cc1Cl";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"Caffeine";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"'='";"370000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232781";"Antiparasitic activity against wild-type Toxoplasma gondii RH tachyzoites infected in HFF cells assessed as parasitic growth inhibition by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"Captopril";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL596";"FENTANYL";"4.0";"336.48";"0";"4.14";"Fentanyl";"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"Carmustine";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL1774452";"";"None";"843.08";"2";"3.61";"29";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(F)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1765152";"";"None";"457.53";"1";"5.52";"29";"CCCCCCCCCCCCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"5290.0";"nM";"5.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1767772";"Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1765007";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";""
"CHEMBL253039";"";"None";"383.43";"0";"3.01";"2l";"COc1cccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL397366";"";"None";"289.33";"0";"4.21";"3";"N#CSCCOc1ccc(Oc2ccc(F)cc2)cc1";"IC50";"'='";"3850.0";"nM";"5.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL897881";"Antiparasitic activity against Toxoplasma gondii tachyzoites m2m3 infected HFF cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1149670";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3307525";"";"";""
"CHEMBL96051";"SCRIPTAID";"None";"326.35";"0";"2.50";"53";"O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185237";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL252966";"";"None";"285.37";"0";"3.02";"1m";"COc1ccc(/C=N/NC(=S)Nc2ccccc2)cc1";"IC50";"'='";"2000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL1213285";"";"None";"343.51";"1";"6.01";"71b";"CCCCCCCCCCCCc1c(C)n(O)c2ccccc2c1=O";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232769";"Antiparasitic activity against Toxoplasma gondii RH assessed as parasitic growth inhibition";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5282665";"";"None";"645.90";"2";"8.65";"13b";"C[C@H]1[C@H](C)CC[C@]2(C(=O)OCCn3cnnc3-c3ccc(F)cc3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"51400.0";"nM";"4.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL546";"OXPRENOLOL";"4.0";"265.35";"0";"1.99";"Oxprenolol";"C=CCOc1ccccc1OCC(O)CNC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"artemisinin";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'='";"2.3";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL993655";"Antimicrobial activity against Toxoplasma gondii in normal human foreskin fibroblasts";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1155772";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL23286";"";"None";"344.40";"0";"1.89";"12h";"COc1ccc(SCc2cnc3nc(N)nc(N)c3n2)cc1OC";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL409194";"";"None";"318.79";"0";"2.53";"12i";"Nc1nc(N)c2nc(CSc3cccc(Cl)c3)cnc2n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL591890";"";"None";"384.50";"0";"3.67";"MMV001255";"CCCCc1ccc(NS(=O)(=O)c2cc3c4c(c2)CCN4C(=O)CC3)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582180";"";"None";"458.63";"1";"5.30";"MMV019741";"Cc1ccc(C)c(Cn2c(N3CCC(C(=O)NCc4cccs4)CC3)nc3ccccc32)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590914";"";"None";"468.47";"1";"5.09";"MMV000617";"COc1ccc(C(O)(CCC(C)C)C(CN2CCOCC2)c2ccc(Cl)cc2)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587825";"";"None";"420.51";"1";"6.71";"MMV020912";"Cc1ccc(-c2nc3ccccc3o2)cc1NCc1cc(Cc2ccccc2)ccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028068";"";"None";"313.36";"0";"2.81";"MMV667492";"CN(N=O)C1=C(NC2CCCCC2)C(=O)c2ccccc2C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548469";"";"None";"432.36";"0";"3.28";"MMV665875";"Cl.Cn1c(=O)n(C)c2cc(CNCCNc3ccnc4cc(Cl)ccc34)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL606159";"";"None";"468.34";"0";"3.78";"MMV006656";"CCOC(=O)C1=CN(C)C=C(C(=O)OCC)C1c1cc(Br)c(OCC)c(OC)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601122";"";"None";"357.25";"1";"5.45";"MMV006522";"CCOc1ccc2nc(C)cc(Nc3ccc(Br)cc3)c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL23021";"";"None";"340.39";"0";"2.13";"2a";"COc1ccc(OC)c(NCc2cnc3nc(N)nc(N)c3c2C)c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813898";"Inhibitory activity against cultured Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1128680";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL287511";"";"None";"326.36";"0";"1.39";"12u";"COc1ccc(OC)c(CCc2cnc3nc(N)nc(N)c3n2)c1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813899";"Inhibition of Toxoplasma gondii cell growth";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1129525";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL253040";"";"None";"383.43";"0";"3.01";"2m";"COc1ccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)cc1";"IC50";"'='";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"PY";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223458";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL81119";"";"None";"314.78";"0";"2.76";"9";"Cc1c(CNc2ccccc2Cl)cnc2nc(N)nc(N)c12";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL813897";"Inhibitory concentration of cell growth from Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1132261";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL529773";"";"None";"328.20";"0";"2.53";"MMV006278";"CCc1c(C)c(=N)c2ccccc2n1C.I";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587989";"";"None";"476.05";"1";"7.29";"MMV666688";"Cc1cc(C=C2SC(=Nc3ccccc3)N(C3CCCC3)C2=O)c(C)n1-c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL124006";"";"None";"279.39";"0";"3.75";"MMV000448";"CN(C)CCCNc1c2ccccc2nc2ccccc12";"IC50";"'='";"25840.0";"nM";"4.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028052";"";"None";"492.91";"1";"5.81";"MMV396679";"COc1ccc(-c2cc3c(SCC(=O)Nc4cc(C(F)(F)F)ccc4Cl)nccn3n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581489";"";"None";"353.38";"0";"1.40";"MMV665916";"COc1ccccc1CNC(=O)CCn1c(=O)[nH]c2ccccc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582666";"";"None";"355.44";"0";"4.97";"MMV006861";"c1ccc2cc3c(Nc4ccc(N5CCOCC5)cc4)ccnc3cc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527131";"";"None";"382.87";"0";"2.65";"MMV006188";"O=C(NCc1ccco1)C1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL526800";"";"None";"484.96";"0";"3.17";"MMV665971";"CCOC(=O)C1=C(C)N=c2sc(=Cc3cc(Cl)ccc3O)c(=O)n2C1c1ccc(OC)cc1";"IC50";"'='";"24930.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584235";"";"None";"346.90";"0";"3.79";"MMV006787";"CC(C)CCNCC(O)Cn1c2ccccc2c2ccccc21.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589422";"";"None";"559.64";"2";"6.40";"MMV000699";"Cc1ccc(C2CC(C(F)(F)F)n3nc(C(=O)N4CCN(C(c5ccccc5)c5ccccc5)CC4)cc3N2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL603686";"";"None";"434.49";"1";"5.47";"MMV007199";"COc1ccccc1N1C(=N)SC(=Cc2ccc(OCc3ccccc3F)cc2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587485";"";"None";"442.32";"1";"6.40";"MMV019241";"O=C(Nc1ccc(-c2nc3cc4ccccc4cc3[nH]2)cc1)c1cccc(Br)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601566";"";"None";"451.57";"1";"7.35";"MMV666597";"CCCCCCc1cc2cc(-c3nc4ccccc4[nH]3)c(=Nc3ccccc3C)oc2cc1O";"IC50";"'='";"6280.0";"nM";"5.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL577014";"";"None";"356.43";"1";"5.57";"MMV007181";"Cc1cc(Nc2ccc(OCc3ccccc3)cc2)nc2cc(O)ccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL546799";"";"None";"726.97";"2";"5.87";"MMV019881";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1623028";"";"None";"254.27";"0";"3.09";"MMV080034";"Nc1nc(Nc2cccc(F)c2)nc2ccccc12";"IC50";"'='";"28990.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL608855";"";"None";"579.12";"2";"9.64";"MMV011436";"CC(C)(C)c1ccc(C2CC3=Nc4ccccc4N(C(=O)c4ccccc4Cl)C(c4ccc(F)cc4)C3=C(O)C2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL427342";"IMIDOCARB";"-1.0";"348.41";"0";"2.03";"MMV665810";"O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581225";"";"None";"410.43";"0";"1.58";"MMV009085";"O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCCO)C(=O)N(CCCCO)C3=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL95606";"CYTIDINE";"3.0";"243.22";"0";"-2.56";"MMV638723";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527234";"";"None";"403.44";"0";"4.51";"MMV665898";"COc1cc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)cc(OC)c1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580188";"";"None";"382.25";"1";"5.79";"MMV665840";"O=C(Nc1ccc(-c2nc3ccccc3[nH]2)cc1)c1ccc(Cl)c(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1594640";"";"None";"392.42";"0";"2.28";"MMV396705";"COc1cccc(Cn2c(Oc3ccccc3)nc3c2c(=O)n(C)c(=O)n3C)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533999";"";"None";"307.38";"0";"2.49";"MMV020942";"CCC(=O)Nc1nnc(Cc2ccc(OC)c(OC)c2)s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591887";"";"None";"383.49";"0";"3.79";"MMV666109";"CCOC(=O)C1(Cc2ccccc2)CCN(Cc2cccc(OC)c2O)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3182074";"";"None";"326.44";"1";"5.12";"128; MMV689480";"CC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL2030049";"";"None";"411.38";"1";"6.19";"28; ELQ-271";"Cc1[nH]c2ccccc2c(=O)c1-c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403511";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs by CellTiter 96Aqueous One cell viability assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4568326";"";"None";"268.32";"0";"2.36";"44; BIPPO";"CC(C)c1n[nH]c2c(=O)[nH]c(Cc3ccccc3)nc12";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403515";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 7 days by crystal violet assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL1256763";"NITRALIN";"None";"345.38";"0";"2.53";"9";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264577";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264580";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL295960";"ORYZALIN";"None";"346.37";"0";"1.78";"10";"CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264582";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256630";"PENDIMETHALIN";"None";"281.31";"0";"3.72";"11";"CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264581";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264574";"Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL1256764";"PROFLURALIN";"None";"347.29";"0";"4.15";"12";"CCCN(CC1CC1)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"22100.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264583";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL31970";"TRIFLURALIN";"None";"335.28";"0";"4.15";"13";"CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1264579";"Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1255423";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2010";"CHEMBL3307525";"";"";""
"CHEMBL253039";"";"None";"383.43";"0";"3.01";"2l";"COc1cccc(/C=N/N=C2\SC(CC(=O)O)C(=O)N2c2ccccc2)c1";"IC50";"'='";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL403381";"";"None";"269.37";"0";"3.32";"1e";"Cc1cccc(/C=N/NC(=S)Nc2ccccc2)c1";"IC50";"'='";"5000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927190";"Inhibition of Toxoplasma gondii infected in african green monkey Vero cells";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Vero";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"CHEMBL3307520";"";"";""
"CHEMBL402358";"";"None";"422.29";"0";"4.31";"2c";"O=C(O)CC1S/C(=N\N=C\c2ccc(Cl)cc2Cl)N(c2ccccc2)C1=O";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL927191";"Inhibition of intracellular parasite Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1140759";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";"";""
"CHEMBL78502";"";"None";"374.42";"0";"2.56";"6j";"CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1228266";"Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1221305";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1201199";"LEUPROLIDE";"4.0";"1209.42";"None";"None";"Leuprorelin";"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"SID11110918";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"Betamethasone";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1217005";"Antimicrobial activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1212812";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL580580";"";"None";"286.77";"0";"3.26";"MMV019110";"Cc1cccc(Nc2nc(N)c3ccccc3n2)c1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL588855";"";"None";"398.51";"1";"5.20";"MMV020549";"CC1CCN(Cc2ccc(NC(=O)c3cc4ccc5cccnc5c4[nH]3)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591637";"";"None";"327.43";"0";"4.18";"MMV001246";"CSc1ccccc1C(=O)Nc1nc(-c2ccccn2)cs1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL317364";"";"None";"277.80";"0";"3.64";"MMV006087";"CCN(CC)CCNc1ccnc2cc(Cl)ccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547476";"";"None";"370.49";"0";"3.80";"MMV006455";"CCCN(CCC)CC(O)COc1ccccc1C(=O)Nc1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590686";"";"None";"363.46";"0";"4.65";"MMV000498";"CCN(CC)c1cc(C)c2cc(NC(=O)c3cccc(OC)c3)ccc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL577012";"";"None";"261.75";"0";"3.90";"MMV665789";"CC(NCc1ccccc1)c1cc(Cl)ccc1O";"IC50";"'='";"21370.0";"nM";"4.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532155";"";"None";"397.54";"0";"3.75";"MMV019313";"Cn1c(=O)c2cc(C(=O)NCCCN3CCCCCC3)sc2c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547825";"";"None";"495.07";"0";"4.07";"MMV019746";"Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)C2CCN(c3nc4ccccc4[nH]3)CC2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL537505";"";"None";"377.87";"0";"4.64";"MMV665803";"CCOc1cc(Cl)c(C(C)NC(=O)c2cccc(OC)c2)cc1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL536421";"";"None";"422.32";"0";"4.75";"MMV665796";"CCOc1cc(Br)c(C(C)NC(=O)c2cccc(OC)c2)cc1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586933";"";"None";"339.35";"0";"3.31";"MMV665890";"COc1ccc(-c2nonc2NC(=O)c2cccc(C)c2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590159";"";"None";"286.20";"0";"4.11";"MMV001344";"CC1CC(C)CN(C(=O)c2ccc(Cl)cc2Cl)C1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530149";"";"None";"323.35";"0";"3.09";"MMV006767";"COc1cc2cc(C(=O)Nc3ccccc3)c(N)nc2cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529348";"";"None";"456.98";"1";"5.34";"MMV020275";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(-c2ccncc2)nc2ccc(Cl)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028059";"";"None";"341.41";"0";"4.86";"MMV396719";"COc1cccc(C2(C)Nc3ccccc3-c3nc4ccccc4n32)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028063";"";"None";"348.31";"0";"4.54";"MMV396794";"CC(C)(C)CC(C)(C)NCC(O)COc1ccc(Cl)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL1738986";"";"None";"393.31";"0";"4.23";"MMV396736";"OC(CNCC1CCCO1)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589224";"";"None";"282.16";"0";"2.54";"MMV000972";"O=C1CC(O)(C(F)(F)C(F)(F)F)Oc2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL459199";"";"None";"325.59";"0";"4.75";"MMV001318";"O=C(Nc1ccc(Br)cc1)Nc1cccc(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601158";"";"None";"245.32";"0";"3.60";"MMV006820";"CCCCc1c(C)nc2c(OC)cccc2c1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600030";"";"None";"312.41";"0";"2.72";"MMV665944";"COc1ccc(CN2CCN(Cc3ccccc3)CC2)c(O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3334527";"";"None";"315.42";"0";"3.21";"24B";"O=C1CS/C(=N/N=C\c2cccs2)N1Cc1ccccc1";"IC50";"'='";"270000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335819";"";"None";"301.42";"0";"3.46";"6B";"C=CCC/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"207000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335818";"";"None";"301.42";"0";"3.46";"5B";"CC(C)=C/C(C)=N\N=C1\SCC(=O)N1Cc1ccccc1";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL589165";"";"None";"225.32";"0";"1.92";"19A";"O=C1CSC(NN=C2CCCCCC2)=N1";"IC50";"'='";"111000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3263906";"";"None";"389.45";"1";"5.25";"103";"O=C1/C(=C/c2cn(CC3CCCCC3)c3ccccc23)Oc2cc(O)cc(O)c21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5237875";"Antiparasitic activity against Toxoplasma gondii RH type 1 infected in human HFF cells assessed as inhibition of parasite proliferation incubated for 30 hrs by Hoechst-33342, YFP2 and Alexa-488 dye based high content imaging analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5236572";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 30.0 hr";"";""
"CHEMBL299988";"";"None";"262.13";"0";"0.57";"NBP7";"CCCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"9100.0";"nM";"5.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5150359";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human foreskin fibroblast incubated for 48 hrs followed by [5,6-3H]uracil addition and measured after 4 hrs by scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5149966";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 52.0 hr";"";""
"CHEMBL585264";"";"None";"463.96";"0";"4.65";"MMV006427";"COc1cc(OC)c(N(C)C(=O)c2cc3c(s2)-c2ccccc2S(=O)(=O)C3)cc1Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587410";"";"None";"510.43";"2";"7.68";"MMV020885";"COc1ccc(Br)cc1C1Nc2ccc3ccccc3c2C2=C1C(=O)CC(c1ccccc1)C2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590674";"";"None";"314.82";"0";"4.55";"MMV000570";"CCc1ccc(Nc2cc(C)c3ccc(O)cc3n2)cc1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL494669";"";"None";"319.45";"0";"4.59";"MMV006203";"Cc1cc(NCCN2CCCCC2)c2ccc3ccccc3c2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL549210";"";"None";"340.40";"0";"3.76";"MMV666691";"COc1ccc(C=C2SC(=N)N(c3ccccc3OC)C2=O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL534190";"";"None";"292.34";"0";"3.42";"MMV006309";"CN(C)c1ccc(C=Cc2nc(=O)c3ccccc3o2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028041";"";"None";"490.67";"1";"5.47";"MMV396594";"COc1ccc(-c2nc(N3CCN(C(=O)C4CCCCC4)CC3)c3c4c(sc3n2)CCCC4)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601786";"";"None";"389.36";"1";"5.79";"MMV007654";"Br.Cc1ccc(C)c(-c2csc(Nc3ccc(C)c(C)c3)n2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533855";"";"None";"662.87";"1";"3.60";"MMV007092";"CCOc1ccc(CN2CCN(CC(O)COc3ccc(OCC(O)CN4CCN(Cc5ccc(OCC)cc5)CC4)cc3)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600356";"";"None";"314.43";"0";"4.75";"MMV665987";"CCCCCCc1cc(O)c2c3c(c(=O)oc2c1)CCC(C)C3";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600549";"";"None";"586.75";"2";"5.63";"MMV007557";"COc1ccc(CCNC(=O)c2cc(S(=O)(=O)N3CC(C)CC(C)C3)ccc2Sc2ccc(F)cc2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582495";"";"None";"406.51";"1";"5.01";"MMV009127";"CC1CCN(Cc2c(O)ccc3cc(-c4nc5ccccc5s4)c(=O)oc23)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4292193";"";"None";"568.67";"1";"3.14";"F4";"CCN1CCN(C(=O)CCC(=O)Oc2ccc(C[C@H]3C(=O)OC[C@@H]3Cc3ccc(OC)c(OC)c3)cc2OC)CC1";"IC50";"'='";"94400.0";"nM";"4.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4291385";"";"None";"543.62";"1";"4.51";"D1";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(Cc4ccccc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"651400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2030555";"";"None";"359.44";"0";"2.62";"MMV688411";"Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2CC1CCNCC1";"IC50";"'='";"6770.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL1784974";"";"None";"464.60";"0";"3.21";"MMV688470";"CS(=O)(=O)N1CCC(CCn2nc(Cc3cccc4ccccc34)c3c(N)ncnc32)CC1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL3637930";"";"None";"391.30";"1";"5.08";"MMV688704";"Cc1cc2nc(NC(=O)C(C)(C)C)nc(Cl)c2n1Cc1ccc(Cl)cc1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL54004";"";"None";"318.24";"0";"2.13";"NBP8";"CCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5150359";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human foreskin fibroblast incubated for 48 hrs followed by [5,6-3H]uracil addition and measured after 4 hrs by scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5149966";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 52.0 hr";"";""
"CHEMBL2324589";"";"None";"333.80";"0";"3.55";"MMV688852";"CC(C)(C)n1nc(Cc2ccc(F)c(Cl)c2)c2c(N)ncnc21";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL3416951";"";"None";"313.43";"0";"4.17";"1";"Cc1ccc(-c2cc3nc(NC(C)(C)C)[nH]c(=O)c3s2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420013";"Antitoxoplasmic activity against tachyzoite stage of Toxoplasma gondii PRU transfected with beta galactosidase infected in HFF assessed as parasite growth inhibition after 96 hrs by colorimetric microtiter assay";"F";"BAO_0000019";"assay format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3414541";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";"";"";""
"CHEMBL4278510";"";"None";"617.72";"2";"3.38";"B4";"COC(=O)[C@H](CCSC)NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"164900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1774296";"";"None";"789.06";"2";"3.11";"17";"C=CCN1C[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775524";"Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"6";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775527";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated immediately after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774452";"";"None";"843.08";"2";"3.61";"29";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(Cc2ccc(F)cc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775528";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated immediately after infection for 48 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1774453";"";"None";"831.14";"2";"3.85";"31";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CC2CCCCC2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775529";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 infected in HFF treated 6 hrs after infection measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1773086";"";"None";"853.15";"2";"3.90";"30";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(CCCc2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775530";"Antiparasitic activity against yellow fluorescent protein expressing Toxoplasma gondii 2F-1 treated 6 hrs after infection for 42 hrs followed by reinoculated into fresh HFF monolayers measured after 48 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1772948";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"Quinolin-8-ol";"Oc1cccc2cccnc12";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL164449";"";"None";"174.16";"0";"2.14";"5-nitroquinoline";"O=[N+]([O-])c1cccc2ncccc12";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1950466";"";"None";"466.63";"1";"6.11";"13";"c1ccc(COc2ccc(CNCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1";"IC50";"'='";"2970.0";"nM";"5.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4143599";"Antiparasitic activity against Toxoplasma gondii RH infected in HFF treated at 4 hrs post infection measured at 5 days post infection by crystal violet staining based method";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4138238";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"Trimethoprim";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"41780.0";"nM";"4.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3099580";"";"None";"308.37";"0";"3.14";"2";"Nc1nc2[nH]c3cccc(Sc4ccccc4)c3c2c(=O)[nH]1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101464";"Antibacterial activity against tachyzoite stage of Toxoplasma gondii PHdeltaHX infected in human TerT cells measured after 4 days";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"TerT";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3098035";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL269671";"";"None";"282.34";"0";"2.39";"ART";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4283112";"";"None";"564.04";"2";"5.10";"D7";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4cccc(Cl)c4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"269400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4279643";"";"None";"561.61";"1";"4.64";"D5";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(Cc4ccc(F)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'>='";"600000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4278112";"";"None";"813.04";"2";"2.70";"Spiramycin";"C[C@@H]1C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@H](C)O2)[C@H](C)C[C@H](CC=O)[C@H](O[C@H]2O[C@@H](C)[C@H](O[C@@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](N(C)C)[C@@H]2O)C[C@H](O)CC(=O)O1";"IC50";"'='";"262200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3334539";"";"None";"391.45";"0";"3.65";"36B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)c1cc2ccccc2oc1=O";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334531";"";"None";"310.38";"0";"2.55";"28B";"O=C1CS/C(=N/N=C\c2cccnc2)N1Cc1ccccc1";"IC50";"'='";"111000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334524";"";"None";"329.47";"0";"4.07";"21B";"C/C(=N/N=C1/SCC(=O)N1Cc1ccccc1)C1CCCCC1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335814";"";"None";"261.35";"0";"2.51";"1B";"CC(C)=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"232000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"Trimethoprim";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335722";"";"None";"223.26";"0";"1.22";"23A";"C/C(=N/N=C1\NC(=O)CS1)c1ccco1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335716";"";"None";"225.32";"0";"1.77";"15A";"CC1CCCC/C1=N/N=C1\NC(=O)CS1";"IC50";"'='";"247000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335638";"";"None";"227.33";"0";"2.16";"8A";"CCCCC/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"110000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335636";"";"None";"211.29";"0";"1.55";"6A";"C=CCC/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"195000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL588859";"";"None";"346.43";"0";"4.20";"MMV665939";"O=C(Nc1ccsc1C(=O)NC1CCCCC1)c1ccc(F)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL587923";"";"None";"413.52";"1";"5.59";"MMV666071";"Cc1ccc(CN2CCC(C(=O)Nc3ccc(-c4cc5ccccc5[nH]4)cc3)CC2)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL591393";"";"None";"333.58";"1";"5.43";"MMV665953";"O=C(Nc1ccc(F)c(Cl)c1)Nc1ccc(Cl)c(Cl)c1";"IC50";"'='";"26490.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL528245";"";"None";"465.59";"0";"3.98";"MMV019662";"COc1ccc(N2CCN(C(CNC(=O)C3CCCCC3)c3ccc4c(c3)OCO4)CC2)cc1";"IC50";"'='";"26620.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL577011";"";"None";"301.41";"0";"3.91";"MMV007571";"Cc1ccc(CSCc2ccc(C(=O)NC3CC3)o2)cc1";"IC50";"'='";"22300.0";"nM";"4.65";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532560";"";"None";"391.49";"0";"4.52";"MMV019738";"Cc1[nH]c(-c2ccc(F)cc2)cc1C(=O)NC1CCN(Cc2ccccc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590680";"";"None";"254.33";"0";"3.28";"MMV666075";"COc1ccc(C2N(C)c3ccccc3N2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL537087";"";"None";"457.83";"0";"4.30";"MMV000248";"CCN(CC)CCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582767";"";"None";"420.18";"0";"4.45";"MMV019918";"Cl.Clc1cc(Br)ccc1-c1ccc(CNCC2CCNCC2)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL547614";"";"None";"349.53";"0";"4.70";"MMV020700";"CC(=O)Nc1nnc(SCc2c(C)cc(C(C)(C)C)cc2C)s1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600904";"";"None";"265.32";"0";"2.98";"MMV008270";"Oc1c2c(nc3cc(-c4ccccc4)nn13)CCCC2";"IC50";"'='";"26200.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581187";"";"None";"456.98";"1";"5.34";"MMV020490";"O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(-c2cccnc2)nc2ccc(Cl)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589946";"";"None";"305.85";"0";"3.63";"MMV001049";"CC(C)c1ccc(CNCC(O)c2ccccc2)cc1.Cl";"IC50";"'='";"18070.0";"nM";"4.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL579300";"";"None";"396.92";"0";"4.96";"MMV665786";"O=c1cc(NC2CCN(CCCc3ccccc3)CC2)c2cc(Cl)ccc2o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585622";"";"None";"337.43";"1";"5.52";"MMV006513";"c1ccc2c(NCCc3c[nH]c4ccccc34)c3ccccc3nc2c1";"IC50";"'='";"3050.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601806";"";"None";"480.59";"1";"5.34";"MMV008173";"COc1cc(OC)cc(N2C(=O)N(Cc3ccc(C(C)(C)C)cc3)c3ccccc3S2(=O)=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL599100";"";"None";"453.33";"1";"5.78";"MMV666022";"COc1ccc(C(=O)NC(c2ccccc2Cl)c2cc(Cl)c3cccnc3c2O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL125044";"";"None";"288.31";"0";"3.36";"MMV666026";"COc1ccc(-c2cc3c(nn2)-c2ccccc2C3=O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2021322";"";"None";"358.44";"1";"6.34";"MMV007113";"c1ccc(/C2=N/c3ccccc3/N=C(/c3ccccc3)c3ccccc32)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL603945";"";"None";"336.39";"0";"4.03";"MMV665813";"CCOC(=O)c1cnc2ccc(OC)cc2c1NCc1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4468948";"";"None";"353.45";"1";"5.61";"3a";"Fc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"162800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL139702";"LICOAGROCHACONE A";"None";"338.40";"0";"4.47";"108";"C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O";"IC50";"'='";"0.848";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3261731";"";"None";"459.40";"1";"6.34";"29; ELQ-316";"COc1cc2[nH]c(C)c(-c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3)c(=O)c2cc1F";"IC50";"'='";"0.007";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403511";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs by CellTiter 96Aqueous One cell viability assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL591128";"";"None";"293.32";"0";"3.76";"70; KGW3";"CCOc1ccc(/C=C/c2nc(=O)c3ccccc3o2)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403520";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL560700";"";"None";"253.33";"0";"2.82";"29";"CC1CCC(=NNc2nc(C(=O)O)cs2)CC1";"IC50";"'>='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032956";"Antiparasitic activity against Toxoplasma gondii 2F tachyzoites infected in HFF assessed as parasite growth inhibition-related decrease in beta-galactosidase activity treated prior to infection measured after 5 days by spectrophotometry";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL1158489";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL99";"TRICHOSTATIN";"1.0";"302.37";"0";"2.58";"1; TSA";"CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185237";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4184137";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL585431";"";"None";"357.41";"0";"2.07";"126";"CCOc1ccccc1NC(=O)CN1CCN(C(=O)c2ccco2)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4095115";"";"None";"412.53";"1";"6.22";"5f";"CCCCCCn1c(-c2ccc(OCc3ccccc3)cc2)nc2ccccc2c1=O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4284991";"";"None";"527.61";"1";"3.84";"F1";"CCN(CC)C(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"205500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4280466";"";"None";"519.59";"1";"4.61";"E6";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCC(=O)Nc3ccc(C)cc3)c(OC)c2)cc1OC";"IC50";"'='";"322400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4288365";"";"None";"505.57";"1";"4.30";"E5";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCC(=O)Nc3ccccc3)c(OC)c2)cc1OC";"IC50";"'='";"40600.0";"nM";"4.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4280080";"";"None";"658.70";"1";"4.48";"B10";"COC(=O)[C@@H](NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC)c1c[nH]c2ccccc12";"IC50";"'='";"187200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2348815";"";"None";"393.83";"0";"4.95";"MMV688472";"CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc2oc(-c3ccncc3)nc2c1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL4286486";"";"None";"547.58";"1";"4.59";"D9";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4ccc(F)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'>='";"600000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4290974";"";"None";"564.04";"2";"5.10";"D8";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(-c4ccc(Cl)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"277900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4288756";"";"None";"583.63";"1";"3.14";"B6";"COC(=O)[C@@H]1CCCN1C(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"43900.0";"nM";"4.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2347842";"";"None";"346.81";"0";"3.51";"MMV688330";"CC(=O)N1CCN(c2ccc(Oc3ccc(Cl)cc3O)cc2)CC1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL2347842";"";"None";"346.81";"0";"3.51";"MMV688330";"CC(=O)N1CCN(c2ccc(Oc3ccc(Cl)cc3O)cc2)CC1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL547443";"";"None";"494.56";"0";"3.01";"MMV667488";"COc1ccc(CCn2c(=N)c(C(=O)NCc3cccnc3)cc3c(=O)n4cccc(C)c4nc32)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL578294";"";"None";"320.40";"0";"4.15";"MMV006825";"COc1ccc(Nc2cc(C)nc(NCc3ccccc3)n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL10835";"";"None";"350.03";"1";"5.94";"MMV665852";"O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc(Cl)c(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028058";"";"None";"491.95";"1";"5.68";"MMV396717";"COc1ccc(CCN2C(=O)c3[nH]nc(-c4cc(Cl)c(C)cc4O)c3C2c2ccccc2F)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028066";"";"None";"389.88";"1";"6.11";"MMV667489";"COC(=O)c1ccc(Cl)c2c1C1C=CCC1C(c1cccc3ccccc13)N2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582072";"";"None";"524.58";"2";"7.52";"MMV011895";"Nc1ccc(-c2nc3cc(Oc4ccc(Oc5ccc6[nH]c(-c7ccc(N)cc7)nc6c5)cc4)ccc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4450682";"";"None";"393.58";"1";"6.27";"3k";"C(=N/Nc1nc(C23CC4CC(CC(C4)C2)C3)cs1)\c1cc2ccccc2s1";"IC50";"'='";"51880.0";"nM";"4.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5280753";"";"None";"735.75";"2";"9.18";"12c";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C/C(=C/c6cn(-c7ccccc7I)nn6)C(=O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"273800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL96051";"SCRIPTAID";"None";"326.35";"0";"2.50";"75b";"O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232773";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs68 cells assessed as parasitic growth inhibition by crystal violet staining based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Hs68";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4468948";"";"None";"353.45";"1";"5.61";"3a";"Fc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"83490.0";"nM";"4.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL587288";"";"None";"359.41";"0";"1.47";"MMV019066";"COc1ccccc1CNC(=O)CCn1c(=O)[nH]c2ccsc2c1=O";"IC50";"'='";"20930.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533563";"";"None";"592.66";"2";"8.20";"MMV085583";"CCCCCC(=O)N1c2ccccc2NC2=C(C(=O)CC(c3ccc(OC)c(OC)c3)C2)C1c1ccc(C(F)(F)F)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL525106";"";"None";"479.85";"0";"3.90";"MMV665902";"Cl.N=c1n(CCN2CCCCC2)c2ccccc2n1CC(O)c1cccc(Br)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL548901";"";"None";"480.01";"1";"5.37";"MMV666067";"COc1ccc(CNC2CCN(c3ccc(NC(=O)c4cccc(Cl)c4)cc3)CC2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL607308";"";"None";"411.63";"0";"4.27";"MMV666110";"C=C(C)CCC(C)N1CCC(N2CCC(C(=O)NCCc3ccccc3)CC2)CC1";"IC50";"'='";"27050.0";"nM";"4.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601528";"";"None";"232.71";"0";"3.49";"MMV007363";"Clc1ccc2c(N3CCCC3)ccnc2c1";"IC50";"'='";"1490.0";"nM";"5.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580654";"";"None";"343.39";"0";"4.49";"MMV019762";"COc1cccc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL586000";"";"None";"359.43";"1";"5.61";"MMV006389";"O=C1c2ccccc2C2=Nc3ccccc3SC(c3cccc(F)c3)C12";"IC50";"'='";"18660.0";"nM";"4.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL609156";"";"None";"245.28";"0";"2.27";"MMV498479";"CCOC(=O)c1c[nH]c2c(CC)cccc2c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL537778";"";"None";"470.17";"1";"6.64";"MMV007224";"Brc1ccc(Nc2nc3ccccc3nc2Nc2ccc(Br)cc2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL546168";"";"None";"341.72";"0";"4.16";"MMV665874";"Cc1cc(Nc2ccc(C)c(Cl)c2)n2nc(C(F)(F)F)nc2n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530223";"";"None";"367.41";"0";"2.53";"MMV665878";"COc1cccc(NC(=O)[C@H](C(C)C)n2c(=O)[nH]c3ccccc3c2=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4226656";"";"None";"385.30";"1";"5.41";"5e";"CCCCCCn1c(-c2ccc(Br)cc2)nc2ccccc2c1=O";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL2058057";"";"None";"301.14";"0";"3.35";"4i";"O=c1[nH]c(-c2ccc(Br)cc2)nc2ccccc12";"IC50";"'='";"92000.0";"nM";"4.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4228626";"";"None";"405.59";"1";"6.27";"6k";"CCCCCCCCCCn1c(-c2ccc(N(C)C)cc2)nc2ccccc2c1=O";"IC50";"'='";"49000.0";"nM";"4.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL2030556";"";"None";"326.79";"0";"3.79";"MMV688417";"CC(C)n1nc(-c2cc3c(Cl)cccc3[nH]2)c2c(N)ncnc21";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL3637928";"";"None";"275.32";"0";"2.68";"MMV688469";"Nc1ncnc2[nH]nc(Cc3cccc4ccccc34)c12";"IC50";"'='";"2310.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL4564866";"";"None";"452.54";"0";"2.65";"5";"O=C(Nc1cccnc1)c1ccc(CNS(=O)(=O)c2ccc(N3CCOCC3)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343684";"Antiparasitic activity against Toxoplasma gondii RH transfected with fluorescent transgene dTom";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4342427";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4589398";"";"None";"490.59";"0";"3.03";"19";"CN1CCN(c2ccc(S(=O)(=O)NCc3ccc(-c4nc(-c5cccnc5)no4)cc3)cc2)CC1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343684";"Antiparasitic activity against Toxoplasma gondii RH transfected with fluorescent transgene dTom";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4342427";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"ATV";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4227231";"";"None";"372.38";"0";"3.79";"5b";"COc1ccc(-n2c(-c3ccc4c(c3)OCO4)nc3ccccc3c2=O)cc1";"IC50";"'='";"40000.0";"nM";"4.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4228884";"";"None";"398.51";"1";"5.69";"6i";"CC(C)CCn1c(-c2ccc(OCc3ccccc3)cc2)nc2ccccc2c1=O";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4222934";"Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4219182";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4279226";"";"None";"559.62";"1";"4.46";"D12";"COc1ccc(-n2cc(COc3ccc(C[C@H]4C(=O)OC[C@@H]4Cc4ccc(OC)c(OC)c4)cc3OC)nn2)cc1";"IC50";"'>='";"600000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL14474";"QUINOLINE";"None";"129.16";"0";"2.23";"Quinoline";"c1ccc2ncccc2c1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4178201";"Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4177528";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4281568";"";"None";"539.63";"1";"3.98";"F3";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)CCC(=O)N3CCCCC3)c(OC)c2)cc1OC";"IC50";"'='";"41000.0";"nM";"4.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL2179170";"";"None";"303.79";"0";"4.60";"3i";"CC(C)(C)c1cccc(NC(=O)c2cc(Cl)ccc2O)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183807";"Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites expressing yellow fluorescent protein infected in HFF cells after 72 hrs by fluorescence assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2176997";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL168";"OLEANOLIC_ACID";"None";"456.71";"1";"7.23";"106";"CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1";"IC50";"'='";"54800.0";"nM";"4.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4294795";"";"None";"578.07";"2";"5.16";"D3";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OCc3cn(Cc4ccc(Cl)cc4)nn3)c(OC)c2)cc1OC";"IC50";"'='";"251400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4276666";"";"None";"633.69";"1";"3.87";"B8";"COC(=O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'>='";"600000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4280864";"";"None";"629.66";"2";"2.58";"B5";"COC(=O)CC[C@H](NC(=O)CCC(=O)Oc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC)C(=O)OC";"IC50";"'='";"156900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL586178";"";"None";"348.40";"0";"4.67";"MMV006250";"CCOC(=O)c1cnc2c(C)cccc2c1Nc1ccc(C(C)=O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL583555";"";"None";"287.37";"0";"4.44";"MMV666079";"Cc1ccc2cc3c(N)c4c(C)ccc(C)c4nc3nc2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592332";"";"None";"303.79";"0";"4.09";"MMV000443";"CCOc1ccc2c(c1)CN(Cc1ccc(Cl)cc1)CO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585983";"";"None";"307.44";"0";"4.53";"MMV665783";"CCN(CC)CCCNc1ccnc2cc3ccccc3cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584240";"";"None";"347.84";"0";"4.08";"MMV000478";"CCOc1cc2c(cc1OCC)C(c1cc(Cl)ccc1O)NCC2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL578030";"";"None";"357.89";"0";"4.75";"MMV007020";"CCOc1ccc2nc(C)cc(Nc3ccc(N(C)C)cc3)c2c1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL609036";"";"None";"371.87";"0";"2.83";"MMV000986";"CN1CCN(c2nc(Nc3ccc(O)cc3)nc3ccccc23)CC1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL532141";"";"None";"636.71";"2";"10.45";"MMV000753";"Oc1ccc(-c2nc(-c3ccc4oc5ccc(-c6[nH]c(-c7ccc(O)cc7)nc6-c6ccccc6)cc5c4c3)c(-c3ccccc3)[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL2028053";"";"None";"476.91";"1";"6.11";"MMV396680";"Cc1ccc(-c2cc3c(SCC(=O)Nc4cc(C(F)(F)F)ccc4Cl)nccn3n2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL4448283";"";"None";"414.35";"1";"6.23";"3c";"Brc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"112880.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3105168";"";"None";"465.58";"0";"2.56";"2";"CN1CCN(c2ccc(S(=O)(=O)NCc3ccc(C(=O)Nc4cccnc4)cc3)cc2)CC1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343684";"Antiparasitic activity against Toxoplasma gondii RH transfected with fluorescent transgene dTom";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4342427";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL3335642";"";"None";"211.29";"0";"1.38";"13A";"CC1CC/C(=N/N=C2\NC(=O)CS2)C1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334525";"";"None";"299.36";"0";"2.75";"22B";"O=C1CS/C(=N/N=C\c2ccco2)N1Cc1ccccc1";"IC50";"'='";"111000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335727";"";"None";"220.26";"0";"0.63";"28A";"O=C1CS/C(=N/N=C\c2cccnc2)N1";"IC50";"'='";"52000.0";"nM";"4.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335719";"";"None";"267.40";"0";"2.80";"18A";"CC(C)(C)C1CCCC/C1=N/N=C1\NC(=O)CS1";"IC50";"'='";"218000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL4277038";"";"None";"525.60";"1";"3.59";"F2";"COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(OC(=O)CCC(=O)N3CCCC3)c(OC)c2)cc1OC";"IC50";"'='";"115200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4293292";"";"None";"485.58";"0";"3.53";"E1";"CCN(CC)C(=O)COc1ccc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"387900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4268001";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4265935";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL317017";"";"None";"311.41";"0";"2.41";"MMV688345";"Nc1nc(N)c2c3c(sc2n1)CN(Cc1ccccc1)CC3";"IC50";"'='";"7060.0";"nM";"5.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL3637930";"";"None";"391.30";"1";"5.08";"MMV688704";"Cc1cc2nc(NC(=O)C(C)(C)C)nc(Cl)c2n1Cc1ccc(Cl)cc1";"IC50";"'='";"";"";"";"";"no inhibition";"";"";"";"";"";"0";"CHEMBL3832822";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment F";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL3637928";"";"None";"275.32";"0";"2.68";"MMV688469";"Nc1ncnc2[nH]nc(Cc3cccc4ccccc34)c12";"IC50";"'='";"3050.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3832823";"AntiToxoplasma gondii activity data 2-day killing assay: IC50 (uM), Experiment G";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3832761";"34";"MMV Pathogen Box";"";"";"None";"";"";""
"CHEMBL532497";"";"None";"431.23";"1";"5.37";"7a";"O=C(Oc1ccc(Cl)cc1C(=O)Nc1ccc([N+](=O)[O-])cc1Cl)c1ccccc1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183807";"Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites expressing yellow fluorescent protein infected in HFF cells after 72 hrs by fluorescence assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL2176997";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL3307525";"";"";""
"CHEMBL4474163";"";"None";"461.35";"1";"6.08";"3d";"Ic1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"143210.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4520262";"";"None";"349.48";"1";"5.78";"3e";"Cc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"115800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"10873710.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409706";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"Sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"12978050.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL106525";"";"None";"368.48";"0";"4.88";"MMV006172";"CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL585243";"";"None";"287.79";"0";"4.31";"MMV006558";"Cc1cc(C)c2c(c1)OCN(Cc1ccccc1Cl)C2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580249";"";"None";"347.84";"0";"4.63";"MMV665800";"CCOc1cc(Cl)c(C(C)NC(=O)c2ccccc2)cc1OCC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL580140";"";"None";"362.44";"0";"4.50";"MMV665979";"FC(F)(F)c1cccc(CNC2CCN(CCc3ccccc3)CC2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL545880";"";"None";"400.95";"0";"4.57";"MMV666108";"O=C(CCc1ccco1)NC1CCN(CC2(c3ccc(Cl)cc3)CCC2)CC1";"IC50";"'='";"24040.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589920";"";"None";"395.53";"1";"5.20";"MMV001230";"CCOc1cccc2sc(N(Cc3cccnc3)C(=O)C3CCCCC3)nc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL589733";"";"None";"315.68";"0";"4.32";"MMV665807";"O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL537071";"";"None";"388.52";"0";"4.85";"MMV665946";"CC(C)=CCN1CCC(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL528734";"";"None";"290.25";"0";"3.79";"SID24824368";"FC(F)(F)c1ccc(Nc2nnnc3ccccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL584676";"";"None";"274.39";"0";"3.85";"MMV009060";"CCN(CC)c1ccc(NC(=O)c2cccs2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL581194";"";"None";"441.33";"0";"4.79";"MMV665901";"O=C(Nc1ccc(CN2CCOCC2)cc1)c1ccc(-c2ccc(Br)cc2)o1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582079";"";"None";"362.27";"0";"3.63";"MMV305841";"CCN(CC)CCNc1ncnc2c1[nH]c1ccc(Br)cc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL536393";"";"None";"373.41";"0";"4.50";"MMV019124";"COc1cc(OC)cc(C(=O)Nc2ccc(-c3nc4ccccc4[nH]3)cc2)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL582070";"";"None";"274.32";"0";"2.76";"MMV007808";"COc1nc(Nc2ccc(C(C)C)cc2)nc(OC)n1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL527730";"";"None";"367.28";"0";"3.70";"MMV019017";"COCCNCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL590212";"";"None";"308.43";"0";"3.69";"MMV000848";"OC(CNC1CCCC1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL596643";"";"None";"283.71";"0";"4.01";"MMV007977";"O=c1nc(C=Cc2ccc(Cl)cc2)oc2ccccc12";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529919";"";"None";"368.66";"0";"4.80";"MMV020654";"CCC(O)c1ccc(Br)cc1NC(=O)c1cccc(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL528533";"";"None";"298.77";"0";"4.95";"MMV007875";"COc1ccc2nc(C)cc(Nc3ccc(Cl)cc3)c2c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL529984";"";"None";"316.79";"0";"4.00";"MMV008212";"COc1ccc2nc(C)cc(Nc3cccc(O)c3)c2c1.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL533598";"";"None";"487.77";"1";"6.43";"MMV666054";"COc1ccc(C(=O)NC(c2ccc(Cl)cc2Cl)c2cc(Cl)c3cccnc3c2O)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL601325";"";"None";"332.51";"0";"4.23";"MMV665980";"OC1CCCCC1C1(NC(=S)Nc2ccccc2)CCCCC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL546531";"";"None";"462.43";"0";"3.68";"MMV019995";"O=C(NCCCN1CCC(N2CCCCC2)CC1)C1=Cc2cc(Br)ccc2OC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL592550";"";"None";"315.84";"0";"4.99";"MMV000442";"CC(C)(C)c1ccc2c(c1)CN(Cc1ccc(Cl)cc1)CO2";"IC50";"'='";"20400.0";"nM";"4.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL607688";"";"None";"460.56";"0";"4.89";"MMV665936";"Cc1ccc(S(=O)(=O)c2c(COC(=O)c3cccc(C)c3)c(-c3ccccc3)nn2C)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL600174";"";"None";"398.46";"1";"5.24";"MMV000917";"COc1ccc2c(c1OC)C(=O)N1c3ccccc3N=C(c3ccc(C)cc3)CC21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL530438";"";"None";"431.56";"1";"6.92";"MMV666692";"CCCCCCc1cc2cc(-c3csc(C=Cc4ccccc4)n3)c(=O)oc2cc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3301450";"MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate.";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3301448";"17";"MMV Malaria Box";"";"";"None";"";"";""
"CHEMBL3334535";"";"None";"348.43";"0";"3.63";"32B";"O=C1CS/C(=N/N=C\c2c[nH]c3ccccc23)N1Cc1ccccc1";"IC50";"'='";"52000.0";"nM";"4.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334521";"";"None";"357.52";"0";"4.71";"18B";"CC(C)(C)C1CCCC/C1=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"102000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3334518";"";"None";"315.44";"0";"3.68";"15B";"CC1CCCC/C1=N/N=C1/SCC(=O)N1Cc1ccccc1";"IC50";"'='";"43000.0";"nM";"4.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335720";"";"None";"239.34";"0";"2.16";"21A";"C/C(=N/N=C1\NC(=O)CS1)C1CCCCC1";"IC50";"'='";"55000.0";"nM";"4.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335637";"";"None";"213.31";"0";"1.63";"7A";"C/C(CC(C)C)=N/N=C1\NC(=O)CS1";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335632";"";"None";"185.25";"0";"0.99";"2A";"CC/C(C)=N\N=C1/NC(=O)CS1";"IC50";"'='";"133000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL3335631";"";"None";"171.22";"0";"0.60";"1A";"CC(C)=N/N=C1\NC(=O)CS1";"IC50";"'='";"210000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"108";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL347862";"CARBOXYMETHOXYLAMINE";"None";"91.07";"0";"-1.04";"120";"NOCC(=O)O";"IC50";"'='";"23.11";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232794";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 72 hrs by fluorescence based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";""
"CHEMBL3219284";"";"None";"449.53";"0";"3.97";"4";"CCOC(=O)c1cn(C2CC2)c2cc(N3CCN(Cc4ccccc4)CC3)c(F)cc2c1=O";"IC50";"'='";"1240.0";"nM";"5.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3223458";"Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"CHEMBL3638188";"Brain";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3217739";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";"";""
"CHEMBL4450682";"";"None";"393.58";"1";"6.27";"3k";"C(=N/Nc1nc(C23CC4CC(CC(C4)C2)C3)cs1)\c1cc2ccccc2s1";"IC50";"'='";"8740.0";"nM";"5.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5274981";"";"None";"688.75";"2";"9.33";"12b";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C/C(=C/c6cn(-c7ccccc7Br)nn6)C(=O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"301700.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL453514";"SPIRAMYCIN";"4.0";"843.06";"2";"2.33";"Spiramycin";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"'='";"262200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL5287465";"";"None";"300.31";"0";"2.00";"77";"COc1cccc(CC(=O)Nc2ccc(C(=O)NO)cc2)c1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232776";"Antiparasitic activity against Toxoplasma gondii type I infected in human foreskin fibroblast incubated for 24 hrs by Hoechst staining based microscopic analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"Foreskin";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL3335641";"";"None";"211.29";"0";"1.38";"12A";"CC1CCC/C1=N/N=C1\NC(=O)CS1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372741";"Antiparasitic activity against Toxoplasma gondii infected in human foreskin fibroblasts assessed as tachyzoite growth inhibition after 5 days by colorimetric assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL3352341";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"43";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403515";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 7 days by crystal violet assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL486822";"ACETYL OLEANOLIC ACID";"None";"498.75";"1";"7.80";"105";"CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4577948";"";"None";"340.25";"0";"2.43";"124";"O=C1C=C/C(=N\Oc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])c2cccnc21";"IC50";"'='";"1340.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL370595";"";"None";"300.10";"0";"4.40";"61b";"O=[N+]([O-])c1ccc(Oc2ccc(Cl)cc2O)c(Cl)c1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1243084";"";"None";"307.73";"0";"4.70";"13";"CCCc1ccc(Oc2ccc([N+](=O)[O-])cc2Cl)c(O)c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1234746";"";"None";"287.75";"0";"4.66";"61f";"CCCc1ccc(Oc2ccc(C#N)cc2Cl)c(O)c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL200492";"";"None";"385.25";"1";"5.98";"61h";"N#Cc1ccccc1CNc1ccc(Oc2ccc(Cl)cc2O)c(Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5280908";"";"None";"699.93";"2";"8.60";"12d";"COc1cc(-n2cc(/C=C3/C[C@@]4(C)[C@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6[C@@H](C)[C@H](C)CC[C@]6(C(=O)O)CC[C@]45C)C(C)(C)C3=O)nn2)cc(OC)c1OC";"IC50";"'='";"301300.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL5286387";"";"None";"627.91";"2";"8.51";"13a";"C[C@H]1[C@H](C)CC[C@]2(C(=O)OCCn3cnnc3-c3ccccc3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"88000.0";"nM";"4.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"26050.0";"nM";"4.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL224182";"";"None";"329.48";"1";"5.70";"71; HDQ";"CCCCCCCCCCCCc1cc(=O)c2ccccc2n1O";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232768";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2035327";"";"None";"312.37";"0";"2.81";"53";"CCN(CC)c1ccc(C(=O)NC(=O)c2ccccc2O)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL169";"URSOLIC ACID";"2.0";"456.71";"1";"7.09";"101";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403510";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4571126";"";"None";"383.45";"0";"4.21";"73; KGW44";"CC(C)(C)C1=CC(=NNC(=O)c2ccc([N+](=O)[O-])cc2)C=C(C(C)(C)C)C1=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4403520";"Antiparasitic activity against Toxoplasma gondii infected in human HFF cells after 4 hrs";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4402536";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5273204";"";"None";"401.23";"0";"1.95";"6a";"Cc1nc[nH]c1C(=O)NNC(=S)Nc1cccc(I)c1";"IC50";"'='";"25670.0";"nM";"4.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5250114";"Antiparasitic activity against Toxoplasma gondii RH infected in human Hs27 cells assessed as parasitic growth inhibition incubated for 24 hrs followed by [5,6-3H] uracil addition and measured after 72 hrs by liquid scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5247617";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 96.0 hr";"";""
"CHEMBL321993";"ARPRINOCID";"2.0";"277.69";"0";"2.25";"98";"Nc1ncnc2c1ncn2Cc1c(F)cccc1Cl";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2104856";"PONAZURIL";"2.0";"457.39";"0";"1.62";"99";"Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(S(=O)(=O)C(F)(F)F)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL88430";"";"None";"359.82";"0";"3.08";"117";"COc1ccc(OC)c(NCc2ccc3nc(N)nc(N)c3c2Cl)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL4519104";"";"None";"369.90";"1";"6.12";"3b";"Clc1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"157990.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4474163";"";"None";"461.35";"1";"6.08";"3d";"Ic1ccc(-c2csc(N/N=C/c3cc4ccccc4s3)n2)cc1";"IC50";"'='";"211820.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"Trimethoprim";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'='";"39230.0";"nM";"4.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409733";"Antiparasitic activity against Toxoplasma gondii ME49 tachyzoites infected in human Hs27 cells assessed as inhibition of parasitic growth preincubated for 24 hrs followed by [5,6-3H]uracil addition and measured after 72 hrs by liquid scintillation counting analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL4406869";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL5282405";"";"None";"298.30";"0";"1.72";"75a";"O=C(CCCN1C(=O)c2cccc3cccc(c23)C1=O)NO";"IC50";"'='";"50.9";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232773";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in human Hs68 cells assessed as parasitic growth inhibition by crystal violet staining based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Hs68";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5287465";"";"None";"300.31";"0";"2.00";"77";"COc1cccc(CC(=O)Nc2ccc(C(=O)NO)cc2)c1";"IC50";"'='";"2270.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232777";"Antiparasitic activity against Toxoplasma gondii type II infected in human foreskin fibroblast incubated for 24 hrs by Hoechst staining based microscopic analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"Foreskin";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"IC50";"'='";"3620.0";"nM";"5.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL1191361";"HYDROXYAMINE";"None";"33.03";"0";"-0.67";"119";"NO";"IC50";"'='";"4.286";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232794";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 72 hrs by fluorescence based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";""
"CHEMBL3182074";"";"None";"326.44";"1";"5.12";"118";"CC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL1213284";"COMPOUND A";"None";"343.51";"1";"6.01";"71a";"CCCCCCCCCCCCc1c(C)c(=O)c2ccccc2n1O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232769";"Antiparasitic activity against Toxoplasma gondii RH assessed as parasitic growth inhibition";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5279112";"";"None";"672.91";"2";"8.42";"13c";"C[C@H]1[C@H](C)CC[C@]2(C(=O)OCCn3cnnc3-c3ccc([N+](=O)[O-])cc3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"128000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL585431";"";"None";"357.41";"0";"2.07";"115";"CCOc1ccccc1NC(=O)CN1CCN(C(=O)c2ccco2)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232792";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 24 hrs by MTS/PMS assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"70.0";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232794";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells assessed as parasitic growth inhibition incubated for 72 hrs by fluorescence based assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";""
"CHEMBL293522";"";"None";"297.14";"0";"0.02";"NBP1";"O=P(O)(O)C(O)(CCc1cccnc1)P(=O)(O)O";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5150359";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human foreskin fibroblast incubated for 48 hrs followed by [5,6-3H]uracil addition and measured after 4 hrs by scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5149966";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 52.0 hr";"";""
"CHEMBL4303669";"ZOLEDRONIC ACID";"4.0";"290.11";"0";"-1.12";"NBP3";"O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5150359";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human foreskin fibroblast incubated for 48 hrs followed by [5,6-3H]uracil addition and measured after 4 hrs by scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5149966";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 52.0 hr";"";""
"CHEMBL200379";"";"None";"271.10";"0";"4.20";"61a";"Oc1ccc(Oc2ccc(Cl)cc2O)c(Cl)c1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1450";"ATOVAQUONE";"4.0";"366.84";"1";"5.51";"64; ATV";"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232768";"Antiparasitic activity against Toxoplasma gondii";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2171124";"";"None";"451.45";"0";"4.37";"85; GSK2606414";"Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232779";"Antiparasitic activity against Toxoplasma gondii RH tachyzoites infected in HFF cells in presence of CPRG by crystal violet staining based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL222102";"KU-55933";"None";"395.51";"0";"4.76";"86; KU-55933";"O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1";"IC50";"'='";"2150.0";"nM";"5.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232781";"Antiparasitic activity against wild-type Toxoplasma gondii RH tachyzoites infected in HFF cells assessed as parasitic growth inhibition by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL298852";"";"None";"332.27";"0";"2.52";"NBP9";"CCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5150359";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human foreskin fibroblast incubated for 48 hrs followed by [5,6-3H]uracil addition and measured after 4 hrs by scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"Fibroblast";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5149966";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 52.0 hr";"";""
"CHEMBL5285326";"";"None";"277.75";"0";"4.37";"61e";"CCCc1ccc(Oc2ccc(N)cc2Cl)c(O)c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5269355";"";"None";"456.71";"1";"7.09";"10";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"72200.0";"nM";"4.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"Itraconazole";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5275341";"";"None";"372.27";"0";"2.24";"114c";"Cc1nnsc1C(=O)NNC(=S)Nc1ccccc1Br";"IC50";"'='";"74.93";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'>'";"500.0";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5289637";"";"None";"452.99";"0";"4.11";"96; GSKJ4";"CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccc2)n1.Cl";"IC50";"'='";"2370.0";"nM";"5.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232785";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in HFF cells assessed as parasitic growth inhibition incubated for 72 hrs in presence of CPRG by absorbance based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";""
"CHEMBL2104931";"TOLTRAZURIL";"2.0";"425.39";"0";"2.94";"101";"Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(SC(F)(F)F)cc1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5287513";"";"None";"329.36";"0";"1.76";"114d";"Cc1nnsc1C(=O)NNC(=S)Nc1ccc(F)cc1F";"IC50";"'='";"92.28";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"fluconazole";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1364304";"";"None";"275.33";"0";"2.63";"114b";"Cc1occc1C(=O)NN=C(S)Nc1ccccc1";"IC50";"'='";"59.0";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5281379";"";"None";"360.24";"1";"6.10";"61i";"Oc1cc(Cl)ccc1Oc1ccc(CNc2ccccc2)cc1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5270798";"";"None";"644.30";"2";"9.23";"12a";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C/C(=C/c6cn(-c7ccccc7Cl)nn6)C(=O)C(C)(C)[C@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"239600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232748";"Antiparasitic activity against Toxoplasma gondii tachyzoites infected in human HeLa cells measured after 24 hrs by MTT assay";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HeLa";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 24.0 hr";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"sulfadiazine";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"'='";"1024.69";"ug.mL-1";"";"Outside typical range";"";"UO_0000274";"";"";"";"";"0";"CHEMBL5232757";"Antiparasitic activity against Toxoplasma gondii tachyzoites";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5269397";"";"None";"336.18";"0";"4.13";"61j";"Oc1cc(Cl)ccc1Oc1ccc(Cn2ccnn2)cc1Cl";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4742221";"";"None";"392.29";"1";"5.47";"61k";"CCCCc1cn(Cc2ccc(Oc3ccc(Cl)cc3O)c(Cl)c2)nn1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5232763";"Antiparasitic activity against Toxoplasma gondii infected in HFF cells by fluorescence based analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"HFF";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5230160";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5275477";"";"None";"320.33";"0";"1.26";"2a";"Cc1nc[nH]c1C(=O)NNC(=S)Nc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"67490.0";"nM";"4.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5250114";"Antiparasitic activity against Toxoplasma gondii RH infected in human Hs27 cells assessed as parasitic growth inhibition incubated for 24 hrs followed by [5,6-3H] uracil addition and measured after 72 hrs by liquid scintillation counter analysis";"F";"BAO_0000218";"organism-based format";"Toxoplasma gondii";"None";"None";"None";"None";"";"";"";"CHEMBL612888";"Toxoplasma gondii";"Toxoplasma gondii";"ORGANISM";"CHEMBL5247617";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 96.0 hr";"";""
